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A key purpose of building a model from clinical data is to predict the outcomes of future 
individual patients. This work introduces a Bayesian patient-specific predictive framework for 
constructing predictive models from data that are optimized to predict well for a particular 
patient case. The construction of such patient-specific models is influenced by the particular 
history, symptoms, laboratory results, and other features of the patient case at hand. This 
approach is in contrast to the commonly used population-wide models that are constructed to 
perform well on average on all future cases. 
The new patient-specific method described in this research uses Bayesian network 
models, carries out Bayesian model averaging over a set of models to predict the outcome of 
interest for the patient case at hand, and employs a patient-specific heuristic to locate a set of 
suitable models to average over. Two versions of the method are developed that differ in the 
representation used for the conditional probability distributions in the Bayesian networks. One 
version uses a representation that captures only the so called global structure among the 
variables of a Bayesian network and the second representation captures additional local structure 
among the variables.  
The patient-specific methods were experimentally evaluated on one synthetic dataset, 21 
UCI datasets and three medical datasets. Their performance was measured using five different 
performance measures and compared to that of several commonly used methods for constructing 
predictive models including naïve Bayes, C4.5 decision tree, logistic regression, neural networks, 
 iv 
  
k-Nearest Neighbor and Lazy Bayesian Rules. Over all the datasets, both patient-specific 
methods performed better on average on all performance measures and against all the 
comparison algorithms. The global structure method that performs Bayesian model averaging in 
conjunction with the patient-specific search heuristic had better performance than either model 
selection with the patient-specific heuristic or non-patient-specific Bayesian model averaging. 
However, the additional learning of local structure by the local structure method did not lead to 
significant improvements over the use of global structure alone. The specific implementation 
limitations of the local structure method may have limited its performance.  
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1.0  INTRODUCTION 
Making predictions, typically under uncertainty, is a common theme in clinical care activities. 
Critical activities in clinical care include risk assessment, diagnosis, and prognosis, all of which 
entail making predictions in individuals. Risk assessment implies predicting the future 
occurrence of disease from current exposure to risk factors; diagnosis entails predicting the 
possibility of disease from current symptoms, signs and tests; and, prognosis involves predicting 
the future course and outcome of disease both with and without therapy [1, 2]. The better these 
predictions can be performed, the better the decisions and the ensuing outcomes are likely to be 
both for the individual and for society at large. Therefore, finding ways to make better 
predictions is an important problem. 
Typically, the clinician makes these predictions implicitly from knowledge obtained from 
medical training as well as experience acquired from past patient care. This is occasionally 
facilitated by paper-based guidelines and flowcharts derived from simple predictive models. 
Such use of explicit models can help in making better predictions, enhance clinical decision 
making, improve patient outcomes, and reduce healthcare costs. In recent years, medical 
artificial intelligence and machine learning techniques are being increasingly used to learn 
sophisticated predictive models in the biomedical domain. However, much work remains to be 
done in improving the performance of such models and incorporating their use in routine clinical 
care. 
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One clear trend in healthcare is the accumulation of more and more data per patient that 
is then available for clinical decision-making. Today’s clinician not only has to assimilate large 
amounts of data but also has to integrate diverse types of patient data: demographic, 
environmental, clinical, genetic, imaging, and outcomes in the course of patient care. Predictive 
models can aid the clinician’s decision-making in the face of this data deluge. Another trend in 
healthcare is the increasing use of computers in clinical care and the availability of patient data in 
electronic form which allows for automatic processing of such data. Thus, it is becoming feasible 
to use sophisticated models that require computationally intensive modeling methods that have 
better predictive performance over simple paper-based flowchart models. For example, it seems 
plausible that the future will see more computationally intensive methods that construct distinct 
models for each individual from patient data in clinical computer systems. The development of 
such methods that learn models tailored to an individual’s characteristics is the focus of the 
research described in this dissertation.  
Even modest improvements in predictive performance can have significant impact on 
healthcare in terms of improved patient care, better outcomes and reduced costs. For example, in 
[3] the authors estimate that if improved prediction of dire outcomes in pneumonia can reduce 
hospital admissions of pneumonia patients by just one percent this can result in 89 million 
dollars of savings per year in the United States without any expected decrease in clinical 
outcomes. Thus, finding ways to improve predictive performance of current modeling techniques 
is an important problem. 
Two fields that have focused on the learning and application of predictive models are 
statistics and machine learning. Both fields use similar terminology. A variable (also known as 
attribute) is a quantity that describes an aspect of an object of the world. A feature is the 
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specification of a variable and its value. For example, eye color is a variable and “eye color = 
black” is a feature. Though often the term feature is used as a synonym for variable, in this 
document the term feature is used exclusively to refer to a variable-value pair. A case (also 
known as example, instance or record) is a single object of the world and is described by a list of 
features. A dataset (also known as database) is a collection of cases.  
Predictive models can be constructed either manually or by methods that automatically 
extract relevant information from datasets. Classical statistical methods typically involve 
substantial expert input for deriving the model. In semi-automatic methods, the model structure 
(e.g., which variables are considered dependent) is derived from experts and the parameters of 
the structure (e.g., coefficients in logistic regression) are extracted from datasets. Completely 
automated methods learn both the structure and the parameters automatically from the dataset 
and are the focus in machine learning. The research described in this dissertation investigates 
automatic machine learning methods that learn models (tailored to an individual’s 
characteristics) from data. 
Among the machine learning methods, classification algorithms are often used for 
learning predictive models from clinical data. Examples of such algorithms include logistic 
regression, neural networks, classification trees (also know as decision trees), Bayesian networks 
and support vector machines. Typically, these methods induce a single model from a training set 
of cases, with the intent of applying it to all future patient cases. I call such a model a 
population-wide model because it is intended to be applied to an entire population of future 
cases. A population-wide model is optimized to predict well on average when applied to 
expected future cases. 
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Recent research in machine learning has shown that inducing models that are specific to 
the particular features of a given instance can improve predictive performance [4]. I call such a 
model an instance-specific model since it is constructed specifically for a particular instance 
(case). The structure and parameters of an instance-specific model are specialized to the 
particular features of an instance, so that it is optimized to predict especially well for that 
instance. In the context of clinical prediction models, I call such a model a patient-specific 
model, because the learning of the model is influenced by the particular history, symptoms, 
laboratory results, and other features of the patient case being predicted. That is, the structure and 
parameters of the model are influenced by the patient case being predicted. In this dissertation 
the term patient-specific is used, though much of the description of patient-specific models 
population-wide 
modeltraining set 
patient case prediction 
apply population-wide method
do inference 
patient-specific 
modeltraining set 
patient case prediction 
apply patient-specific method
 do inference 
Figure 1-1: A general characterization of the induction and inference of population-wide (top 
panel) and patient-specific (bottom panel) models. In the bottom panel, there is an extra arc from 
patient case to model, because the structure and parameters of the model are influenced by the 
features of the patient case at hand. 
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applies to the more general instance-specific models. The goal of inducing a patient-specific 
model is to have optimal prediction for the patient case at hand. This is in contrast to the 
construction of a population-wide model where the goal is to have optimal predictive 
performance on average on all future patient cases. 
Predictive modeling consists of two steps: induction of a model or models from a training 
set of cases and inference of the variable of interest in a patient case at hand to derive a 
prediction. Inference always involves the use of the features of the patient case at hand in 
conjunction with a model. In the biomedical literature, the adjective patient-specific in the 
context of predictive modeling is sometimes used more loosely to refer to model inference. 
However, the use of patient features for inference does not necessarily make the model or the 
method used for induction patient-specific. I designate only those methods as patient-specific 
that use the features of the patient case at hand in conjunction with a training set of cases in order 
to induce a model. This situation is illustrated in Figure 1-1 which shows that the patient case 
being predicted is used for inference in both population-wide and patient-specific methods; 
however, for induction, only the patient-specific method uses the patient case. 
This work presents a decision-theoretic framework for induction of patient-specific 
models, and investigates methods for learning Bayesian network models for prediction in a 
patient-specific manner. 
1.1 OVERVIEW OF PROPOSED PATIENT-SPECIFIC METHOD 
There are several possible approaches for learning predictive models that are relevant to a single 
patient case. One approach is to learn a model from a subset of cases in the dataset that consist of 
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patients that are similar in some way to the patient case at hand. Another approach is to learn a 
model from a subset of variables that are pertinent in some fashion to the patient case at hand. A 
third approach, applicable to model averaging where a set of models is collectively used for 
prediction, is to locate a set of models that are relevant to prediction for the patient case at hand.  
In this work, I investigate a new method for learning predictive models that uses (1) 
Bayesian network models, (2) carries out Bayesian model averaging over a set of models to 
predict the outcome of interest for the patient case at hand, and (3) employs a patient-specific 
heuristic to locate a set of suitable models to average over. The remainder of this section gives a 
brief description of each of these characteristics. 
Bayesian networks (BNs) are probabilistic graphical models that provide a powerful 
formalism for representation, reasoning and learning under uncertainty [5-7]. These graphical 
models are sometimes referred to as probabilistic networks, belief networks or Bayesian belief 
networks. The last two decades have witnessed significant advances in the theoretical 
development of BNs as well as in their application to a growing number of domains. A BN 
combines a graphical representation with numerical information to represent a probability 
distribution over a set of random variables in a domain. The graphical representation constitutes 
the BN structure, and it explicitly highlights the probabilistic independencies among the domain 
variables. The complementary numerical information constitutes the BN parameterization, 
which quantifies the probabilistic relationships among the variables.  
At the outset, BNs were constructed manually from knowledge acquired from domain 
experts, which proved to be both time-consuming and difficult. Subsequent advances in BN 
learning have culminated in numerous machine learning algorithms that learn both model 
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structure and model parameters automatically from data. Such algorithms underlie most current 
methods that use BNs for predictive modeling.  
Typically, methods that learn predictive models from data, including those that learn BN 
models, perform model selection. In model selection a single good model is selected that 
summarizes the data well; it is then used to make future predictions. However, given finite data, 
there is uncertainty in choosing one model to the exclusion of all others, and this can be 
especially problematic when the selected model is one of several distinct models that all 
summarize the data more or less equally well. A coherent approach to dealing with the 
uncertainty in model selection is Bayesian model averaging (BMA). BMA is the standard 
Bayesian approach wherein the prediction is obtained from a weighted average of the predictions 
of a set of models, with better models influencing the prediction more than others. In practical 
situations, the number of models to be considered is enormous and averaging the predictions 
over all of them is infeasible. A pragmatic approach is to average over a few good models, 
termed selective Bayesian model averaging, which serves to approximate the prediction obtained 
from averaging over all models. The patient-specific method performs selective Bayesian model 
averaging over a set of models that have been selected in a patient-specific fashion. 
The patient-specific method learns both the structure and parameters of BNs 
automatically from data. The patient-specific characteristic of the method is motivated by the 
intuition that in constructing predictive models, all the available information should be utilized 
including available knowledge of the features of the current patient case. Specifically, the 
patient-specific method uses the features of the patient case to inform the BN learning algorithm 
to select models that differ considerably in their predictions for the outcome of interest in the 
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patient case at hand. The differing predictions of the selected models are then combined to 
predict the outcome of interest. 
1.2 AIMS OF THE DISSERTATION 
The main aim of this dissertation is to introduce a new patient-specific method and evaluate 
whether it yields better predictive performance than commonly applied population-wide 
methods. The performance of the patient-specific method outlined in the previous section is 
compared to six other machine learning algorithms. Four of these comparison methods are 
standard machine learning algorithms that induce population-wide models. These are naïve 
Bayes, C4.5 decision tree, logistic regression and neural networks. Two other comparison 
methods, k-Nearest Neighbor and Lazy Bayesian Rules, are instance-based methods. In addition, 
the patient-specific method is compared to a model selection version of the method whereby a 
single model is selected for prediction. The methods are compared and evaluated on five 
performance measures: misclassification rate, area under the Receiver Operating Characteristic 
(ROC) curve, squared error, logarithmic loss, and a calibration score. The datasets on which the 
experiments are conducted include 21 publicly available datasets obtained from the UCI 
Machine Learning repository and three real world medical datasets. 
The null (H0) and alternate hypotheses (H1) for the primary aim are as follows: 
H0: Patient-specific Bayesian network models do not predict better than population-wide 
models. 
H1: For at least some performance measures patient-specific Bayesian network models 
predict better than population-wide models. 
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1.3 OVERVIEW OF DISSERTATION 
Chapter 2 provides relevant background to set the context for patient-specific modeling and 
surveys some of the related work in machine learning and in medical predictive modeling. 
Chapter 3 introduces the Bayesian network formalism, describes several representations for 
modeling BNs, and reviews methods for learning BNs for data. In particular, it focuses on the 
Bayesian approach to BN learning, learning BNs for classification, and Bayesian model 
averaging over BNs.   
Chapter 4 describes in detail the proposed patient-specific learning method, the patient-
specific search for BNs and the patient-specific score for evaluating BNs. Chapter 5 presents the 
results of the experimental evaluation of the patient-specific method and compares its 
performance to that of the algorithms listed in the previous section. Chapter 6 summarizes the 
contributions of this dissertation and presents some potential extensions of this work for future 
research. 
 9 
  
 
2.0  BACKGROUND 
This chapter provides the background and context for patient-specific modeling and reviews 
related work in machine learning and in medical predictive modeling. Section 2.1 highlights the 
importance of improving predictive modeling in healthcare. Section 2.2 provides illustrative 
examples where patient-specific modeling can improve upon population-wide models and 
Section 2.3 provides a decision theoretic comparison of the two paradigms. The patient-specific 
method described in the dissertation is characterized by the use of model averaging for 
prediction, induction of models in a lazy fashion, and the use of atemporal data. The following 
sections provide background on these characteristics of the patient-specific method. Section 2.4 
compares model selection with model averaging and Section 2.5 compares lazy and eager 
methods for learning models. Section 2.6 presents time-varying patient-specific modeling as an 
extension of the patient-specific method. The final two sections summarize some of the relevant 
literature in machine learning and medicine respectively that is related to predictive modeling. 
2.1 PREDICTION IN CLINICAL MEDICINE 
A common characteristic of clinical care activities like risk assessment, diagnosis, and prognosis 
in individuals is making predictions [1]. Risk assessment is an important component of 
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preventive healthcare where healthcare providers judge the chances of an individual developing 
future medical problems based on the individual’s past and current history of exposure to risk 
factors. For example, individuals who are judged to be at high risk for developing hypertension 
may undergo further medical evaluation and testing and may be advised to make changes to their 
lifestyle and diet. Accurate risk assessment is necessary to identify individuals at risk for 
developing hypertension correctly, since lifestyle and dietary changes are very difficult to initiate 
and maintain for most individuals.  
Accurate and timely diagnosis in individuals with current symptoms is important in 
making decisions such as the need for additional testing, for choosing appropriate therapy, and 
the need for hospitalization. Inappropriate decisions arising from erroneous diagnoses can lead to 
unnecessary distress and incorrect therapy for the individual as well as needless expenditure of 
healthcare resources.  
Prognosis entails the prediction of the course and outcome of disease and is an important 
component of management of an individual with a disease [2]. Given accurate diagnoses, 
choosing the appropriate therapy entails predicting accurately the course and outcome of the 
disease in the individual under various available therapies. For example, for the same disease, the 
optimal medication for one individual may be different from that for another individual due to 
differences in genetic and environmental characteristics. Thus, improvement in predictive 
performance is an important healthcare problem since it has the potential to improve clinical 
decision-making, which in turn can lead to better outcomes in patients. In addition, efficient use 
of healthcare resources depends on being able to determine accurately when and where a 
resource is likely to be useful, which in turn depends on accurately anticipating patients’ 
healthcare-resource requirements. 
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A second common feature of clinical care activities that involve prediction is uncertainty. 
Uncertainty in medicine arises from various causes: uncertainty from incomplete medical 
knowledge, uncertainty from incomplete patient data, and uncertainty from noisy patient data 
[1]. Thus, risk assessment, diagnosis, and prognosis in individuals are associated with various 
degrees of uncertainty. Judging and handling uncertainty appropriately is imperative for 
improving predictions.  
One important way to assist healthcare providers in making better predictions under 
uncertainty is to supplement their clinical judgments with predictions from mathematical models. 
Such models embedded in clinical computer systems have the potential to complement the 
clinician’s assessment at the point-of-care. Clinical computer systems that help in clinical 
decision-making, called clinical decision support systems (CDSSs), have been in developed 
since the early 1960s. CDSSs have the potential to improve healthcare by improving patient 
safety, by improving quality of care, and by improving efficiency in health care delivery [8]. 
Though researchers have developed numerous CDSSs, few are in routine clinical use. A variety 
of factors have been implicated in this failure, such as, lack of deep causal knowledge in the 
medical domain, poor user interfaces, failure to fit into the clinical workflow, and inadequate 
predictive performance of the models incorporated into such systems [9].  
Numerous decision-support models have been developed and employed in CDSSs. The 
earliest CDSSs used simple branching logic (equivalent to a flowchart). For example, Bliech and 
his colleagues developed a computerized flowchart using branching logic to diagnose acid-base 
disorders [10]. This was followed by the development of rule-based models that were 
incorporated into expert system CDSSs. A rule-based model represents the domain knowledge as 
a set of rules that is applied to patient data by a logical reasoning engine. A well known example 
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of such a system is MYCIN that was introduced by Shortliffe to diagnose organisms causing 
infections in patients [11]. Simple logical and rule-based models, however, could not handle well 
the ubiquitous uncertainty in clinical decision making.  
One of the earliest theoretical developments of a CDSS model, outlined in a classic paper 
published in 1959 by Ledley and Lusted [12], stated that logic should be combined with 
probabilistic reasoning for automated reasoning and prediction in the medical domain. With the 
development of Bayesian network models (also known as probabilistic networks, belief networks 
or Bayesian belief networks) in the late 1980s, full-fledged probabilistic reasoning using such 
models was implemented in the medical domain. Examples of medical models based on 
Bayesian networks include the Pathfinder [13, 14], a pathology diagnostic system for diagnosing 
lymph-node diseases, and the probabilistic version of INTERNIST-1/QMR [15, 16], an internal 
medicine diagnostic system for diagnosing medical disorders. A PubMed search showed that 378 
articles have been published in the biomedical literature in the last 10 years (from July 1997 to 
June 2007) with one of the following phrases in the title or abstract: “Bayesian network”, 
“Bayesian networks”, “probabilistic network”, “probabilistic networks”, “belief network”, 
“belief networks”, “Bayesian belief network” or “Bayesian belief networks”. Thus, Bayesian 
networks remain popular and their application to biomedical and clinical problems is an active 
area of research. 
In this dissertation, the focus is on probabilistic models that make predictions in the 
clinical domain, and, in particular, on models that are learned from a training dataset of patient 
cases. Datasets in the clinical domain can be broadly categorized into two major types. 
Observational data are often used for assessing diagnostic conditions; experimental data (e.g., 
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from randomized controlled trials) are often used for evaluating therapeutic interventions. The 
data collected in both these scenarios can be used for inducing predictive models.  
Numerous statistical and machine learning methods have been developed for learning 
probabilistic models from a dataset of cases and several of them have been applied for learning 
predictive models from clinical and biomedical data [17].  A survey of the machine learning 
literature and the medical literature is provided in sections 2.8 and 2.9 respectively. Almost 
always, these are population-wide methods that learn a single population-wide model from a set 
of known patient cases, with the intent of applying it to all future patient cases. By design 
population-wide models are expected to perform well on average on all future patient cases, but 
can potentially perform poorly on a particular patient case. Little literature is available on 
methods that take into account the current patient case while learning a model. Such a patient-
specific method constructs a patient-specific model for each future patient that is optimized to 
predict especially well for the particular patient case at hand. The following section illustrates 
how patient-specific models can have better performance than population-wide models. 
2.2 PATIENT-SPECIFIC METHODS CAN HAVE BETTER PERFORMANCE 
Figure 1-1 illustrates the key difference between population-wide and patient-specific models: 
the patient-specific model is constructed from data in the training set, as well as, from available 
data about the particular patient case to which it will be applied. In contrast, the population-wide 
model is constructed only from data in the training set. Thus, intuitively, the extra information 
available to the patient-specific method can facilitate inducing a model that provides better 
prediction for the patient-specific case. In patient-specific modeling, different patient cases will 
 14 
  
potentially result in different models, because the cases contain potentially different values for 
the features. The patient-specific models may differ in the variables included in the model 
(variable selection or also known as feature selection), in the interaction among the included 
variables (encoded in the structure of the model), and in the strength of the interaction (encoded 
in the parameters of the model). Another approach is to select a subset of the training data that 
are similar in their feature values to those of the patient case at hand and learn the model from 
the subset. A generalization of this is to weight the cases in the training dataset such that cases 
that are more similar to the patient case are assigned greater weights than others, and then learn 
the model from the weighted dataset. The following are two illustrative examples where patient-
specific methods may perform better than population-wide methods.  
Variable selection. Many model induction methods implicitly or explicitly perform 
variable selection, a process by which a subset of the domain variables is selected for model 
construction. For example, logistic regression is often used with a stepwise variable selection 
process. A patient-specific version of logistic regression may select different variables for 
different patients being predicted, compared to the standard population-wide version that selects 
a single subset of variables. In the context of a healthcare scenario in the not-too-distant future, 
consider a gene G that has several alleles. Suppose that allele a1 is rare, and it is the only allele 
that predicts the development of disease D; indeed, it predicts D with high probability. For future 
patients, the aim is to predict P(D | G). In a population-wide logistic regression model, G may 
not be included as a predictor (variable) of D, because in the vast majority of cases in the dataset 
G ≠ a1 and D is absent, and having G as a predictor would just increase the overall noise in 
predicting D. In contrast, if there is a patient case at hand in which G = a1, then the training data 
may contain enough cases to indicate that D is highly likely. In this situation, G would be added 
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as a predictor in a patient-specific model. Thus, for a patient in whom G = a1, the typical 
population-wide logistic regression model would predict poorly.   
This idea can be extended to examples with more than one predictor, in which some 
predictors are characterized by having particular values that are relatively rare but strongly 
predictive for the outcome. A population-wide model tends to include only those predictors that 
on average provide the best predictive performance. In contrast, a patient-specific model will 
potentially include predictors that are highly predictive for the particular patient case at hand; 
such predictors could be different from those included in the population-wide model.  
Value-specific interactions. Variable selection is one important way in which models 
can be tailored to individual patient cases, as just described. Feature interaction (dependence) is 
another major way. Continuing with a genetic example, consider two genes E and F. When E = 
e1 and F = f1, disease K usually occurs; otherwise, K rarely occurs. Thus, when E = e1 and F = 
f1, there is an interaction between E and F in predicting K, and otherwise, there is not an 
interaction. Such value-specific interactions form another basis for constructing patient-specific 
models that take those interactions into account. Thus, patient-specific methods can construct 
better models by employing better variable selection and by capturing value-specific interactions 
among features. 
2.3 DECISION THEORETIC COMPARISON OF POPULATION-WIDE AND 
PATIENT-SPECIFIC MODELS 
This section first introduces some notation and definitions and then compares population-wide 
with patient-specific models in decision theoretic terms. Capital letters like X, Z, denote random 
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variables and corresponding lower case letters, x, z, denote specific values assigned to them. A 
feature is a specification of a variable and its value. Thus, X = x is a feature that specifies that 
variable X is assigned the value x. Bold upper case letters, such as X, Z, represent sets of 
variables or random vectors and their realization is denoted by the corresponding bold lower case 
letters, x, z. A feature vector is a list of features. Thus, X = x is a feature vector that specifies that 
the variables in X have the values given by x. In addition, Z denotes the target variable (class 
variable) being predicted, X denotes the set of predictor variables, M denotes a model (and 
includes both structure and parameters), D denotes the training dataset, Ci ≡ <Xi, Zi> denotes a 
generic training case in D and Ct ≡ <Xt, Zt> denotes a generic test case that is not in D. A test 
case t is one in which the unknown value of the target variable Zt is to be predicted from the 
known values of the predictors Xt and the known values of <Xi, Zi> of a set of training cases. 
A probabilistic model is a family of probability distributions indexed by a set of 
parameters. Model selection refers to the problem of using data to select one model from a set of 
models under consideration [18]. Model averaging refers to the process of estimating some 
quantity (e.g., prediction of an outcome for a patient) under each of the models under 
consideration and then obtaining a weighted average of their estimates [18]. 
Both model selection and model averaging can be done using either non-Bayesian or 
Bayesian approaches. Non-Bayesian methods of model selection include choosing among 
competing models by maximizing the likelihood, by maximizing a penalized version of the 
likelihood or by maximizing some measure of interest (e.g., accuracy) using cross-validation. 
Examples of non-Bayesian methods of model averaging include bagging and boosting. In both 
bagging and boosting, the data are resampled several times, a model is constructed from each 
sample, and the predictions of the individual models are averaged to obtain the final prediction. 
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In the non-Bayesian approach, the heuristics used in model selection and model averaging are 
typically different. In contrast, the Bayesian approach to model selection and model averaging 
both involve computing the posterior probability of each model under consideration.  
In Bayesian model selection the single model found that has the highest posterior 
probability is chosen. In Bayesian model averaging the prediction is the weighted average of the 
individual predictions of the models with the model posterior probabilities comprising the 
weights.  
When the goal is prediction of future data or future values of the target variable, Bayesian 
model averaging is preferred, since it suitably incorporates the uncertainty about the true model. 
However, sometimes interest is focused on a single model. For example, a single model may be 
useful for providing insight into the relationships among the domain variables or can be used as a 
computationally less expensive method for prediction. In such cases, Bayesian model selection 
maybe preferred to Bayesian model averaging. However, the proper Bayesian approach is to 
perform model averaging, and model selection, is at best, an approximation to model averaging.  
Population-wide model selection and patient-specific model selection are characterized in 
decision theoretic terms as follows. Given training data D and a generic test case <Xt, Zt>, the 
optimal population-wide model is: 
[ ]
⎭⎬
⎫
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⎧∑
tX
ttt XXX )|(),|(),,|(maxarg DPMZPDZPU tt
M
,  (2.1) 
where the utility function U gives the utility of approximating the Bayes optimal estimate P(Zt | 
Xt, D) with the estimate P(Zt | Xt, M) obtained from model M. For a model M, Expression 2.1 
considers all possible instantiations of Xt and for each instantiation computes the utility of 
estimating P(Zt | Xt, D) with the specific model estimate P(Zt | Xt, M), and weights that utility by 
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the posterior probability of that instantiation. The maximization is over the models M in a given 
model space. 
The Bayes optimal estimate P(Zt | Xt, D) in Expression 2.1 is obtained by combining the 
estimates of all models (in a given model space) weighted by their posterior probabilities: 
dMDMPMZPDZP
M
tttt )|(),|(),|( ∫= XX .   (2.2) 
 
The term P(Xt | D) in Expression 2.1 is given by: 
dMDMPMPDP
M
tt )|()|()|( ∫= XX .    (2.3) 
 
The optimal patient-specific model for estimating Zt is the one that maximizes the following: 
[ ]{ }),|(),,|(maxarg MZPDZPU tt
M
tt xx ,    (2.4) 
 
where xt are the values of the predictors of the test case Xt for which the target variable Zt is to be 
predicted. The Bayes optimal estimate P(Zt | xt, D) is derived using Equation 2.2, for the special 
case in which Xt = xt, as follows: 
dMDMPMZPDZP
M
tttt )|(),|(),|( ∫= xx .   (2.5) 
 
The difference between the population-wide and the patient-specific model selection can be 
noted by comparing Expressions 2.1 and 2.4. Expression 2.1 for the population-wide model 
selects the model that on average will have the greatest utility. Expression 2.4 for the patient-
specific model, however, selects the model that will have the greatest utility for the specific case 
Xt = xt. For predicting Zt given case Xt = xt, application of the model selected using 
Expression 2.1 can never have an expected utility greater than the application of the model 
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selected using Expression 2.4. This observation provides support for developing patient-specific 
models. 
2.4 MODEL SELECTION VERSUS MODEL AVERAGING 
Equations 2.2 and 2.3 carry out Bayesian model averaging over all models in some specified 
model space. Expressions 2.1 and 2.4 include Equation 2.2; thus, these expressions for 
population-wide and patient-specific model selection, respectively, are theoretical ideals. 
Moreover, Equation 2.2 is the Bayes optimal prediction of Zt. Thus, in order to do optimal model 
selection, the optimal prediction obtained from Bayesian model averaging must already be 
known. 
Model selection, even if performed ideally, ignores the uncertainty inherent in choosing a 
single model based on limited data. Bayesian model averaging is a normative approach for 
dealing with the uncertainty in model selection, and has been shown to improve predictive 
performance as well as provide more accurate estimates of the error in prediction. Several 
examples of significant decrease in prediction errors with the use of Bayesian model averaging 
are described in [19]. Such averaging is primarily useful when no single model in the model 
space under consideration has a high posterior probability. However, since the number of models 
in practically useful model spaces is enormous, complete Bayesian model averaging, where the 
averaging is done over the entire model space, is usually not feasible. That is, it is usually not 
computationally feasible to solve for the exact solution given by Equation 2.2. In such cases, 
selective Bayesian model averaging is typically performed, where the averaging is done over a 
selected subset of models.  
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Methods for inducing predictive models can be classified along two axes as shown in 
Table 2-1. Along the horizontal axis are population-wide and patient-specific methods that differ 
chiefly in whether the features of the test case are utilized or not in developing the model. Along 
the vertical axis are model selection and model averaging.  
The table focuses on a subset of supervised learning methods, namely, model-based 
learning methods. Model-based methods and instance-based methods (variants of which are 
known as instance-based learning, memory-based learning, exemplar-based learning or case-
based reasoning) belong to two extremes of supervised learning methods [20]. Model-based 
methods learn an explicit model or models from the training cases that are then applied to the test 
case. In contrast, instance-based methods estimate the target variable in the test case by 
combining the values of the target variable in a subset of the training cases that are similar in 
some sense to the test case. Thus, instance-based methods are characterized by the use of a 
similarity (or distance) measure necessary for measuring the similarity between cases. The 
canonical example of an instance-based method is the k-Nearest Neighbor technique where the 
prediction of the target variable in the test case is based on the majority vote of the values of the 
target variable in the k-nearest cases (for classification) or the average over a set of k-nearest 
Table 2-1: Categories of methods for predictive modeling. 
 population-wide method patient-specific method (instance-specific method) 
model selection 
(mainly non-Bayesian) 
1. Commonly used for 
predictive modeling; e.g., 
logistic regression, neural 
networks 
3. Less commonly used for 
predictive modeling; e.g., Lazy 
Bayesian Rules [20] 
model averaging 
(mainly Bayesian) 
2. Less commonly used for 
predictive modeling; e.g., 
averaging over rule-sets [8], 
averaging over discrete 
Bayesian networks [10] 
4. None described in the 
literature for predictive 
modeling; e.g., the patient-
specific method described in 
this dissertation 
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training cases (for regression). It should be pointed out that instance-specific methods including 
patient-specific methods discussed in this dissertation are not instance-based methods but are 
rather model-based methods. In particular, the patient-specific methods explored here induce a 
model or set of models that are influenced by the values of the features of the test case; a 
similarity measure is not used. To keep the distinction between instance-specific methods and 
instance-based methods clear, I will refer to instance-based methods as similarity-based methods.  
The typical predictive algorithms, both in machine learning and in the medical literature, 
perform non-Bayesian model selection to induce a population-wide model (cell 1 in Table 2-1). 
Examples of such methods are logistic regression, neural networks, CART-like decision trees, 
Bayesian networks1 and support vector machines [17]. Less commonly, model averaging over 
population-wide models (cell 2 in Table 2-1) has been used for prediction; such techniques can 
improve predictive performance over population-wide model selection. One such example is the 
algorithm for classification that is described in [21]. This algorithm uses stochastic search to find 
multiple models of rule-sets over which to perform selective Bayesian model averaging. 
Instance-specific methods that perform model selection (cell 3 in Table 2-1) are also not that 
common. One example of such a method is Lazy Bayesian Rules that is described in detail in 
Section 2.8. It is a model-based, instance-specific method and not a similarity based method, and 
it has been shown to improve predictive performance over several population-wide model 
selection methods. 
In this dissertation, I describe a method that belongs to the fourth category (cell 4 in 
Table 2-1): a patient-specific method that performs selective Bayesian model averaging. The key 
component of such a method is the heuristic used for searching and selecting models in the 
                                                 
1 The Bayesian networks referred to here typically perform inference using non-Bayesian methods, and are hence 
properly classified under non-Bayesian methods. 
 22 
  
model space over which model averaging is done. The patient-specific method employs a 
heuristic that searches the model space in a patient-specific manner. That is, the values of the 
features in the test case are used to direct the search. The algorithm is described in detail in 
Chapter 4. 
2.5 LAZY LEARNING VERSUS EAGER LEARNING 
Machine learning methods that defer model construction until a response to a test case is 
required are said to employ lazy learning. This is in contrast to methods that induce a model 
from the training data before ever encountering a test case, which are said to employ eager 
learning [22]. In terms of computation, lazy methods often have higher memory and time costs 
since they, typically, store the entire training data and construct a new model for every test case. 
In contrast, eager methods, usually, discard the original training cases and retain only the model 
that is then applied to all future cases. Table 2-2 illustrates the application of lazy versus eager 
Table 2-2: Eager and lazy learning. 
 population-wide method patient-specific method (instance-specific method) 
eager learning 
1. Very common; e.g., logistic 
regression, neural networks, 
decision tree, etc., typically use 
eager learning. 
3. In theory, it is possible to learn 
all possible patient-specific models 
in an eager fashion and then retrieve 
the appropriate model for a test 
case. However, this is feasible only 
if a small number of possible test 
cases exist. 
lazy learning 
2. While it is possible to construct 
models mentioned in cell 1. in a 
lazy fashion, it is uncommon to do 
so since the increase in memory and 
time requirements may not be offset 
by better performance. 
4. Lazy learning is the usual 
approach used to learn patient-
specific models. 
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learning to population-wide and patient-specific methods. Population-wide methods are usually 
eager, but they need not be, and patient-specific methods are usually lazy, but in theory they 
need not be (see cell 3 in Table 2-2). Since population-wide methods learn a single model that is 
applied to all future cases, it is usually more efficient in computation time to eagerly learn the 
model once from the training data. In addition, with eager learning, only the model needs to be 
retained after learning and typically the model requires lesser memory than the entire training 
data. Patient-specific methods are usually lazy since they require the test case for guiding model 
induction. The increased computation time and memory requirements of the lazy method can be 
offset by better predictive performance, as for example in the case of Lazy Bayesian Rules that is 
discussed in greater detail in Section 2.8.  
2.6 TIME-VARYING PATIENT-SPECIFIC MODELS 
In the clinical literature, patient-specific models sometimes refer to models that are induced from 
a time series of data obtained from a patient. Many of the variables included in such models have 
values that have been measured over multiple time points. Such time-varying patient-specific 
models are distinct from atemporal patient-specific models that are induced from atemporal data 
and/or a single (e.g., initial) time slice of data. In this work, I investigate atemporal patient-
specific models, and for brevity I will refer to them as patient-specific models. This approach to 
patient-specific modeling is complementary to the methods that assume a time series, since the 
atemporal approach can construct an initial model from atemporal data (e.g., demographics of 
the patient) and/or data for an initial time slice (e.g., vital signs like blood pressure and 
temperature at the time of admission to the hospital). The initial model can then be revised based 
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on the time series data obtained from a specific patient (e.g., blood pressure and temperature 
measurements over time). 
2.7 RELATED WORK 
The following sections review some of the literature related to the machine learning methods 
introduced in the previous section. While not comprehensive in its coverage, this review 
provides a representative sample of related previous work in machine learning and in clinical 
predictive modeling that is most closely related to patient-specific modeling. 
2.8 RELATED WORK IN MACHINE LEARNING 
There exists a vast literature in machine learning, data mining and pattern recognition that is 
concerned with the problem of predictive modeling and supervised learning. This section focuses 
on some of the aspects of the similarity-based methods followed by a review of some recent 
work on instance-specific methods. 
Similarity-based methods. These methods are also known as memory-based, case-
based, instance-based, or exemplar-based learners. They (1) use a similarity or a distance 
measure, (2) defer most of the processing until a test case is encountered (i.e., they are lazy), (3) 
combine the training cases in some fashion to predict the target in the test case, and (4) discard 
the answer and any intermediate results after the prediction [23]. Typically, no explicit model is 
induced from the training cases at the time of prediction. The similarity measure evaluates the 
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similarity between the test case and the training cases and selects the appropriate training cases 
and their relative weights in response to the test case [24]. The selected training cases can be 
equally weighted or weighted according to their similarity to the test case. To predict the target 
variable in the test case, the values of the target variable in the selected training cases are 
combined in some simple fashion such as majority vote, simple numerical average or fitted with 
a polynomial. 
The nearest-neighbor technique is the canonical similarity-based method. When a test 
case is encountered, the training case that is most similar to the test case is located and its target 
value is returned as the prediction [25]. A straight-forward extension to the nearest-neighbor 
technique is the k-Nearest Neighbor (kNN) method. For a test case, this method selects the k 
most similar training cases and either averages or takes a majority vote of their target values. 
Another extension is the distance-weighted k-Nearest Neighbor method. This weights the 
contribution of each of the k most similar training cases according to its similarity to the test 
case, assigning greater weights to more similar cases [26]. A further extension is locally 
weighted regression that selects cases similar to the test case, weights them according to their 
similarity, and performs regression to predict the target [27]. 
One drawback of the similarity-based methods is that they may perform poorly when 
predictors are redundant, irrelevant or noisy. To make the similarity metric more robust, variable 
selection and variable weighting have been employed [28]. Two generic approaches that have 
been used for variable selection and weighting are filter methods and wrapper methods [23]. 
Filter methods determine whether variables are predictive of the target variable using heuristics 
based on characteristics of the data. Typically, filter methods are applied as a preprocessing step 
and search for an optimal variable subset in the space of variable subsets independent of the 
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classification method to be applied subsequently. An example of a filter method is the selection 
of a subset of variables that are highly correlated with the target variable as measured by mutual 
information between each predictor variable and the target variable. Wrapper methods make use 
of the classification method that will ultimately be applied to the data in order to evaluate the 
predictive power of predictors. Typically, wrapper methods search for an optimal variable subset 
in the space of variable subsets using the criterion optimized by the classification method. An 
example of a wrapper method is the selection of a subset of variables that produces high 
accuracy when used by the classification method [29]. 
Instance-specific methods. Instance-specific methods in general and patient-specific 
methods in particular are model-based methods that take advantage of the features in the test 
case while inducing the model. Such methods are not as reliant on a similarity measure, if they 
use one at all, as the similarity-based methods.  
Friedman et al. [30] describe one such algorithm called LazyDT that searches for the best 
CART-like decision tree for a test case. As implemented by the authors, LazyDT did not perform 
pruning and processed only nominal variables. The algorithm was compared to ID3 and C4.5 
(standard population-wide methods for inducing decision trees), each with and without pruning. 
When evaluated on 28 datasets from the UCI Machine Learning repository, LazyDT generally 
out-performed both ID3 and C4.5 without pruning and performed slightly better than C4.5 with 
pruning. 
Ting et al. [31] have developed a framework for inducing rules in a lazy fashion that are 
tailored to the features of the test case. Zheng et al. [32] describe an implementation of this 
framework called the Lazy Bayesian Rules (LBR) learner that induces a rule tailored to the 
features of the test case that is then used to classify it. A LBR rule consists of (1) a conjunction 
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of the variable-value pairs present in the test case as the antecedent and (2) a local naive Bayes 
classifier as the consequent. The structure of the local naive Bayes classifier consists of the target 
variable as the parent of all other variables that do not appear in the antecedent, and the 
parameters of the classifier are estimated from those training cases that satisfy the antecedent. 
Figure 2-1 shows an example of a LBR rule constructed using five predictor variables and a 
target variable from the pneumonia dataset (described in Chapter 5). The rule has two predictors 
in the antecedent and a naive Bayes classifier with three predictors in the consequent. A greedy 
step-forward search selects the optimal LBR rule for a test case to be classified. In particular, 
each predictor is added to the antecedent of the current best rule and evaluated for whether it 
reduces the overall error rate on the training set. The predictor that most reduces the overall error 
rate is added to the antecedent and removed from the consequent, and the search continues; if no 
single predictor move can decrease the current error rate, then the search halts and the current 
rule is applied to predict the outcome for the test case. LBR is an example of a patient-specific 
method that utilizes feature information available in the test case to direct the search for a 
suitable model in the model space.  
Status = retired Glucose = >250 
Gender Cough Infiltrate 
Dire outcome 
Figure 2-1: A LBR model (or rule) with five predictors and a target variable (dire outcome). The 
two nodes at the top represent predictors in the antecedent of the LBR rule that have been 
instantiated to their respective values in the test case. The node in the center (the target variable 
being predicted) and the three nodes at the bottom form the local naive Bayes classifier present in 
the consequent of the LBR rule. 
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The performance of LBR was evaluated by Zheng et al. [32] on 29 datasets from the UCI 
Machine Learning repository and compared to that of six algorithms: a naïve Bayes classifier 
(NB), a decision tree algorithm (C4.5), a Bayesian tree learning algorithm (NBTree) [33], a 
constructive Bayesian classifier that replaces single variables with new variables constructed 
from Cartesian products of existing nominal variables (BSEJ) [34], a selective naive Bayes 
classifier that deletes irrelevant variables using Backward Sequential Elimination (BSE) [35], 
and LazyDT, which is described above. Based on ten three-fold cross validation trials (for a total 
of 30 trials), LBR achieved the lowest average error rate across the 29 datasets. The average 
relative error reduction of LBR over NB, C4.5, NBTree, BSEJ, BSE and LazyDT were 9%, 10%, 
2%, 3%, 5% and 16% respectively. LBR performed significantly better than all other algorithms 
except BSE; compared to BSE its performance was better but not statistically significantly so. 
Some of the more recent algorithms have some limitations in that they can process only 
discrete variables – continuous variables have to be discretized. Also, they are computationally 
more intensive than many other learning algorithms. However, they have been shown to have 
better accuracy than several of the population-wide methods. These results provide empirical 
support for the possibility that patient-specific methods can have better predictive performance 
than population-wide models constructed using standard eager techniques. 
2.9 RELATED WORK IN PREDICTIVE MODELING IN MEDICINE 
In the medical domain, machine learning methods are been increasingly used for the induction of 
predictive models. In a recent study, Dreiseitl and Ohno-Machado [17] examined the number of 
publications indexed in Medline that used modeling and found that logistic regression, neural 
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networks, k-Nearest Neighbors (kNN), CART-like decision trees (classification trees) and 
support vector machines (SVM) were the most popular in descending order. Logistic regression 
is widely used in many clinical domains: for example, APACHE II is a severity of disease 
classification system that computes a score based upon routine physiologic measurements, age, 
and previous health status to provide a general measure of severity of disease [36]. Logistic 
regression models (without interaction terms) are easy to construct and interpret; however, they 
may not capture dependencies among attributes adequately. In contrast, neural networks, which 
generalize logistic regression models, are more flexible since they can express complex non-
linear relationships among the attributes.  
The kNN is the most commonly used similarity-based method in the medical domain. For 
example, it has been applied in searching for patterns in radiographic images for diagnostic 
purposes [37] and for diagnosis of diseases from gene expression profiles [38]. Though less 
commonly used than the preceding methods, CART-like decision trees are attractive since they 
provide a representation that lends itself to easy interpretation by humans. They can also be 
easily translated into a disjunction of conjunctions or the more convenient ‘if-then’ rules. 
Support vector machines have been used for several clinical problems ranging from diagnosis of 
breast cancer on ultrasound images [39] to classification of tumors based on gene expression 
profiles [40]. The basic SVM binary classification algorithm computes a maximum-margin 
hyperplane in a transformed predictor space. The hyperplane separates training cases of one class 
from the other such that the distance from the closest cases (the margin) to the hyperplane is 
maximized [41]. 
Several of the patient-specific models described in the medical literature are models that 
are induced from a time series of data about a patient. Such a model may be trained only on data 
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obtained from the patient for whom it will be used, or it may be trained from a combination of 
population data and data obtained from the patient. As an example, patient-specific modeling has 
been used to detect onset of seizures in real-time during long-term electroencephalogram (EEG) 
monitoring of epileptic patients. The model is trained from labeled seizure and nonseizure EEG 
data recorded in a patient and is then applied to ongoing EEG recording of that patient [42]. EEG 
patterns of seizures are very stereotypic for a given patient but vary widely among patients even 
for the same type of seizures. Thus, models induced from data from several patients usually 
perform poorly when compared to those constructed from a single patient and applied to that 
patient [43]. 
An example of patient-specific modeling that combines population data with data from a 
patient is the Bayesian method for forecasting drug dosage developed by Sheiner et al. [44, 45]. 
Here, the future drug dosage is individualized by revising the estimates of that individual’s 
pharmacokinetic (PK) parameters. The individual’s estimates of the PK parameters are obtained 
by combining information from population PK parameters (that describe the typical relationship 
between dosage and drug concentrations derived from a population of individuals) and past 
measurements of drug concentrations from that individual (that provide information on the 
relationship between dosage and drug concentrations specific to that individual). The initial 
prediction of a drug dose for an individual is based on just the population PK parameters, since 
no measurements of drug concentrations from that individual are yet available. This method has 
been shown to provide more accurate estimates of the individual’s PK parameters than methods 
that use only one of the sources of information [46]. In this dissertation the focus is on 
developing methods that can improve initial such predictions based on data already available on 
the individual. Such methods aim to improve the predictive performance when repeated 
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measurements of the target variable are not possible (e.g., mortality) or when the initial value of 
a target variable that can be measured repeatedly has to be predicted (e.g., blood level after the 
first dose of a drug). 
Though numerous predictive models in the clinical domain have been published by 
researchers, few are in routine clinical use. Lack of clinical credibility and lack of evidence of 
accuracy, generality, and effectiveness were some of the reasons identified by Wyatt et al. for the 
failure of acceptance of prognostic models in medicine [9]. Newer machine learning methods, 
such as the one described in this proposal, have the potential to improve the accuracy of 
predictive models. With increasing use of ever more powerful computers in clinical care and the 
increasing capture of patient information in clinical computer systems, computationally intensive 
modeling methods as part of decision support systems will become more feasible. If such 
methods can predict patient outcomes well and are incorporated in clinical decision support 
systems, they are likely to be clinically useful. In support of this point, a recent study 
demonstrated that physicians are quite amenable to having the recommendations of decision 
support systems for clinical decision making [47]. 
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3.0  BAYESIAN NETWORKS 
This chapter describes the formalism of Bayesian networks (BN) and reviews the methods for 
learning them from datasets. This provides the necessary background for the patient-specific 
algorithms that learn both structure and parameters of BNs from data. Section 3.1 introduces 
some notation and Section 3.2 briefly describes the BN formalism. Section 3.3 describes several 
representations of probability distributions in BNs. Sections 3.4 and 3.5 review some of the 
commonly used methods for learning the structure and parameters of BNs from data. In 
particular, the Bayesian approach to BN learning is reviewed in detail, including a description of 
the Bayesian scoring metric that is defined to be the posterior probability of the BN structure 
conditioned on the observed data. Section 3.6 focuses on the learning of BNs for the purpose of 
classification and reviews the utility of the Bayesian scoring metric for classification. Finally, 
Section 3.7 describes Bayesian model averaging as a coherent approach for improving 
predictions. 
3.1 NOTATION 
Random variables are denoted with upper case letters, such as X, Z, and their instantiation or 
assignment with the corresponding lower case letters x, z. Thus, X = x denotes that random 
variable X is assigned the value (or state) x. Likewise, sets of variables or random vectors are 
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denoted with bold upper case letters, such as X, Z, and their instantiation or assignment with the 
corresponding bold lower case letters x, z. Thus, X = x denotes that the random variables in X 
have the values (or states) given by x. Given a domain of interest, X = denotes the 
complete set of variables in the domain and x =  represents a complete instantiation of 
the variables in X.  For a discrete random variable Xi, ri denotes its number of values and 
denote the domain of the values.  
},...,{ 1 nXX
},...,{ 1 nxx
}...,,{ 21 inii xxx
Generally, Z denotes the target (class) variable being predicted, X denotes the set of 
predictor variables excluding the class variable, M denotes a model, D denotes the training 
dataset, Ci ≡ <Xi, Zi> denotes a generic training case and Ct ≡ <Xt, Zt> denotes a generic test 
case. The goal is to predict the value of the target variable Zt of the test case Ct. 
3.2 BAYESIAN NETWORK REPRESENTATION 
A Bayesian network (BN) is a probabilistic model that combines a graphical representation (the 
BN structure) with quantitative information (the BN parameterization) to represent a joint 
probability distribution over a set of random variables [5, 6]. More specifically, a Bayesian 
network model M representing the set of random variables X for some domain consists of a pair 
(G, θG). The first component G is a directed acyclic graph (DAG) that contains a node for every 
variable in X and an arc between a pair of nodes if the corresponding variables are directly 
probabilistically dependent. Conversely, the absence of an arc between a pair of nodes denotes 
probabilistic independence between the corresponding variables. In this document, the terms 
variable and node are used interchangeably in the context of random variables being modeled by 
 34 
  
history 
of smoking 
X1 
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bronchitis 
lung X2 X3 cancer 
X5 X4 
mass seen on 
chest X-ray 
fatigue 
P(X1 = F) = 0.80 
 
P(X2 = F | X1 = F) = 0.95 
nodes in a BN. A variable Xi in the domain of interest will usually be represented by a node 
labeled Xi in the BN graph.  
The terminology of kinship is used to denote various relationships among nodes in a 
graph. These kinship relations are defined along the direction of the arcs. Predecessors of a node 
Xi in G, both immediate and remote, are called the ancestors of Xi. In particular, the immediate 
predecessors of Xi are called the parents of Xi. The set of parents of Xi in G is denoted by 
Figure 3-1: A simple hypothetical Bayesian network for a medical domain, taken from [48]. All 
the nodes represent binary variables, taking values in the domain {T, F} where T stands for True 
and F for False. The graph at the top represents the Bayesian network structure. Associated with 
each variable (node) is a conditional probability table representing the probability of each 
variable’s value conditioned on its parent set. (Note: these probabilities are for illustration only; 
they are not intended to reflect frequency of events in any actual patient population.) 
P(X2 = F | X1 = T) = 0.75 
 
P(X3 = F | X1 = F) = 0.995 
P(X3 = F | X1 = T) = 0.997 
 
P(X4 = F | X1 = F, X3 = F) = 0.99995 
P(X4 = F | X1 = F, X3 = T) = 0.50 
P(X4 = F | X1 = T, X3 = F) = 0.90 
P(X4 = F | X1 = T, X3 = T) = 0.25 
 
P(X5 = F | X1 = F) = 0.98 
P(X5 = F | X1 = T) = 0.40 
 
P(X1 = T) = 0.20 
 
P(X2 = T | X1 = F) = 0.05 
P(X2 = T | X1 = T) = 0.25 
 
P(X3 = T | X1 = F) = 0.005 
P(X3 = T | X1 = T) = 0.003 
 
P(X4 = T | X1 = F, X3 = F) = 0.00005 
P(X4 = T | X1 = F, X3 = T) = 0.50 
P(X4 = T | X1 = T, X3 = F) = 0.10 
P(X4 = T | X1 = T, X3 = T) = 0.75 
 
P(X5 = T | X1 = F) = 0.02 
P(X5 = T | X1 = T) = 0.60 
Node X1  
 
Node X2  
 
 
Node X3  
 
 
Node X4  
 
 
 
 
Node X5  
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Pa(Xi, G) or more simply as Pai when the BN structure is obvious from the context. In a similar 
fashion, successors of Xi in G, both immediate and remote, are called the descendants of Xi, and 
the immediate successors are called the children of Xi. A node Xj is termed a spouse of Xi if Xj is 
a parent of a child of Xi. The set of nodes consisting of a node Xi and its parents is called the 
family of Xi. Figure 3-1 gives an illustrative example of a simple hypothetical BN taken from 
[48], where the top panel shows the graphical or the structural component G of the BN. In the 
figure, the variable history of smoking is a parent of the variable lung cancer as well as a parent 
of the variable chronic bronchitis. The variable fatigue is a child of the variable lung cancer as 
well as a child of the variable chronic bronchitis. A descendant of a node Xi is a node Xj that can 
be reached by a directed path from Xi to Xj. In the example, variables lung cancer and mass seen 
on chest X-ray are descendants of the variable history of smoking.  
The second component θG represents the parameterization of the probability distribution 
over the space of possible instantiations of X and is a set of local probabilistic models that 
encode quantitatively the nature of dependence of each variable on its parents. For each node Xi 
there is a local probability distribution (that may be discrete or continuous) defined on that node 
for each state of its parents. The set of all the local probability distributions associated with all 
the nodes comprises the complete parameterization of the BN. The bottom panel in Figure 3-1 
gives an example of a set of parameters for G. Taken together, the top and bottom panels in 
Figure 3-1 provide a fully specified structural and quantitative representation for the BN.  
3.2.1 Local Markov condition and factorization of the joint probability distribution 
The topology of the graph G encodes compactly the set of independencies among the variables in 
the domain. These independence relations include both marginal and conditional independencies 
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and can be enumerated for a BN by the application of the local and global Markov conditions to 
the topology of the network. This section describes the local Markov condition and the next 
section describes the global Markov condition. 
The local Markov condition identifies the independencies local to a node: A node is 
conditionally independent of its non-descendants given just the states its parents [5]. In Figure 
3-1, one such independence relation is this: the variable history of smoking is independent of the 
variable mass seen on chest X-ray given the state of the variable lung cancer.  
The local Markov condition provides a factored representation for the complete joint 
probability distribution over the variables in the domain, which is a crucial characteristic of a 
BN. This factored representation can be substantially more compact than the complete joint 
probability distribution, especially when the graph is sparse. The joint probability distribution is 
factored by applying the chain rule of probability followed by simplification of the terms based 
on the independencies asserted by the local Markov condition. Let the variables in X = 
 be topologically sorted relative to G, such that if i < j then Xi is a non-descendant of 
Xj in G. Using the chain rule of probability the joint distribution is factored as: 
},...,{ 1 nXX
∏
=
−=
n
i
iin XXXPXXP
1
111 ),...,|(),...,(  .    (3.1) 
The local Markov condition asserts that for all Xi in X, 
)|(),...,|( 11 iPaiii XPXXXP =− ,     (3.2) 
where , because in the sorting of the variables all of the parents of Xi are in 
the set , and none of the descendants of Xi are in this set. Substituting Equation 3.2 
into Equation 3.1 gives the following equation, which is also known as the chain rule for 
Bayesian networks: 
},...,{ 11 −⊆ iXXiPa
},...,{ 11 −iXX
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As an example, applying the local Markov condition to the BN in Figure 3-1 leads to the 
following factorization: 
)|(),|()|()|()(),,,,( 353241312154321 XXPXXXPXXPXXPXPXXXXXP =  (3.4) 
The local Markov condition, thus, translates a high dimensional multivariate joint probability 
distribution into a product of potentially low dimensional univariate probability distributions. 
The BN network represents and stores univariate probability distributions which typically require 
fewer parameters for specification than the complete joint probability distribution. For example, 
the BN in Figure 3-1 requires only 11 independent probabilities to be specified (the probabilities 
in the right hand column are redundant), while the full joint probability distribution for the same 
example where a probability is to be specified for each instantiation of the five variables would 
require 25 – 1 = 31 independent probabilities. 
3.2.2 Global Markov condition and d-separation  
The global Markov condition also identifies independencies with respect to a node: A node is 
conditionally independent of all other nodes in the network, given its parents, its children, and 
the children’s parents. This set of nodes is also known as the Markov blanket of the node and is 
described in the next section. Figure 3-2 distinguishes graphically the local and the global 
Markov conditions. 
The global Markov condition can be extended to identify independencies among disjoint 
sets of nodes in a BN. A topological procedure called d-separation can identify the complete set 
of conditional independencies in the graph implied by the global Markov condition [5]. Pearl 
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describes the application of d-separation as follows. Consider three disjoint subsets of nodes X, Y 
and Z in graph G. Whether X is independent of Y given Z is tested by testing whether the nodes 
in Z “block” all paths from nodes in X to nodes in Y. A path refers to a sequence of consecutive 
arcs (of any directionality) in the graph, and “blocking” is interpreted as barring the dependency 
between variables that are connected by such paths. A path p is said to be d-separated or 
“blocked” by a set of nodes Z if and only if: 
1. p contains a chain kj  or a fork kji XXX →→ i XXX →←  such that the 
middle node Xj is in Z 
2. p contains a collider kji XXX ←→  such that the middle node Xj is not in Z and 
also no descendant of Xj is in Z 
A set Z is said to d-separate X from Y if and only if Z blocks every path from a node in X to a 
node in Y. The global Markov condition states that X and Y are conditionally independent given 
Z if and only if Z d-separates X from Y [5, 49]. Thus, d-separation identifies all the conditional 
independencies implied by the global Markov condition.  
Figure 3-2: Examples of the local Markov condition and the global Markov condition. (a) Local 
Markov condition: The node X6 (shown stippled) is conditionally independent of its non-
descendants given its parents (shown shaded). (b) Global Markov condition: the node X6 (shown 
stippled) is conditionally independent of all other nodes in the network given its Markov blanket 
(shown shaded). 
X1 X2 X3 
X5 X7 X6 
X4 
X9 X8 
X10 X11 
(a) 
X1 X2 X3 
X5 X7 X6 
X4 
X9 X8 
X10 X11 
(b)
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In a BN, the local Markov condition implies the global Markov condition and vice-versa 
and both conditions identify all the independencies implied by the topology of the network [49, 
50]. 
3.2.3 Markov blanket 
The Markov blanket (MB) of a variable Z, denoted by MB(Xi), is a minimal set of variables such 
that Xi is conditionally independent of all other variables given MB(Xi) [5]. This entails that the 
variables in MB(Xi) are sufficient to determine the probability distribution of Xi. Since d-
separation is applied to the graphical structure of a BN to identify all conditional independence 
relations, it can also be applied to identify the MB of a node in a BN. The MB of a node Xi 
consists of its parents, its children, and its children’s parents and is illustrated in Figure 3-3. The 
parents and children of Xi are directly connected to it and are hence in its MB. In addition, the 
spouses are also included in the MB, because of the phenomenon of explaining away which 
X5 
X1 X2 X3 
X7 X6 
X4 
X9 X8 
X10 X11 
Figure 3-3: Example of a Markov blanket. The Markov blanket of the node X6 (shown stippled) 
comprises the set of parents, children and spouses of the node and is indicated by the shaded 
nodes. The nodes in the Markov blanket include X2 and X3 as parents, X8 and X9 as children, and 
X5 and X7 as spouses of X6. X1, X4, X2 and X10 and X11 are not in the Markov blanket of X6. 
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refers to the observation that when a child node is instantiated its parents in general are 
statistically dependent.  
The MB of a node is noteworthy because it identifies all the variables that shield the node 
from the rest of the network. In particular, when interest centers on the distribution of a specific 
target node, as is the case in classification, the structure and parameters of only the MB of the 
target node need be learned.  
3.3 REPRESENTATION OF LOCAL PROBABILITY DISTRIBUTIONS 
The global structure of the BN represented by the arcs connecting the nodes implies a set of 
conditional independencies that allows the decomposition of a high dimensional joint probability 
distribution into a product of potentially low dimensional conditional probability distributions 
(CPDs). Each factor P(Xi | Pai) on the right hand side of Equation 3.3 is a set of CPDs that is 
associated with Xi. This section describes several representations for these CPDs, including some 
representations that capture additional regularities that are not implied by the global structure. 
The choice of representation depends on the type of the variables involved (i.e., discrete or 
continuous), on the nature of the relationship among the variables (i.e., deterministic or 
probabilistic), and on the need to represent local dependencies among parameters. 
In domains with discrete random variables, the tabular representation for CPDs is simple 
and straight-forward. In this representation, P(Xi | Pai) is a table that contains an entry for each 
joint instantiation of Xi and Pai. Each column (or row) in the table represents a single conditional 
probability distribution, P(Xi | Pai = pai), corresponding to a particular instantiation of Pai. 
Tabular CPDs are aptly called conditional probability tables (CPTs) and are almost always the 
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representation used in discrete BNs. For example, the CPD for node X4 in the top panel in 
Figure 3-1 is represented by the hypothetical CPT shown in the bottom panel in Figure 3-1 that 
contains four independent parameters. CPTs are a very general representation for discrete nodes 
in that every possible discrete conditional probability distribution can be represented by a 
conditional probability table. However, the CPT representation has several disadvantages. First, 
in general the number of parameters of a CPT of a node grows exponentially in the number of 
parents of the node, and when parameters are estimated from data, this expansion of the CPT 
leads to poor estimates of the parameters since fewer data points contribute to the estimate of 
each parameter. Second, the tabular representation ignores structure and regularities within the 
CPDs; capturing such regularities provides additional domain knowledge about the interactions 
among the parents and reduces the number of parameters needed to specify the CPDs. 
Interactions among parents are captured by a type of independence relation called context-
specific independence and is described in the next section. The subsequent sections briefly 
describe several representations for CPDs that explicitly capture context-specific independencies. 
3.3.1 Context-specific independence 
The DAG of a BN encodes statements of variable independence. For example, a variable X is 
independent of Y given variable Z if P(x | y, z) = P(x | z) for all values x, y and z that the variables 
X, Y, Z can take. 
In the standard discrete BN, the graphical structure makes explicit independence relations 
of the form which implies that ZYX |⊥ )|(),|( ZXPZYXP = for all values of the variables X, 
Y and Z. However, these are not the only independencies that may be present in a domain. For 
instance, value-specific independencies that hold for only particular assignments of values to 
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certain nodes cannot be represented by the BN graphical structure. Value-specific 
independencies are of the form zZYX =⊥ |  which implies that 
for all values of the variables X and Y when Z takes the particular 
value z. This type of independence relation is also known as context-specific independence; the 
preceding example can be interpreted as X is independent of Y in the context of Z taking the 
value z. In general, these independent statements imply that in some contexts, defined by an 
assignment of specific values to the variables in the BN, the conditional probability of a variable 
is independent of some of its parents [51].  
)|(),|( zZXPzZYXP ===
=⊥ 324 | XXX
In the CPT representation, context-specific independencies become apparent only on 
examining the numerical values of the parameters. Context-specific independence is present 
when the conditional probability distributions for two or more parent states have identical values 
of the parameters; such an independence relation is not explicitly represented in the CPT 
structure. For example, in Figure 3-4 (b), an examination of the parameters in the CPT reveals 
that three of the four possible parent states have the same parameter values (0.6, 0.4) implying 
that context-specific independencies are present. Indeed, the following two context-specific 
independence relations among the variables can be identified:   
(1)  T  (i.e., fatigue⊥ chronic bronchitis | lung cancer = T) 
(2)  T (i.e., fatigue=⊥ 434 | XXX ⊥  lung cancer | chronic bronchitis = T) 
BNs that do not explicitly represent context-specific structure are referred to as BNs with 
global structure, in contrast to BNs that explicitly capture context-specific structure which are 
referred to as BNs with local structure. Several CPD representations have been developed for 
discrete variables that explicitly capture context-specific structure. The following sections 
describe two such local structure representations, namely, decision trees and decision graphs.  
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Figure 3-4: Examples of CPD representations. Several CPD representations for the BN node X4
(fatigue) in panel (a) are shown in subsequent panels. Panel (b) shows a CPT for the node X4 with 
four parameters. The CPT can be equivalently represented by a complete decision tree as shown 
in panel (c). Panels (d) and (e) show alternate decision trees where each one captures one of the 
two context specific independence relations that is present but not both (see text for details). 
Panel (f) shows a decision graph that captures both the context specific independence relations
(see text for details). Nodes of a BN are shown as ellipses with single lines while nodes of 
decision trees and decision graphs are shown as either circles with double lines (interior nodes) or 
as rectangles with double lines (leaf nodes). 
(b)
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3.3.2 Decision tree CPDs 
Friedman and Goldszmidt describe a decision tree representation for learning BNs with local 
structure from data [51]. In this representation, a decision tree is used to represent the local 
structure for a BN node Xi. Such a representation is called a decision tree CPD or a tree CPD for 
short. A decision tree is a graph where the root node has no parents, and all other nodes have a 
single parent. Nodes that have children and appear in the interior of the tree are called interior 
nodes and terminal nodes are called leaf nodes. Each leaf node in the tree contains a conditional 
distribution over Xi, and the path to the leaf from the root provides the context in which the 
distribution is valid. Each interior node is annotated with the name of one of the parent variables 
Xj  Pai and out-going arcs from that interior node are annotated with mutually exclusive and 
collectively exhaustive sets of values for the variable Xj. In other words, values of parent nodes 
of Xi appear along the path and determine the parent states for which the distribution in the 
corresponding leaf node is applicable. Each leaf node contains a set of k parameters – where k is 
the number of states of Xi – that defines a single conditional probability distribution 
P(Xi | Pai = pai) corresponding to a particular instantiation of Pai. 
∈
As an example, Figure 3-4 (d) shows a decision tree CPD that represents the local 
structure of the node X4 in Figure 3-4 (a). The decision tree representation is more compact than 
the CPT representation in that the decision tree CPD contains one less CPD and hence requires 
one fewer set of parameters than the CPT. This is achieved by capturing the context-specific 
independence relation =⊥ 324 | XXX  T (fatigue ⊥  chronic bronchitis | lung cancer = T), 
which is seen in Figure 3-4 (d) by noticing that the path along the right from the root node X3 
(lung cancer) does not contain a node for the variable chronic bronchitis. An alternate decision 
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tree, shown in Figure 3-4 (e), that has as the root node the variable X2 (chronic bronchitis) can 
capture the other context-specific independence relation =⊥ 434 | XXX  T (fatigue ⊥  lung 
cancer | chronic bronchitis = T). However, no decision tree is unable to capture both context-
specific independence relations given in the example.  
3.3.3 Decision graph CPDs 
Chickering et al. generalized the decision tree representation to decision graphs, which can 
represent a richer set of context-specific independence relations [52]. A decision tree is a graph 
where the root node has no parents, and all other nodes have one or more parents. Nodes that 
have children and appear in the interior of the tree are called interior nodes and terminal nodes 
are called leaf nodes. A decision graph differs from a decision tree in that an interior node may 
have multiple parents, rather than just one parent. A decision graph, thus, allows two or more 
distinct paths from the root node to terminate in the same leaf node. Such a representation is 
called a decision graph CPD or a graph CPD for short. For a BN node Xi that is represented by a 
decision graph, the leaf nodes contain conditional distributions over Xi similar to those in a 
decision tree, and interior nodes and outgoing arcs in a decision graph are annotated in a similar 
fashion as in a decision tree. All paths that lead to the same leaf node represent distinct parent 
states for which Xi has the same conditional distribution. The decision graph representation is 
more general than the decision tree representation, in that, any local structure that can be 
represented compactly as a tree can be represented as a graph, but the converse is not true.  
As an example, Figure 3-4 (f) shows a decision graph CPD representing the local 
structure of the node X4 in Figure 3-4 (a). In this example, the decision graph CPD is more 
compact than either the CPT or the decision tree representation since it requires one less set of 
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parameters than the decision tree CPD and two fewer sets of parameters than the CPT. The 
decision graph is able to capture both context-specific independence relations given in the 
example, demonstrating that it is a more general representation than the decision tree.  
3.3.4 Summary of CPD representations 
From the preceding discussion, it is evident that the CPDs in BNs can be represented with 
varying degrees of parsimony. Representations of CPDs that do not attempt to capture context 
specific independencies are the least parsimonious; such representations explicitly capture only 
the global structure. The classical representation for a CPD is the complete table (commonly 
known as the CPT); each node Xi stores ii rq ×  parameters in a large table where qi is the number 
of parent states for Xi and ri the number of states of Xi. An equivalent representation to the 
complete table is the complete decision tree which can represent all of the parameters in a 
complete table. A complete decision tree for a node Xi is a tree of depth qi such that every 
interior node at level l is annotated by the lth parent Xl ∈  Pai and has exactly as many children as 
there are states in Xl. It follows from this definition that a complete decision tree has the same 
number of leaf nodes as the number of columns in an equivalent complete table. For example, 
the CPT in Figure 3-4 (b) is equivalently represented by the complete decision tree in 
Table 3-1: Labels for CPDs, BNs and MBs based on the CPD representation. 
structure CPD representation CPD label BN label MB label 
complete table (CPT) tabular CPD tabular CPD BN tabular CPD MB global 
complete decision tree complete CPD complete CPD BN complete CPD MB 
decision tree decision tree CPD decision tree CPD BN decision tree CPD MB local 
decision graph decision graph 
CPD 
decision graph CPD 
BN 
decision graph CPD 
MB 
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Figure 3-4 (c). I will refer to a BN with tabular CPDs as a tabular CPD BN, and a BN with 
complete decision tree CPDs as a complete CPD BN. 
Representations for CPDs that explicitly represent context-specific independence 
relations include decision trees and decision graphs. I will refer to a BN with decision tree CPDs 
as a tree CPD BN, and a BN with decision graph CPDs as a graph CPD BN. Both tree CPD BNs 
and graph CPD BNs capture the local structure. Of note, the local structure implies the global 
structure. This can be seen from the observation that the parents of a BN node Xi are those nodes 
that appear in the decision tree or the decision graph associated with Xi. Table 3-1 summarizes 
the nomenclature for BNs based on the CPD representations. 
3.4 LEARNING BAYESIAN NETWORKS FROM DATA 
Learning a BN from a dataset of cases consists of learning its two components: the graphical 
structure of conditional dependencies (structure learning) and the conditional probability 
distributions (parameter estimation). Given a fixed network structure, parameter estimation is 
the easier problem and frequentist or Bayesian statistical approaches can be applied to the 
problem. The learning of the graphical structure that best fits the data is a more challenging task. 
3.4.1 Parameter estimation 
This section focuses on the estimation of the parameters of the conditional probability 
distributions P(Xi | Pai) under the assumptions that the BN structure is known, all the variables 
are discrete and the data has no missing values for any of the variables. There are two main 
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approaches for parameter estimation: the maximum likelihood approach that depends only on the 
data and the Bayesian approach that combines prior probabilities for the parameters with the 
data. In both approaches, the task is to find a good value or a set of good values for each 
parameter in the BN. This can be formulated as a learning task that consists of a hypothesis space 
which defines the set of all possible values being considered and a scoring function that scores 
different hypotheses in the space relative to the given data. The BN structure reduces the 
parameter estimation problem to a set of unrelated simpler parameter estimation problems 
involving only a node and its parents. In particular, for discrete variables in which conditional 
probability distributions are multinomial distributions whose parameters are stored in tables, 
decision trees or decision graphs, the parameters for each multinomial distribution can be 
estimated independently.  
3.4.1.1 Maximum likelihood estimation  
The scoring function in maximum likelihood estimation is the standard likelihood. The 
likelihood function computes the probability of the data as a function of the parameter values. 
Parameter values with higher likelihood are more likely to generate the data; thus the likelihood 
function measures how well different parameter values predict the data. In the maximum 
likelihood method, the parameter values that maximize the likelihood are selected, and the 
estimator is called the maximum likelihood estimator (MLE). For many parametric distributions, 
including the multinomial distribution, the likelihood function is maximized easily in closed 
form. 
In a discrete BN with n nodes, the parameterization θ over the entire network can be 
decomposed as where each θi represents the set of parameters defining the },...,,...,{ 1 ni θθθθ =
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conditional distributions P(Xi | Pai) associated with node Xi. It is typically assumed that the θi are 
mutually independent; an assumption that is referred to as the global parameter independence. 
Further, each θi is decomposed as },...,,...,{ 1 iiqiji θθθθ i =  where qi is the number of possible 
instantiations of Pai.. Each θij represents the parameters defining the single conditional 
distribution P(Xi | Pai = j). It is typically assumed that the θij are mutually independent; an 
assumption that is referred to as the local parameter independence. For a discrete variable each 
θij parameterizes a multinomial distribution. Thus, for each instantiation Pai = j, 
)( ijθl)|( iPa multinomiajXP i == ,     (3.5) 
where, and θijk = P(Xi = k | Pai = j). Similarly, the multinomial likelihood 
function for a discrete BN decomposes into a product of local likelihood functions over the 
nodes, and the local likelihood function at each node further decomposes into a product of simple 
likelihood functions over the instantiations of the parent nodes. Each simple likelihood function 
is a multinomial likelihood function that is easily maximized to obtain the following MLE 
parameters: 
},...,,...,{ 1 iijnijkij θθθθ ij =
ij
ijk
ijk N
N=θˆ ,        (3.6) 
where, Nijk is the number of cases in the training data such that node i has value k and the parents 
of i have the state denoted by j, and ∑= k ijkij NN . 
3.4.1.2 Bayesian parameter estimation 
The MLE approach attempts to find a single set of parameter values  that explain the data well. 
The Bayesian approach, in contrast, does not attempt to find a single set of best parameter 
values. Rather, it provides a distribution over the possible parameter values that quantifies the 
θˆ
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uncertainty of each of the values. Thus, it combines prior knowledge of the parameterization θ 
with the data to arrive at a posterior distribution over θ. The prior knowledge of θ is encoded 
with a probability distribution; this distribution represents the a priori knowledge and beliefs 
about the different values of the parameters. Then, a joint distribution over θ and the data D 
captures all the necessary information: 
)()|(),( θθθ PDPDP =       (3.7) 
The first term on the right hand side is the likelihood function, which is the same function that is 
used for obtaining the MLE estimates. The second term is the prior distribution over the 
parameter values. Once the likelihood function and the prior have been specified, Bayes rule is 
applied to obtain the posterior distribution over the parameters: 
)(
)()|()|(
DP
PDPDP θθθ = .      (3.8) 
The term P(D) in the denominator is the marginal likelihood of the data obtained by integrating 
the likelihood over all possible parameter values: 
θθθ dPDPDP ∫=
θ
)()|()( .      (3.9) 
This term represents the a priori likelihood of observing the obtained data given the prior beliefs. 
 In a discrete BN, when the variables are multinomial, typically the prior over the 
parameters of the multinomial distributions are represented by Dirichlet distributions. For a node 
Xi with the distribution 
)()()|( 1 iijrijk, ijiji ,...,θ...,θθlmultinomialmultinomiajXP ≡== θPai , (3.10) 
the Dirichlet prior is specified as: 
),...,,...,()()( 1 iijrijkijijij DirichletDirichletP ααα≡= αθ ,  (3.11) 
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where the parameters ijkα  of the Dirichlet distribution are called hyperparameters. Applying 
Bayes rule to a Dirichlet prior and a multinomial likelihood produces a posterior that is also a 
Dirichlet distribution: 
),...,,...,()|( 11
ii ijrijrijkijkijijij
NNNDirichletDP +++= αααθ , (3.12) 
where, Nijk is the number of occurrences of P(Xi = k | Pai = j) in the data.  
The posterior summarizes all the information available about the different values of the 
parameters. A common use of a BN, which has been parameterized from a training dataset D of 
N cases {X1, X2,…, XN }, is to predict the probability of a new case XN +1 taking the value x, that 
is, compute the predictive probability distribution P(XN +1 = x | D). This prediction is obtained by 
averaging over all the parameters weighted by the posterior as follows: 
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When the prior and corresponding posterior are Dirichlet, under the assumptions of global and 
local parameter independence, the prediction for a future example can be decomposed as 
follows: 
 .   (3.14) 
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Assuming that in the future example X = x, Xi = k and Pai = j, the computation yields: 
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From Equations 3.6 and 3.15, it can be seen that the maximum likelihood and the Bayesian 
parameter estimators have similar form. Both rely on sufficient statistics of the data that are 
counts of the form count(Xi = k and Pai = j) that can all be collected simultaneously in a single 
pass through the data. Both estimators are asymptotically correct in that as the number of cases 
increases, both methods converge to the true parameter values if the data is actually generated 
from the given network structure. However, in the finite sample setting the maximum likelihood 
estimator may overfit. In the Bayesian method such overfitting is counteracted by the use of 
suitable parameter priors as described in Section 3.4.4. 
3.4.2 Structure learning 
Learning the structure of a BN is harder than estimating the parameters of a known structure. 
Typically, structure learning methods learn the structure as well as the parameters of the 
structure to generate a fully specified BN. Structure learning is influenced by the goal of the 
learning task as well as the representation used for the conditional probability distributions. 
There are two main motivations for learning a BN from data. The first is for knowledge 
acquisition – to learn important dependencies and independencies among the domain variables.  
A BN structure not only discovers the independencies but also distinguishes between direct and 
indirect dependencies both of which lead to correlations in the data. Since the data available for 
learning is finite and noisily sampled from the actual but unknown joint probability distribution 
P*, it is not possible with complete reliability to detect all the independencies in the underlying 
distribution. Thus, the learned structure may contain fewer arcs and miss true dependencies or 
may learn more arcs some of which are spurious dependencies. Additionally, several different 
BN structures can all represent the same distribution; such structures are said to be members of 
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the Markov equivalence class of G*. Members of G* cannot be distinguished based on 
observational data alone. Observational data is data that is passively observed in contrast to 
experimental data in which one or more variables are manipulated and the effects on other 
variables are measured [48]. In causal learning, for example, it is important to try to distinguish 
between members of a Markov equivalence class since different member graphs represent 
different causal knowledge. 
The second reason to learn a BN structure is for density estimation. Here it is less 
important to capture the actual dependencies and independencies in G* than it is to approximate 
the underlying P* well. That is, the aim is to estimate well a statistical model of the underlying 
joint probability distribution. Typically, the goal is to learn a statistical model from a training set 
of data that can be applied to future cases. For example, in classification, the goal is to be able to 
correctly predict the true state of a target variable using the BN structure learned from the 
training set.  
At first glance it appears that as G* captures the true dependencies and independencies in 
the domain, the best generalization will be obtained by recovering the structure G*. Moreover it 
appears that it is better to err on having too many arcs in the learned structure than too few, since 
a more complex structure can still represent the data-generating distribution P*. However, it 
turns out that because data available for learning is limited, complex structures can lead to less 
reliable parameter estimates. For example, adding more parents to a variable Z leads to a larger 
CPT for Z with fewer data available for estimating each cell of the CPT. Thus, it is often better to 
prefer a sparser structure even if this structure cannot accurately represent the underlying P*. 
There are two major approaches for learning BNs: (1) constraint-based methods that 
employ independence tests among the domain variables, and (2) search-and-score methods that 
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employ a scoring metric to evaluate the goodness of the statistical model represented by a BN 
structure. More recently, methods that combine these two traditional approaches have emerged.  
Constraint-based methods. These methods view a BN as a representation of 
independence relations among the domain variables. They attempt to discover a set of 
conditional dependence and independence relations in the data and use them to determine the 
presence or absence of arcs in the network. The final induced BN structure is then hopefully one 
that best captures the independencies in the domain. A key component of these methods is the 
use of statistical tests that are applied repeatedly to the data for testing conditional independence 
relations. The main disadvantage of these methods is that with limited data the statistical tests 
can sometimes fail, and a few errors made by the testing procedure can significantly mislead the 
network construction procedure.  
Search-and-score methods. These methods view a BN as a representation of a statistical 
model of the domain variables. The scoring function measures the goodness of a BN in terms of 
how well the corresponding statistical model fits the observed data. The methods then search a 
hypothesis space of possible network structures to find a single structure or a set of high scoring 
structures. However, the space of BN structures suffers from combinatorial explosion; it contains 
a superexponential number of structures – , where n is the number of nodes in the 
network. In general, finding the highest-scoring network has been shown to be NP-hard for a 
variety of scores, and various heuristic search techniques are used to locate good networks [53].  
)2(
2nO
 Search-and-score methods consider the whole structure at once, and are therefore less 
sensitive to the absence or presence of a few erroneous arcs. In general, finding the optimal BN 
is intractable and heuristic search is typically used. 
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 The subsequent sections give details of the search-and-score methods, since the patient-
specific methods explored in this dissertation employ these methods to learn BNs from data. 
3.4.3 Structure scores 
Learning a fully specified BN from data using the search-and-score method consists of three 
components: (1) a scoring function that measures the quality of a network structure with respect 
to the data; (2) a heuristic search method for exploring the space of network structures; and (3) 
an estimator for learning the parameters of the conditional probability distributions associated 
with a specified network structure. 
 Several scoring metrics have been described. The non-Bayesian scores are discussed first 
followed by a detailed discussion of the Bayesian scores. 
Likelihood score. The simplest scoring function is the likelihood function. This is the 
same function as the one used for maximum likelihood parameter estimation. Maximizing the 
likelihood of a BN entails finding both a graph structure and parameters for that structure that 
maximize the likelihood. For a given structure the likelihood is maximized by simply choosing 
the maximum likelihood parameters as noted in the parameter estimation section. Extending this, 
in a given set of BN structures the maximum likelihood structure G is the one which has the 
highest likelihood when parameterized with MLE estimates: 
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Therefore, the likelihood structure score is defined as: 
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);ˆ,(log);();( DGLDBLLDGscore GL 〉〈=≡ θ ,   (3.17) 
where, are the maximum likelihood parameters for G. The logarithmic form of the likelihood 
function is usually used as it makes mathematical manipulations easier. For a discrete BN, the 
likelihood structure score is: 
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The likelihood score is a good measure of the fit of a BN to the training data. Typically, the 
likelihood score overfits the training data and the maximum likelihood BN generalizes poorly. 
The likelihood score learns a model that precisely fits the specifics of the empirical distribution 
in the training data, and hence the model captures both true dependencies present in P* and 
spurious dependencies that are artifacts of the specific set of cases in the training data. In BN 
structure learning with the likelihood score, on average the addition of an arc never decreases the 
score and the highest scoring structure is the completely connected network. The completely 
connected network will obviously generalize poorly since it captures no independencies present 
in P*. 
 The likelihood score is still useful when additional constraints are present that disallow 
more complex structures. For example, limiting the maximum number of parents for a node can 
overcome the likelihood score’s tendency to overfit. Another alternative, that is widely used, is 
to penalize the likelihood score; typically with a term that in some manner measures the 
complexity of the structure. 
Description Length score. The structure learning method based on the Minimum 
Description Length (MDL) principle searches for a BN that minimizes the combined length of 
the encoding of the model and the data. The model score is the length of the encoding and is 
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called the Description Length which consists of two components: (1) the length of the encoding 
of the model (for a BN the model consists of the domain variables, the structure and the 
parameters), and (2) the length of the encoding of the observed data. The first component 
penalizes model complexity, while the second component rewards the model’s fitness to the 
data. Thus, the MDL criterion optimizes the trade-off between the complexity of the selected 
structure and its fit to the training data. For a discrete BN, the Description Length structure score 
is defined as: 
[ ] );(log);( DBLLNGDimDGscoreDL −= 2 ,    (3.19) 
where  is the number of independent parameters in the BN and N is the cardinality of the 
data D.  
[ ]GDim
3.4.4 Bayesian score 
In the Bayesian approach, the scoring function is based on the posterior probability P(G | D) of 
the BN structure G given data D. The Bayesian approach treats both the structure and parameters 
as random uncertain quantities and incorporates prior distributions for both. The specification of 
the structure prior P(G) assigns prior probabilities for the different graph structures, and the 
specification of the parameter prior ) assigns prior probabilities for the possible 
parameter values for a specified structure. Application of Bayes rule gives: 
GP G |(θ
)(
)()|()|(
DP
GPGDPDGP = .      (3.20) 
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Since the denominator P(D) does not vary with the structure, it simply acts as a normalizing 
factor that does not distinguish between different structures. Dropping the denominator gives the 
Bayesian score which is defined as: 
)(log)|(log);( GPGDPDGscoreB += .    (3.21) 
The second term on the right is the prior over structures, while the first term is the marginal 
likelihood (also know as the integrated likelihood or evidence) which measures the goodness of 
fit of the given structure to the data. The marginal likelihood is computed as follows: 
GGG dGPGDPGDP
G
θθθ
θ
)|(),|()|( ∫= ,    (3.22) 
where is the likelihood of the data given the BN (G, θG) and  is the 
specified prior distribution over the possible parameter values for the network structure G. 
Intuitively, the marginal likelihood measures the goodness of fit of the structure over all possible 
values of its parameters. It is to be noted that the marginal likelihood is distinct from the 
maximum likelihood, though both are computed from the same function: the likelihood of the 
data given the structure. The maximum likelihood is the maximum value of this function while 
the marginal likelihood is the integrated (or the average) value of this function with the 
integration being carried out with respect to the prior . 
),|( GDP Gθ )|( GP Gθ
)|( GP Gθ
Marginal likelihood for discrete Bayesian networks. Equation 3.22 can be evaluated 
analytically when the following assumptions hold: (1) the variables are discrete and the data D is 
a multinomial random sample with no missing values; (2) global parameter independence, that 
is, the parameters associated with each variable are independent [54]; (3) local parameter 
independence, that is, the parameters associated with each parent state of a variable are 
independent [54]; and (4) the parameters’ prior distribution is Dirichlet. Under the above 
assumptions, the closed form for P(D | G) is given by [54-57]: 
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where is the Gamma function, and )(•Γ ∑= k ijkij αα . Also, as previously described, Nijk is the 
number of cases in the data where node i has value k and the parents of i have the state denoted 
by j, and . The Bayesian score based on the marginal likelihood is called the 
Bayesian-Dirichlet metric because of the assumption that the parameters are distributed 
according to a Dirichlet distribution [56]. 
∑= k ijkNijN
Priors. The Bayesian score in Equation 3.22 incorporates both structure and parameter 
priors. The term P(G) is called the structure prior and is the prior probability assigned to the BN 
structure G. In many situations, a uniform prior over all structures is used, in which case the 
Bayesian score reduces to the marginal likelihood. Heckerman et al. suggest the following 
structure prior with reference to a prior structure specified by an expert [56]: 
δκcGP =)( ,        (3.24) 
where c is a normalization constant, ]1,0(∈κ  is a factor that penalizes the structure for each 
unmatched arc with the prior structure, and δ is the so-called symmetric difference between G 
and the prior structure. If the prior structure is set to the empty network, the Bayesian scoring 
metric based on this prior gives preference to simpler structures. In the case of BN structures that 
represent local structure in the form of decision trees or decision graphs, the structure prior will 
incorporate terms for priors on the global structure as well as terms for priors on the local 
structures. An example of such a prior is described in the next chapter. 
The parameter priors are incorporated in the marginal likelihood as is obvious from 
Equation 3.23. In the case of the Bayesian-Dirichlet metric several parameter priors have been 
described. Cooper and Herkovits introduced the K2 metric where all hyperparameters ijkα  in 
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Equation 3.24 are set to 1 [55, 58].  Heckerman et al. showed that if for all nodes i the sum 
is constant, then Equation 3.23 yields the same score for all Markov equivalent 
structures given D. Due to this property of likelihood equivalence, this scoring metric is known 
as the Bayesian Dirichlet likelihood-equivalent (BDe) metric. A special case of the BDe metric is 
the BDeu (Bayesian Dirichlet likelihood-equivalent and uniform) metric that uses uniform priors 
such that 
∑= jk ijkαα 0
ijk ii rq/0αα =  where qi is the number of parent states of Xi and ri is the number of 
values of Xi [59]. 
Bayesian score avoids overfitting. The difference between the marginal likelihood and 
the maximum likelihood provides one view of why the Bayesian score avoids overfitting. The 
maximum likelihood overfits because it evaluates the likelihood function at the best parameter 
values for the training data. These parameter values need not be the optimal values for the data in 
general because of noise in the training data. The Bayesian approach concurs that the MLE 
parameter values are the most likely given the training data; however, it emphasizes that there 
are other parameter values which though less likely are still plausible and should be taken into 
consideration. By integrating  rather than maximizing it, the Bayesian approach 
measures the expected likelihood averaged over different choices of , which typically leads to 
a more conservative estimate of the goodness of fit of the model. 
),|( GDP Gθ
Gθ
3.4.5 Search methods 
Given a scoring function, a training dataset and a space of possible network structures, the goal 
of a search-and-score method is to find a network structure or a set of network structures that 
maximize the score. Efficient algorithms have been developed for learning network structures 
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under certain restrictions. For example, in the restricted space of networks that are trees the 
optimal tree can be learned efficiently in polynomial time [56, 60]. Also, given an ordering on 
the domain variables finding the network with the highest score consistent with the ordering is 
not NP-hard [55, 59]. Unfortunately, the task of finding a network structure that optimizes the 
score is a combinatorial optimization problem, and is known to be NP-hard [53, 61], even if each 
node is restricted to having at most two parents. Since it is unlikely that there is an efficient 
algorithm for finding the highest scoring structure, the search-and-score methods employ 
heuristic search that attempts to find the best network but is not guaranteed to do so. In practice 
several heuristic search methods like greedy hill-climbing search work well. 
 Several properties of the scoring function make heuristic search computationally 
efficient. A key property that aids the search algorithm is the decomposability of the score, that 
is, the score can be expressed as a sum of sub-scores where each sub-score is a function of only 
one node and its parents (termed FamScore below): 
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To appreciate the advantage of a decomposable score, consider two network structures that differ 
only in the presence or absence of an arc into a node Xi. To compare the scores of the two 
networks, it suffices to compute the sub-score for both structures; the 
remaining sub-scores are the same for both structures and need not be recomputed. Since the cost 
of computing the scores of structures usually consumes most of the running time of the 
algorithm, score decomposability provides a large reduction in running time. 
);|( GXFamScore ii Pa
A second property of a scoring function that is useful is score equivalence, that is, if two 
structures belong to the same Markov equivalence class they are assigned the same score. In the 
standard representation of BN that uses DAGs, several distinct DAGs may represent the same 
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statistical model because they encode the same set of conditional independencies. All DAGs that 
encode the same set of conditional independencies are said to belong to a single Markov 
equivalence class. Searching in the space of DAGs to find high scoring statistical models can be 
wasteful since the search procedure is likely to score multiple structures in the same equivalence 
class. A score equivalent scoring function can enable the search algorithm to search in the space 
of equivalence classes which is smaller than the corresponding space of DAGs. Typically, this 
property is less crucial than score decomposability for the search algorithm. 
Heuristic search for BN structures encompasses several aspects. The major components 
of heuristic search include the search space together with the operators for navigating this space, 
the scoring function for evaluating candidate network structures, and the search procedure. 
The search space is a graph where each vertex represents a candidate network structure 
and each arc connects two vertices where a network structure represented by one vertex can be 
converted to the network structure represented by the neighboring vertex by the single 
application of a valid operator. Each vertex in the search space is associated with a score (that is 
computed by the scoring function) and has a set of neighboring vertices. The search procedure 
begins at one vertex and explores the search space via the neighboring vertices to find a high 
scoring vertex. 
One of the earliest search-and-score methods that was developed is the K2 algorithm 
[55]. This algorithm assumes a topological ordering on the nodes and constrains the number of 
parents that a node can have. For each node Xi, the search procedure iteratively adds as a parent 
the node from the set of predecessors of Xi (given in the topological ordering) that most increases 
the K2 score. The search for the parents of Xi terminates when none of the remaining predecessor 
nodes when added to the parent set increases the score, or the number of parents exceeds a 
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predetermined constant. Since an ordering of the nodes may not be easily obtainable in many 
domains, attempts have been made to relax this requirement. Cooper and Herskovits describe a 
modification of the K2 algorithm that is based on many random node orderings, and thus does 
not require a pre-specified node ordering [55]. Another method that overcomes the necessity for 
a node ordering performs heuristic search over the space of node orderings rather than the space 
of network structures [62]. 
The search-and-score methods for leaning BN structures traverse the space of structures 
by making small modifications to the structure at each step, typically a single arc change, and 
evaluating the merit of each change. The K2 algorithm, for example, at each iteration of the 
search selects a new BN structure that has one more arc more than the current structure. The K2 
algorithm uses a single operator of adding an arc between two unlinked nodes to generate 
candidate BN structures. More typically, search-and-score methods employ several single arc 
change operators  [57]. The commonly used operators to make single arc changes are: 
• add an arc between two nodes if there is no arc connecting them, 
• remove an existing arc, and 
• reverse an existing arc. 
In the application of these operators only those operations are considered that result in a legal 
network: the network should be acyclic and should satisfy other additional constraints that may 
have been specified like a maximum indegree. These algorithms are typically coupled with a 
decomposable score that consists of a sum of sub-scores, one for each node. The application of 
the above operators to a structure results in structures whose scores differ from that of the 
previous structure either in one sub-score (in the case of addition or deletion of an arc) or in two 
sub-scores (in the case of arc reversal).  
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 These algorithms are said to employ local search procedures (hence they are known 
local search algorithms) where the search procedure moves from one candidate structure to a 
neighboring structure that differs from the previous structure in a single arc resulting from the 
application of a single operator. The simplest, and often used, local search procedure is the 
greedy hill-climbing procedure. At each iteration, the search procedure selects the neighboring 
structure with the largest improvement in the score to replace the current structure. The search 
terminates when no neighboring structure can be found that improves on the score of the current 
structure. Greedy hill-climbing often works well in practice, although it has the propensity of 
terminating in a local maximum or a plateau.  
Several strategies are employed to escape from local maxima or plateaus and improve on 
the performance of greedy hill-climbing. One effective strategy is TABU search [63]. TABU 
search keeps a list of the recently applied operators and at each iteration those operators that 
result in the reversal of the effect of the recently applied operators are not considered. This forces 
the search to explore new directions in the search space and escape local maxima. 
Another strategy is random restart search. When greedy hill-climbing search terminates, 
the resulting best network is perturbed by the application of several randomly chosen operators, 
and the greedy search is restarted from the new network. A third strategy is simulated annealing 
that interleaves regular hill-climbing moves with random moves that may temporarily decrease 
the score in the hopes of leading the search to eventually find models with higher scores.  
Finally, more exhaustive search methods like best-first search and beam search can 
improve on the performance of local search methods. Recent advances in structure learning have 
led to efficient methods of discovering the optimal structure in small to medium sized domains 
using exhaustive search. Koivisto describes an algorithm that is only O(n2n) in time complexity 
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and O(n2n) in space complexity where n is the number of domain variables, and demonstrates 
that the algorithm is practically feasible for domains containing up to 25 variables [64, 65]. This 
algorithm obtains computational time savings of the order of n2 over standard structure learning 
methods. 
3.5 LEARNING BAYESIAN NETWORKS WITH LOCAL STRUCTURE 
The discussion on structure learning has so far focused on tabular CPD BNs and the same 
discussion is also applicable to complete CPD BNs which use the alternate representation of 
complete decision trees for CPDs. When additional local structure is captured by the use of 
decision tree CPDs or decision graph CPDs, the standard scoring metrics and search methods 
described previously can be used with minor modifications. This section describes the 
modifications to the standard search-and-score method for learning decision graph CPD BNs, 
and in particular, focuses on the Bayesian score and greedy hill-climbing search. 
Learning decision tree CPD BNs where the local CPDs are represented by decision trees 
is discussed in detail by Friedman and Goldszmidt [51].  Chickering et al. describe in detail the 
learning of decision graph CPD BNs where the local CPDs are represented by decision graphs 
[52]. As noted previously, decision graph CPDs are a generalization of decision tree CPDs in 
that they can represent a richer set of equality constraints among local parameters than either 
decision tree CPDs or CPTs. 
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parent state index j j = 1 j = 2 j = 3 j = 4 
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Figure 3-5: Examples of indexing of parent states in CPDs. Several CPD representations for the 
BN node X4 (fatigue) in panel (a) are shown in subsequent panels. Panel (b) shows a CPT 
associated with node X4 in which the parent states of X4 are indexed by j as indicated in the 
shaded row. The CPT can be equivalently represented by a full decision tree as shown in panel (c) 
in which the parent states of X4 are indexed by l as indicated in the shaded boxes. Panel (d) shows 
a decision graph CPD for the node X4 in which the parent states are indexed by l as indicated in 
the shaded boxes. In both decision tree and decision graph CPDs the indexing of parent states is 
carried over the set of leaf nodes. 
 
 
  
3.5.1 Bayesian score 
A tabular CPD BN or a complete CPD BN is represented by the pair (G, θG) where G, the global 
network structure, specifies the set of parents for each node Xi. The local conditional probability 
distributions  for each Xi in a tabular CPD BN are represented by a unique CPT, the 
size of which is determined by the number of parent states and the number of states of Xi. 
Equivalently, in a complete CPD BN the local conditional probability distributions for each Xi 
are represented by a complete decision tree. For both these representations, the Bayesian score of 
the BN structure is given by Equation 3.21 and the Bayesian parameter estimates for the CPDs at 
each node Xi are given by Equation 3.15. 
)|( iPaiXP
For a decision graph CPD BN, the specification of the structure S consists of the global 
network structure G that specifies the set of parents for each node Xi, and, additionally, a local 
decision graph structure DGi for each Xi. Thus, the fully specified decision graph CPD BN is 
given by SnDGDGGS θ},,...,,{ 1≡  where each DGi represents the local conditional probability 
distributions  for the corresponding node Xi. In both complete CPD BNs and 
decision graph CPD BNs, the BN nodes are indexed by the variable i and the states of a BN node 
Xi are indexed by the variable k. However, the two representations will potentially differ in the 
number of parent states for a BN node Xi. An illustrative example is given in Figure 3-5. For the 
BN node X4 in Figure 3-5 (a), the CPT representation is given in Figure 3-5 (b) where each 
column corresponds to a parent state and the columns are indexed by the variable j. For the same 
node, the decision graph representation is given in Figure 3-5 (d) where each leaf node 
corresponds to a set of parent states that have the same CPD and the leaf nodes are indexed by 
the variable l. Both representations have the same number of parent states and differ only in the 
)|( iPaiXP
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name of the indexing variable: CPT columns are indexed by variable j and decision graph leaf 
nodes are indexed by the variable l. Of note, the CPT in Figure 3-5 (b) can also be represented by 
a complete decision tree as shown in 3-5 (c). 
The Bayesian score and the Bayesian parameter estimates for the decision graph CPD 
BN are now derived. Analogous to the tabular CPD BN Bayesian score given by Equation 3.21, 
the Bayesian score for the decision graph CPD BN is: 
)(log)|(log);( SPSDPDSscoreB += .    (3.26) 
The marginal likelihood is derived in an analogous fashion to the marginal likelihood of the 
tabular CPD BN given by Equation 3.23: 
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where iL  is the cardinality of the set of leaves in the decision graph DGi of Xi, Nilk is the number 
of cases in the dataset D that have Xi = k and have parent states of Xi that correspond to one of 
the paths in the decision graph leading to the leaf node l, and ∑= k ilkil NN . The key difference 
between Equation 3.23 and 3.27 is in the middle product, which in Equation 3.23 runs over all 
the columns in the CPT, while in Equation 3.27 it runs over all the leaf nodes of the decision 
graph of Xi. 
 The structure prior P(S) in Equation 3.26 can be decomposed into a prior over the global 
structure G and a prior for each decision graph structure DGi: 
     (3.28) 
,)|()(
)|,...,,()(
),...,,,()(
1
21
21
∏
=
=
=
≡
n
i
i
n
n
GDGPGP
GDGDGDGPGP
DGDGDGGPSP
 69 
  
where, the decomposition in the second line is obtained by the application of the chain rule of 
probability and the product in the third line is based on the assumption that the priors for the 
local structure at each node are specified independently of each other. Substituting Equation 3.28 
into Equation 3.26 and expanding S gives: 
∑
=
++=
n
i
innB GDGPGPDGDGGDPDDGDGGscore
1
11 )|(log)(log),...,,|(log);,...,,(  
          (3.29) 
A complete specification of a decomposable prior over both the global BN structure and the local 
decision graph structures is given in the next chapter in conjunction with the description of the 
patient-specific algorithms. 
The Bayesian parameter estimates for the decision graph CPDs of Xi are derived in a 
similar fashion to the parameter estimates for the CPT of Xi (which is given in Equation 3.15): 
ilil
ilkilk
ilk N
N
+
+= α
αθˆ ,       (3.30) 
where, Nilk is the number of cases in the dataset D that have Xi = k and have parent states of Xi 
that correspond to one of the paths in the decision graph leading to the leaf node l, 
and .  ∑= k ilkil NN
3.5.2 Search methods 
The search space for learning decision graph CPD BNs is richer than the corresponding space for 
learning tabular CPD BNs (or equivalently the complete CPD BNs). The tabular representation 
provides a single CPT associated with a node Xi, while the decision graph representation 
provides several possible decision graphs for the node Xi, where each decision graph asserts a 
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distinct set of equality constraints among the local parameters for Xi. Consequently, the search in 
the space of decision graph CPD BNs has to include a search over the local structure of the 
nodes. There are two approaches to performing this search. 
Encapsulated search spaces. This approach uses a two-tier search procedure that 
consists of an outer search procedure and an inner search procedure. The outer search procedure 
generates candidate global structures while the inner search procedure refines a given global 
structure by generating and evaluating candidate local structures. The operators used in the outer 
search procedure will be referred to as global operators to distinguish them from those that are 
used in the inner search procedure which will be referred to as local operators. Also, two types 
of nodes will be distinguished. The nodes in the DAG structure of the BN will be termed as BN 
nodes while the nodes in the decision graph structure will be termed as DG nodes. 
The global operators modify the DAG structure of the BN by adding, removing or 
reversing an arc between the BN nodes (see Figure 3-6). Application of a global operator results 
in a new global structure that has one more arc, one less arc or an arc that is reversed which 
implies that the parent sets of at most two BN nodes have changed.  
Figure 3-6: Bayesian network global operators: (a) the original BN with three BN nodes where 
X1 is a parent of X3, (b) the result of applying the add operator, which adds an arc from X2 to X3, 
(c) the result of applying the remove operator, which removes the existing arc between X1 to X3, 
and (d) the result of applying the reverse operator, which reverses the existing arc between X2 and
X3. The add and remove operators modify the parent set of a single BN node while the reverse
operator modifies the parent set of a pair BN nodes. 
 
X1 X2 
X3 
(b)(a) 
X2 
X3 
(c)
X1 X1 X2 
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X1 X2 
X3 
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Following the generation of a new global structure by the outer search procedure, the 
inner search procedure searches for an optimal decision graph for only those BN nodes whose 
parent sets have changed by the application of the global operator. A decision graph for a BN 
node Xi is a graph that contains two types of DG nodes: internal DG nodes and leaf DG nodes. 
An internal DG node represents a parent of Xi and a leaf DG node represents the parameters of a 
CPD of Xi. To traverse the space of decision graph structures associated with Xi, a set of three 
local operators was defined by Chickering [52].  The three local operators are the complete split, 
the binary split, and the merge. Each local operator modifies the current set of leaf DG nodes in 
the decision graph structure as follows (see Figure 3-7): 
• The complete split local operator replaces a leaf DG node in the graph with an internal 
DG node corresponding to a variable from the parent set. New leaf DG nodes are added 
as children to the new internal DG node, with one leaf DG node for each distinct state of 
the variable. 
• The binary split local operator also replaces a leaf DG node in the graph with an internal 
DG node corresponding to a variable from the parent set. However, only two new leaf 
DG nodes are added as children to the new internal DG node, with one leaf DG node for 
a distinct value of the variable and the remaining leaf DG node for all other states of the 
variable. 
• The merge local operator merges two distinct leaf DG nodes into a single leaf DG node 
that inherits all incoming arcs from both the original leaf DG nodes. 
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Examples of the application of these local operators are shown in Figure 3-7. These operators are 
sufficient for moving from a decision graph structure to any other one in the search space. For 
example, starting with a decision graph containing a single DG leaf node, a complete decision 
tree can be generated by repeatedly applying the complete split operator. By repeatedly applying 
the merge operator to the leaves of the complete decision tree, a graph that represents any 
parameter set equalities can be generated. Though the complete split operator is not essential 
since it can replaced by a series of applications of the binary split operator, it is included to 
enable the search procedure to move more efficiently in the search space.  
Typically, greedy hill-climbing search is used to locate a high-scoring decision graph 
structure. The search starts with a decision graph containing a single DG leaf node and applies 
the local operators to generate candidate local structures. An example showing search in an 
Figure 3-7: Bayesian network local operators: (a) the original decision graph for the BN node X3, 
showing one parent X1 that is in X3’s decision graph, (b) the result of applying the complete split
operator, which splits based on all values of X1, (c) the result of applying the binary split operator, 
which splits one state of X2 from all other states, and (d) the result of applying the merge operator, 
which merges two values of X1 into a single value. In this figure, all the variables have three 
states, but in general each variable can have an arbitrary number of discrete states. Figure 
modified from [52]. 
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Figure 3-8: Example of encapsulated search demonstrating the application of a global operator 
followed by the application of two local operators. BN nodes are shown as ellipses with a single 
border and DG nodes are shown as circular or rectangular nodes with double borders. Application 
of the global operator add that adds an arc from node X3 to X4 to the structure in (a) results in the 
structure in (b). Application of the local operator complete split to the left hand leaf node of the 
decision graph of X4 in (b) results in the decision graph in (c). Application of the local operator 
merge to the two right hand leaf nodes of the decision graph of X4 in (c) results in the decision 
graph in (d).  
encapsulated search space is given in Figure 3-8. 
Unified search spaces. An alternative approach for learning the local structure of a BN 
node employs a unified search space. Instead of two sets of operators, one for modifying the 
global DAG and another for modifying the local decision graph, a single set of operators modify 
the joint representation of the global network and the local structures in a single search space. 
  
This is feasible since the local structure associated with the BN node Xi identifies the set of BN 
nodes that are the parents of Xi; the set of all local structures thus identifies the parents of every 
BN node which is sufficient to uniquely identify the DAG of the BN.  
 In the case of decision graph CPD BNs, each member in the unified search space consists 
of a collection of n decision graphs nDGDG ,...,1  that represent the local structures associated 
(a) 
X3 
T F 
Figure 3-9: Example of unified search demonstrating the application of two operators. BN nodes 
are shown as ellipses with a single border and DG nodes are shown as circular or rectangular 
nodes with double borders. In each panel, the set of local structures is shown at the top enclosed 
in a box and the implied global structure is shown at the bottom. Application of the operator 
complete split to the left hand leaf node of the lower decision graph in (a) results in the decision 
graph in (b). Application of the operator merge to the two right hand leaf nodes of the lower 
decision graph in (b) results in the decision graph in (c). 
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with the n domain variables . A collection of local structures induces a unique network 
structure among the domain variables: an arc  is present in the network structure if 
there is a node for Xj in the decision graph DGi. Only those collections of decision graphs that 
induce an acyclic network among the domain variables are legal members of the search space. 
The operators for moving in this search space are typically the same ones that modify the local 
structure in the encapsulated search space, namely, the complete split, binary split, and merge 
local operators described above. The global operators of adding, deleting and reversing arcs are 
not needed in this search space. 
nXX ,...,1
ij XX →
 Typically, greedy hill-climbing search is used to locate a high-scoring structure. The 
search starts with an empty network with each node’s decision graph initialized to a single root 
DG node. Each node Xi is considered in turn as follows. All non-descendants that are not already 
parents of Xi are added to the parent set of Xi and the highest scoring decision graph is learned in 
a greedy fashion. This decision graph DGi becomes the local structure for Xi. Any parent variable 
that is not present in DGi is removed from the parent set of Xi and the corresponding arc 
is deleted from the global structure. The search terminates after all the nodes have been 
considered. An example showing search in a unified search space is given in Figure 3-9. 
ij XX →
3.6 LEARNING BAYESIAN NETWORK CLASSIFIERS FROM DATA 
Classification is a central problem in machine learning that involves inducing a classifier from a 
set of classified training cases that can be applied to unclassified cases. The goal in classification 
is to predict the value of a discrete class variable Z from the known values of a set of predictor 
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variables . Given a set of classified training cases 
 a classification algorithm induces a classifier or a 
classification rule c(x) that is capable of predicting the likely value of Z for future cases where 
only the values of the predictor variables X are known. 
},...,,{ 21 nXXX=X
,(),...,,(),, 2211 zz mxx )}{( mzD x=
Probabilistic classifiers specify a probability distribution over the class variable 
conditioned on the predictor variables. This distribution is then used for deciding the predicted 
class for a test case where the values of the predictor variables are known. For example, if the 
class variable is binary, a threshold is selected and the test case is assigned to one class value if 
the predicted probability is above the threshold or to the other class value if below the threshold. 
A test case where the predicted probability is equal to the threshold may be assigned to either 
class value. For a class variable with more than two classes, the test case is typically assigned to 
the class value with the highest probability. 
In the decision-theoretic framework, the distribution over the class variable specified by 
the probabilistic classifier is combined with a loss function (or cost function) to formally specify 
a decision rule which is termed a classification rule in the context of classification. A 
classification rule c(x) is a function that maps every possible combination of variable values x, to 
a class value z.  A loss function specifies the loss or cost that is incurred by predicting 
the class value zi when the true value is zj, for all values zi and zj. The expected loss or expected 
misclassification cost, incurred in predicting the class value zi on observing the variable values x 
is: 
),( ji zzL
)|(),()|( xx jji
j
i zpzzLzEL ∑= .     (3.31) 
 77 
  
This is the weighted average of the losses incurred by predicting the particular class value zi as 
the true class value ranges over all possible values zj, with each loss corresponding to the true 
class value zj being weighted by the predicted probability for that class. According to 
the Bayes decision procedure, the optimal class value is the one that minimizes the expected loss 
or the expected classification cost. Thus, the classification rule is: 
)|( xjzp
[ )|(minarg)( xi
z
zELxc
i
= ].      (3.32) 
To summarize, probabilistic classifiers such as BN classifiers (described later), operate 
by estimating the probability distribution for a test case at hand, which is then used in 
computing the expected misclassification costs for each of the class values using equation 3.31. 
Finally, the classification rule in equation 3.32 selects the class value with the minimum 
expected misclassification cost. Thus, the predicted class value depends on both the probabilities 
estimated by the classifier and the specified loss function. 
)|( xzp
3.6.1 Minimum error rate classification 
A commonly used criterion for evaluating the performance of classifiers is the misclassification 
error rate or simply the error rate. If the true class value is zi, then predicting any class value 
other than zi results in a misclassification error. If the error rate is to be low then it is natural to 
seek a classification rule that minimizes the probability of error. The loss function used for 
minimizing the error rate is the zero-one loss function, which assigns zero loss to a correct 
classification and unit loss to any misclassification thus penalizing all errors equally: 
otherwiseandjiifzzL ji 01),( ≠= .    (3.33) 
The expected loss for predicting the class value zj is: 
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where the last term  is the average probability of error, since is the 
conditional probability that the class value zj is correct given x is observed. The classification 
rule according to the Bayes decision procedure is 
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which states that the average probability of error is minimized when the class value zj with the 
highest predicted probability is selected. Thus, the optimal minimum error rate classifier simply 
chooses the class value with the highest probability. 
3.6.2 Calibration 
Another criterion that is used for evaluating the performance of a classifier is calibration. 
Calibration is the extent to which the classifier’s probability estimate agrees with the true 
probability. More precisely, the predicted probability p of a class zi is well calibrated when the 
cases assigned a probability p of belonging to class zi actually belong to that class a fraction p of 
the time.  
It is possible for a classifier to have a small error rate yet have poor calibration. For 
example, consider a classifier that consistently produces excessively high probabilities for the 
true class. The classifier remains accurate if it produces any probability that is higher than the 
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calibrated probability p for the true class. However, its predicted probability for the true class is 
far too high leading to poor calibration. Naïve Bayes classifiers have been shown to produce 
probabilities that are arbitrarily close to 1 or arbitrarily close to 0 that are more extreme than 
warranted [66]. This behavior typically does not increase the error rate but leads to poor 
calibration. 
Quite commonly, a classifier learns a classification rule by directly optimizing the error 
rate or the zero-one loss function. However, this may be inappropriate when the correct loss 
function is unknown or the zero-one loss function is unsuitable. For example, in predicting 
clinical outcomes with classifiers, the misclassification cost may be significantly influenced by 
patient utilities in which case the misclassification loss function varies from case to case. 
Therefore minimizing the error rate, which corresponds to minimizing a fixed misclassification 
cost, is inappropriate. If the estimated probabilities are well calibrated, optimal predictions will 
be obtained for any future misclassification costs that may need to be applied. 
3.6.3 Bayesian network classifiers 
Several probabilistic classification algorithms use Bayesian network models for classification. 
The naïve Bayes classifier is the simplest BN classifier that is learned very efficiently from data. 
Among its early applications was in the context of a medical diagnostic system [67]. In spite of 
its simplicity it often has excellent misclassification error rates and it is widely used as a 
benchmark against which to compare new classifiers. The naïve Bayes classifier makes the 
strong assumption that the predictor variables are mutually independent conditioned on the class 
variable, which implies that all predictors are considered equally important for classification and 
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that the predictors do not interact. This assumption allows for a very parsimonious representation 
of the joint probability distribution over the domain variables: 
∏
=
=
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i ZXpZpZp
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)|()(),( X .     (3.36) 
Learning the naïve Bayes classifier from data, without variable selection, is simple since no 
structure learning is necessary. The learning of the parameters of the model requires estimating 
the class probability distribution  and the conditional probabilities  for each 
predictor variable Xi. This is done easily and efficiently from data using either the Bayesian or 
the non-Bayesian methods described in Section 3.4.1. 
)(Zp )|( ZXp i
The Tree Augmented Naïve Bayes (TAN) classifier extends the naïve Bayes classifier by 
relaxing the naïve Bayes structure to allow one extra parent per predictor variable in addition to 
the class variable. This enables the modeling of interactions among predictor variables not 
captured by the class variable and thus overcomes the main weakness of the naïve Bayes 
classifier. The TAN classifier has been shown to improve on the accuracy of the naïve Bayes 
classifier while maintaining its computational simplicity of learning [68].  
However, extending the TAN classifier to the general Bayesian network classifier does 
not necessarily improve on the classification performance over simpler BN structures. 
Intuitively, learning general BNs corresponds to solving the more general problem of learning 
the joint probability distribution over all the variables in the domain, whereas learning a 
classifier corresponds to solving the simpler problem of learning the conditional distribution of 
the class variable given the predictor variables. The standard scores used for learning BNs are 
proportional to the joint likelihood of all the variables. The Bayesian score, for example, is 
proportional to the log marginal likelihood, log , which can be decomposed as )|( MDp
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where, DZ is the segment of the training dataset limited to the values of the target variable Z and 
DX is the remaining portion of the dataset limited to the values of the predictor variables X. The 
first term on the right hand side of Equation 3.37 measures how well M estimates the probability 
of the target variable Z given the predictor variables X, and this term directly relates to the 
performance of M as a classifier. Note, however, that as the number of predictors increases the 
second term dominates the overall score. Thus, it is possible for a high scoring BN structure to 
have a high misclassification error rate if the contribution of the second term to the score is 
relatively larger than that of the first term to the overall score. 
This first term, known as the conditional likelihood, can form the basis for a better score 
for learning BN classifiers. However, the conditional likelihood does not decompose into 
separate terms for each variable and hence is not node-decomposable as is the case for the 
marginal likelihood. There is, also, no known closed form for computing the parameters that 
maximize the conditional likelihood, as is the case for the marginal likelihood; hence there is no 
known tractable algorithm that learns both the structure and parameters of a general Bayesian 
network that maximizes the conditional likelihood. Recently, efforts have been made to induce 
Bayesian network classifiers that approximately maximize the conditional likelihood. One 
approach uses a numerical method to estimate parameter values that maximize the conditional 
likelihood of a given BN structure [69]. Another approach computes the conditional likelihood of 
a BN structure using the easily estimated maximum likelihood parameter values rather than the 
maximum conditional likelihood parameter values [70]. These approaches have been shown to 
improve on the performance of naïve Bayes and TAN classifiers. 
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3.7 BAYESIAN MODEL AVERAGING 
Choosing a single BN structure that has a large Bayesian score as described so far is a form of 
model selection that can sometimes serve as an approximation to the complete Bayesian 
approach of model averaging. In Bayesian model averaging (BMA) with BNs, in addition to 
modeling the uncertainty in parameters, the uncertainty in the BN structure is modeled as well.  
The general procedure for BMA is as follows [19]. If h is a quantity of interest, such as 
an effect size, a future observable, or the utility of a course of action, BMA computes the 
probability distribution of h given the data D by averaging over possible structures and their 
parameters: 
∑=
m
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where 
∫= mmm dDmpmhpDmhp θθθ ),|(),|(),|( .    (3.39) 
Equation 3.39 emphasizes that the probability distribution of h is an average of the probability 
distributions of h under each model m weighted by the posterior probability of that model given 
the data. Equation 3.38 shows that for each model m, the probability distribution of h is obtained 
by integrating over all parameters.  
Given data, the posterior distributions for each m and  are obtained by applying Bayes’ 
rule: 
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where 
 .    (3.42) ∫= mmm dmpmDpmDp θθθ )|(),|()|(
The term  is called the marginal likelihood or the integrated likelihood. Here the 
uncertainty about m is encoded in the prior distribution p(m). In addition, for each model 
structure m, the uncertainty about  is encoded in the prior distribution . 
)|( mDp
mθ )|( mp mθ
When BNs structures are used for classification, the quantity of interest h is the value of 
the class variable Zt for a future case t with features Xt = xt. According to BMA, the posterior 
distribution P(Zt | xt, D) is obtained by averaging over all BN structures G: 
∑=
G
tt DGPDGZPDZP )|(),,|(),|( tt xx .    (3.43) 
Averaging over all the models in this fashion provides better predictive ability, as measured by 
logarithmic loss than using any single model [71, 72]. 
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4.0  METHODOLOGY 
This chapter describes the patient-specific approach to learning Bayesian networks from data. 
After a summary of the main ideas of this approach that have been covered in the previous 
chapters, a detailed description of two versions of the patient-specific algorithm is given. 
The goal of the patient-specific algorithm is to predict well a discrete target variable of 
interest, such as a patient outcome. In particular, the focus is on the prediction of low-
dimensional, atemporal outcomes (e.g., binary outcomes such as death versus survival). In 
machine learning terminology, the patient-specific algorithm is an example of an instance-
specific classification algorithm.  
Relative to some model space, Bayesian model averaging is the optimal method for 
making predictions in the sense that it achieves the lowest expected error rate in predicting the 
outcomes of future cases. Such Bayes optimal predictions involve averaging over all models in 
the model space which is usually computationally intractable. One approach, termed selective 
model averaging, has been to approximate the Bayes optimal prediction by averaging over a 
subset of the possible models and has been shown to improve predictive performance [19, 71, 
72]. The patient-specific algorithm performs selective model averaging and uses a novel 
heuristic search to select the models over which averaging is done. The patient-specific 
characteristic of the algorithm arises from the observation that the search heuristic is sensitive to 
the features of the particular case at hand. 
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The model space employed by the patient-specific algorithm is the space of Bayesian 
networks over the domain variables. In particular, the algorithm considers only Markov blankets 
of the target node, since this is sufficient for predicting the target variable. Two versions of the 
patient-specific algorithm are considered that differ in the representation employed for the 
conditional probability distributions. The patient-specific Markov blanket global structure 
(PSMBg) algorithm learns MBs that allow for explicit representation of only global 
independencies among nodes of the MB. The patient-specific Markov blanket local structure 
(PSMBl) algorithm learns MBs that allow for explicit representation of value-specific 
independencies in the conditional distributions associated with a node. This implies that the 
PSMBl algorithm employs a richer space of models than the PSMBg algorithm. 
The remainder of the chapter describes the patient-specific algorithms in terms of the (1) 
model space, (2) representations of the models, (3) scoring metrics including parameter and 
structure priors, and (4) the search procedure for exploring the space of models. The current 
versions of the algorithms handle only discrete variables and do not handle missing values. 
4.1 MODEL SPACE 
The primary goal is to compute the predictive distribution of the target variable. In a BN, the 
nodes that effect the distribution of the target node are those contained in the Markov blanket 
(MB) of the target, and include the parents, the children and the parents of the children (spouses) 
of the target node. Provided the MB nodes of the target are observable, nodes of the BN that are 
not part of the MB are not required for determining the distribution of the target and are hence 
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not needed for inference as asserted by the global Markov condition. Therefore, the patient-
specific algorithms learn MBs of the target variable rather than entire BNs over all the variables. 
Typically, BN structure learning algorithms that learn from data, such as the search-and-
score and the constraint-based methods described in the previous chapter, induce a BN structure 
over all the variables in the domain. The MB of the target variable can be extracted from the 
learned BN structure by ignoring those nodes and their relations that are not members of the MB. 
However, it is practically somewhat more efficient to modify the typical BN structure learning 
algorithm to learn only MBs of the target node of interest, by using a set of global operators that 
have been modified to generate only the MB structures of the target variable. 
The patient-specific Markov blanket algorithms are search-and-score methods that search 
in the space of possible MB structures. The Bayesian network structure learning algorithms 
search in the space of possible BN structures which is exponential in the number of domain 
variables. The number of BN structures with n variables is given by the following recurrence 
formula where BN(n) is the number of DAGs that can be constructed from n nodes [73, 74]: 
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,  (4.1) 
where, C(n, k) is the count of the number ways to choose k objects from n distinct objects. 
Hence, exhaustive search in the space of BN structures is infeasible for domains containing more 
than a few variables and heuristic search is appropriate.  
The number of MB structures with respect to a single target variable in a domain with m 
variables (where m excludes the target variable) is given by the following equation: 
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where, m  is number of parent nodes, m  is the number of child nodes, mo is the number of other 
nodes, and is computed as m  = m - m  – m . BN(m ) is the number of DAGs that can be 
constructed from n  nodes and is computed from Equation 4.1. The derivation of the recurrence 
formula in Equation 4.2 is given in Appendix A. 
Table 4-1 gives the number of BN and MB structures for domains having up to 12 
variables. It can be seen from the table that while there are fewer MB structures of the target 
variable than there are BN structures, the number of MB structures is nevertheless exponential in 
the number of variables. Thus, exhaustive search in the space of MB structures is also infeasible 
for domain priate. 
o p o c
c
s containing more than a few variables and heuristic search is appro
Table 4-1: Number of Bayesian network structures BN(n) and Markov blanket structures MB(n-1) 
as a function of number of nodes n. The number of Markov blanket structures is with respect to a 
single node and is not a count of all Markov blanket structures for all nodes. The last column gives 
the ratio of the two types of structures. Both BN(n) and MB(n-1) are exponential in n.  
BN(n) MB(n-1) BN(n) / MB(n-1)n 
0 1 - - 
1 1 1  1.0 
2 3 3  1.0 
3 25 15 1.67 
4 543 153 3.55 
5 29281 3567 8.21 
6 3781503 196833 19.21 
7 1138779265 25604415 44.48 
8 783702329343 7727833473 101.41 
9 1213442454842881 5321887813887 228.01 
10 4175098976430598143 8241841773665793 506.57 
11 31603459396418917607425 28359559029362676735 1114.38 
12 521939651343829405020504063 214672167825864945784833 2431.33 
  
4.2 MARKOV BLANKET LOCAL STRUCTURE 
The PSMBg algorithm learns complete CPD MBs in which the CPDs are represented with 
Figure 4-1: An example in which the local Markov blanket structure depends on the value of 
lung cancer. Panel (a) shows the global structure and the associated parameters for the node X4. 
Panel (b) illustrates four structures that explicitly demonstrate how the structure varies for 
complete decision trees. Complete decision trees capture only the global structure, that is, 
different values of lung cancer. The values T and F stand for True and False respectively.  
X2=F X3=F 
X4 
chronic 
bronchitis 
lung 
cancer 
fatigue 
X2=F X3=T 
X4 
chronic 
bronchitis 
lung 
cancer 
fatigue 
X2=T X3=F 
X4 
chronic 
bronchitis 
lung 
cancer 
fatigue 
X2=T X3=T 
X4 
chronic 
bronchitis 
lung 
cancer 
fatigue 
X2 X3 
X4 
chronic 
bronchitis 
lung 
cancer 
fatigue (a) 
(b) 
P(X4 = F | X2 = F, X3 = F) = 0.95 
P(X4 = F | X2 = T, X3 = F) = 0.90 
P(X4 = F | X2 = F, X3 = T) = 0.40 
P(X4 = F | X2 = T, X3 = T) = 0.40 
 
P(X4 = T | X2 = F, X3 = F) = 0.05 
P(X4 = T | X2 = T, X3 = F) = 0.10 
P(X4 = T | X2 = F, X3 = T) = 0.60 
P(X4 = T | X2 = T, X3 = T) = 0.60 
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independence relations among variables that hold for all values of the variables. The PSMBl 
algorithm learns graph CPD MBs in which CPDs are represented with decision graphs. Decision 
graphs 
fewer parameters [75]. Corresponding to the parents of a node in a global Bayesian network, in a 
local Bayesian network, a node Xi has a set of global parents Pai. However, in general, for a 
particular instantiation of the variables in Pai, only some of those variables will be correlated 
capture the local structure, that is, value-specific independencies among the variables. 
Value-specific independencies are those that hold only for particular assignments of values to 
certain nodes and cannot be explicitly represented by the global structure.  
Bayesian networks that can represent local structure (i.e., local constraints) that hold 
among the parameters of a node have been shown to capture additional independences with 
lung cancer F F T T 
Figure 4-2: A decision tree representation of the local structure for the variable fatigue that 
captures the four structures shown in Figure 4-1 (b). The parameters at the leaves are explained in 
the table. 
chronic bronchitis F T F T 
fatigue = F θ1 θ2 θ3 θ4 
fatigue = T 1- θ  1 – θ  1 – θ  1 – θ  1 2 3 4
lung 
cancer
chronic 
F T 
T 
θ3 =  θ4
bronchitis
F
θ1 θ2 
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with Xi. For example, in Figure 4-1 (a), suppose when the node lung cancer has the value True, 
the nod
 
representation of the local structure for the variable fatigue given in Figure 4-1. The parameters 
used for the CPDs at the leaves of the decision tree are shown in the associated table in the 
figure. Root-to-leaf paths in the tree correspond to value-specific parents of the variable fatigue.  
Another representation for the local structure is the decision graph which is a 
generalization of the decision tree; this representation is described in detail in Section 3.3.3. 
Briefly, in a decision graph non-root nodes can have multiple parents, rather than a single parent 
as in a decision tree  [52]. A decision graph, thus, allows two or more branches of a decision tree 
to share the same leaf node, which expresses the following equality constraint: conditioned on 
the variable values in any one of the shared branches (the parents), the conditional probability 
distribution of the leaf node (the child) is the same. All equality constraints represented by 
decision trees can be represented by decision graphs, but not vice-versa. Figure 4-3 illustrates a 
decision graph representation for the decision tree in Figure 4-2. Figure 4-4 shows an example of 
e chronic bronchitis has no influence on the node fatigue. Indeed the probabilities in 
Figure 4-1 (a) reflect this situation. Figure 4-1 (b) illustrates the local Bayesian network structure 
that represents this example. 
One representation for the local structure is the decision tree; this representation is 
described in detail in Section 3.3.2. Briefly, in this representation, a decision tree is used to 
represent the local structure between a node and its parents in a Bayesian network [76]. The 
decision tree used here is not a decision analytic decision tree, but a CART-like probability tree 
in which branches denote variable values. Each leaf node in the tree contains the probability 
distribution of the variable being predicted given the values of the predictor variables that appear 
along the path that goes from the root node to that leaf node. Figure 4-2 shows a decision tree
 91 
  
lung 
cancer
chronic 
bronchitis
F T 
T 
θ1 
a decision graph where the shared leaf node expresses that P(fatigue = T | lung cancer = F, 
chronic bronchitis = T) = P(fatigue = T | lung cancer = T, chronic bronchitis = F). This is an 
example of a local structure that cannot be represented with a decision tree. 
The PSMBl algorithm uses decision graphs to represent and explicitly capture value-
specific independences among the CPDs of a node, while the PSMBg algorithm represents the 
CPDs of a node with a complete decision tree which is equivalent to a conditional probability 
table. Figure 4-5 shows an example of a complete decision tree that would be used by the 
A decision graph representation of the local structure represented by the decision tree 
in Figure 4-2. 
decision tree. 
Figure 4-3: 
Figure 4-4: A decision graph representation of a local structure that cannot be represented by a 
θ2 θ3 =  θ4 
T 
chronic 
bronchitis
F F
lung 
cancer
chronic 
bronchitis
F T 
T 
θ1 θ4 θ2 =  θ3 
T 
chronic 
bronchitis
F F
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lung 
cancer
chronic 
bronchitis
F T 
T 
PSMBg
o of parent states. A formula for 
countin
 algorithm. Note that the complete decision tree is a type of decision graph, in which, 
every possible parent state is accorded a distinct leaf node. In effect, the complete decision tree 
encodes the same parameters as the equivalent CPT; each leaf node contains a table that 
corresponds to a column in the CPT that encodes the parameters of a conditional probability 
distribution.   
Given a set of parents, a MB node has a single global structure while it can have several 
possible local structures. The single global structure can be represented by a complete table 
(CPT) or a complete decision tree. The number of possible local structures is the number of all 
possible decisi n graphs that can be constructed for a given set 
g all possible decision graphs is derived in Section 4.3.2. From this it follows that the 
PSMBl algorithm’s model space is richer than the PSMBg algorithm’s model space; in fact the 
latter is a subset of former. 
Figure 4-5: An example of a complete decision tree representation used by the PSMBg algorithm 
to represent the probability distributions associated with the node fatigue. 
θ1 θ4 
T 
chronic 
bronchitis
F F
θ2 θ3 
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4.3 PATIENT-SPECIFIC BAYESIAN MODEL AVERAGING 
The objective of the patient-specific algorithms is to derive the posterior distribution P(Zt | xt, D) 
for the target variable Zt in the case at hand, given the values of the other variables Xt = xt and the 
training data D. The Bayes decision rule is then applied to select the target value with the highest 
post y Bayesian 
model averaging is as follows: 
t t t t
below. This parameterization of  
G produces predictions equivalent to those obtained by inte  possible 
parameterizations for G. The second term, P(G | D), is the posterior probability of the MB 
erior probability. The ideal computation of the posterior distribution P(Zt | xt, D) b
∑
∈
=
MG
tt DGPDGZPDZP )|(),,|(),|( tt xx  ,   (4.3) 
where the sum is taken over all MB structures G in the model space M. The first term on the 
right hand side, P(Z  | x , G, D), is the probability P(Z  | x ) computed with a MB that has 
structure G and parameters θG that are given by Equation 4.4 
grating over all the
structure G given the data D. In essence, Equation 4.3 states that a conditional probability of 
interest P(Zt | xt) is derived by taking a weighted average of that probability over all MB 
structures, where the weight associated with a MB structure is the probability of that MB 
structure given the data. In general, P(Z t | xt) will have different values for the different sets of 
MB structures over which the averaging is carried out. 
4.3.1 Inference in Markov blankets 
Computing P(Zt | xt, G, D) in Equation 4.3 involves doing inference in the MB with a specified 
global structure G: 
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 3.4.1.2. In summary, under the assumptions of (1) the variables are discrete 
D consists of independent and identically di issing 
values; (2) parameterization θG over the entire MB of n nodes can be decomposed as θG = 
i i
i ij
conditional distribution of Xi, are mutually independent (local parameter independence); and (4) 
the parameter prior distribution is Dirichlet; the parameter estimates are given by the following 
The parameters for the MB structure G are estimated using Bayesian parameter estimation that is 
described in Section
and the dataset stributed (i.i.d.) cases without m
},...,,...,,{ 21 θθθθ where the θi, the parameters associated with node Xi, are mutually 
independent (global parameter independence); (3) parameterization θ  of a node with q  parent 
states is decomposed as θ  = },...,,...,,{ where the θ , the parameters of a single 
expression: 
ini
21 iiqijii
θθθθ
ijij
ijkii N+
ijkijk NjPakXP
+=≡== α
αθ)|( ,    (4.5) 
 by j, (2)  (3) αijk is a parameter prior that can be interpreted as belief 
equivalent to having prev  prior to arents of 
Xi have the state denoted by 
where (1) Nijk is the number of cases in dataset D in which Xi = k and the parents of Xi have the 
state denoted ∑= k ijkij NN ,
iously (i.e.,
j, and (4) 
D) seen αijk cases in which Xi = k and the p
.∑= k ijkij αα  For the patient-specific algorithms αijk is set 
to 1 for all i, j, and k, as a simple non-informative parameter prior [55]. 
For decision graph representations of CPDs, the interpretation of Equation 4.5 has to be 
Xi
modified slightly. Specifically, the parent state index j is replaced with a new index l that ranges 
over the leaf nodes in the decision graph for node . Thus, Equation 4.5 now becomes: 
ilil
ilkilk
ilkii N
NlPakXP +
+=≡== α
αθ)|( ,     (4.6) 
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where 
and N431 
represents the number of cases in D wher he parent 
configuration index l = 3. This index corresponds to a single parent configuration represented by 
421
2 3
2
d is computed by applying Bayes rule as follows: 
(1) Nilk is the number of cases in dataset D in which Xi = k and the parents of Xi have a 
configuration corresponding to any of the paths that converge to the leaf node l in the decision 
graph. For example, in Figure 4-4, l ranges over the three leaves in the decision graph 
e fatigue = F (i.e., i = 4 and X4 = 1) with t
the path leading to θ4, namely, lung cancer (T) → chronic bronchitis (T) → θ4 (the rightmost 
path in the figure). As another example, consider N , which represents the number of cases in D 
where fatigue = F (i.e., i = 4 and X4 = 1) with the parent configuration index l = 2. This index 
corresponds to two parent configurations represented by the two paths converging on θ  = θ , 
namely, (1) lung cancer (F) → chronic bronchitis (T) → θ  and (2) lung cancer (T) → chronic 
bronchitis (F) → θ3 (the two paths along the middle in the figure). The same interpretation is also 
applicable to a decision tree representation of CPDs (e.g., the decision trees shown in Figure 4-2 
and Figure 4-5), since a decision tree is a type of a decision graph. Equation 4.6 is applicable to 
both the PSMBl algorithm (which uses decision graph CPDS) and the PSMBg algorithm (which 
uses complete decision tree CPDs).  
4.3.2 Bayesian score of Markov blankets 
The second term on the right hand side in Equation 4.3, P(G | D), is the posterior probability of 
the MB structure G given the data an
)(
)()|()|(
DP
GPGDPDGP = ,      (4.7) 
where P(D) is a constant for all G and need not be computed. Thus, the Bayesian score for G, as 
previously shown in Equation 3.21, is: 
 96 
  
(log)|(log);( GPGDPDGscoreB += ) .    (4.8) 
The computation of the marginal likelihood, P(D | G), for the decision graph representation is 
parameter 
independence, that is, the param  (3) local 
parameter independence, that is, the parameters associated with each parent state of a variable 
are independent; and (4) the parameter prior distribution is Dirichlet; the marginal likelihood is: 
 
derived in Section 3.5.1. In summary, under the assumptions of (1) the variables are discrete and 
the data D is a multinomial random sample with no missing values; (2) global 
eters associated with each variable are independent;
∏∏ ∏
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 is the cardinality of the set of leaves in the decision graph DG  of X , N  is the number iLwhere i i ilk
of cases in the dataset D that have Xi = k and have parent states of Xi that correspond to one of 
the paths in the decision graph leading to the leaf node l, and ∑= NN k ilkil
and PSMBl algorithms use the logarithmic form of Equation 4.9 in computing the Bayesian 
score as follows: 
. Both the PSMBg 
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The term
the data was generated by some distribution that can be modeled with the MB structure G. For 
the PSMBg algorithm, a uniform prior belief over all G is assumed which reduces the term P(G) 
to a constant. Thus, P(G | D) is equal to P(D | G) up to a proportionality constant and the 
.     (4.11) 
 P(G) in Equation 4.8 is the structure prior which represents the prior belief that 
Bayesian score for G is defined simply as the logarithmic marginal likelihood as follows: 
PSMBg )|(log);( GDPDGscoreB =
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Equatio
ntrast, 
in the PSMBl algorithm, a specified gl ructures 
DAG structure as 
before 
          (4.12) 
As in the case of the PSMBg algorithm, a uniform prior belief over all G is assumed, and 
therefore the term P(G) reduces to a constant. Given G, a uniform prior belief over all possible 
decision graph structures for each MB node is assumed. The number of possible decision graph 
structures is the same as the number of ways in which the parent configurations can be 
partitioned into nonempty sets. The number of ways in which n elements can be partitioned into 
mber is 
n 4.11 implies that the PSMBg algorithm evaluates MB structures only on the basis of 
the marginal likelihood and does not apply a penalty for structure complexity. 
For the PSMBl algorithm, a two-level hierarchical structure prior is derived 
corresponding to the global and the local structures. In the PSMBg algorithm, specification of 
the global DAG structure uniquely specifies each MB node’s complete decision tree. In co
obal structure corresponds to a family of local st
consisting of all possible decision graphs for each of the MB nodes, and the complete structure 
specification is given by {G, DG1, …, DGi, …, DGn} where G is the global 
and DGi is the local decision graph structure for node Xi. Including both the global and 
local structure priors, the Bayesian score in Equation 4.8 is rewritten as (see Section 3.5.1 for the 
derivation): 
∑
=
++=
n
i
innB GDGPGPDGDGGDPDDGDGGscore
1
11 )|(log)(log),...,,|(log);,...,,( . 
nonempty subsets is called a Bell number and is denoted by B(n) [77]. The Bell nu
typically computed as the following sum: 
∑
=
=
n
k
knSnB
1
),()( ,       (4.13) 
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where, S(n, k) is a Stirling number of the second kind which is the number of ways in which n 
elements can be partitioned into k nonempty sets [78]. The Stirling number of the second kind is 
computed as: 
∑
=
− nik iikC ),()1 ,     (4.14) −=
k
ik
knS
0
(
!
1),(
MBl algorithm is now defined as: 
where C(k, i) is the binomial coefficient. The prior for the local structure associated with node Xi 
is then given by 1 / B( |Pai| ), where |Pai| is the number of parent states of Xi. The Bayesian score 
used by the PS
∑−= n in BDGDGGDP 1 )(log),...,,|(log Pa . 
=i
n
PSMBl
B DDGDGGscore
1
1 );,...,,( (4.15) 
the algorithm will prefer decision graphs with a 
smaller number of nodes to ones with a larger number of nodes. By incorporating a hierarchical 
structure prior, the Bayesian score given by Equation 4.15 penalizes complex structures. This is 
has no 
raging given by Equation 4.3 is approximated with selective 
model averaging, and heuristic search (described in the next section) is used to sample the model 
The derivation of the two terms needed for the computation of Equation 4.3 is now complete.  
The structure prior just described biases the PSMBl algorithm to prefer simpler local 
structures over more complex ones. On average, 
in contrast to the Bayesian score used by the PSMBg algorithm (given by Equation 4.11) which 
analogous structure penalty. 
4.3.3 Selective Bayesian Model Averaging 
Since Equation 4.3 sums over a very large number of MB structures, it is not feasible to solve it 
exactly. Hence, complete model ave
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space. For a set R of MB structures that have been chosen from the model space by heuristic 
search, selective model averaging estimates P(Zt | xt, D) as: 
∑
∑
∈
∈≅
RG
RGDZP
t
t ),|(
t
tx .   (4.16) 
 
The computations for the inference of the target variable Zt and the posterior probability for the 
MB structure G are described in the preceding Sections 4.31 and 4.32 res
DGP
DGPDGZP
)|(
)|(),,|( x
pectively. 
4.4 PATIENT-SPECIFIC SEARCH 
ch to sample 
the space of MB structures. A high level description of the two-phase search is now given. The 
first phase ignores the current patient case evidence xt at hand, while searching for MB structures 
that best fit the tra  the set of MB structures 
obtained from the first phase, but now searches for MB structures that have the greatest impact 
e first phase search terminates in a local 
maxim
The patient-specific algorithms that I developed and applied use a two-phase sear
ining data. The second phase continues to add to
on the prediction of Zt for the current patient case.  
The first phase uses greedy hill-climbing search and accumulates the best model 
discovered at each iteration of the search in a set R. At each iteration of the search, successor 
models are generated from the current best model; the best of the successor models is added to R 
only if this model is better than current best model; and the remaining successor models are 
discarded. Since, no backtracking is possible, th
um. 
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The second phase uses best-first search and adds the best model discovered at each 
iteration of the search to the set R. Unlike greedy hill-climbing search, best-first search holds 
models that have not been expanded (i.e., whose successors have not be generated) in a priority 
queue Q. At each iteration of the search, successor models are generated from the current best 
model 
MBg search and operators 
ich the CPDs are 
represented as complete decision trees, and the operators used in traversing this space are the 
ture learning with minor modifications. As mentioned in 
the previous chapter, the standard BN structure learning operators are (1) add an arc between two 
and added to Q; the best model from Q is added to R even if this model is not better than 
the current best model. The second phase search terminates when a user set criterion is satisfied. 
Since, the number of successor models that are generated can be quite large, the priority queue Q 
is limited to a capacity of at most w models. Thus, if Q already contains w models, addition of a 
new model to it leads to removal of the worst model from it. The queue allows the algorithm to 
keep in memory up to w good scoring models, and facilitates limited backtracking to escape local 
maxima. 
The next section describes in detail the search used by the PSMBg algorithm and the 
section after that describes in detail the search used by the PSMBl algorithm.  
4.4.1 PS
The PSMBg algorithm searches in the space of global MB structures in wh
same as those used in standard BN struc
nodes if one does not exist, (2) delete an existing arc, and (3) reverse an existing arc, with the 
constraint that an operation is considered valid only if it generates a legal BN structure. This 
constraint simply implies that the graph of the generated BN structure be a DAG. A similar 
constraint is applicable to the generation of global MB structures, namely, that an operation is 
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considered valid if it produces a legal MB structure of the target node. This constraint entails that 
some of the operations be deemed invalid, as illustrated in the following examples. With respect 
to a MB, the nodes can be categorized into five groups: (1) the target node, (2) parent nodes of 
the target, (3) child nodes of the target, (4) spousal nodes, which are parents of the children, and 
(5) other nodes, which are not part of the current MB. Incoming arcs into parents or spouses are 
not part of the MB structure and, hence operations that add such arcs are deemed invalid.  Arcs 
between nodes not in the MB are not part of the MB structure and, hence operations that add 
such arcs are also deemed invalid. Figure 4-6 gives exhaustively the validity of the MB global 
operators. Furthermore, the application of the delete arc or the reverse arc operators may lead to 
additional removal of arcs to produce a valid MB structure (see Figure 4-7 for an example).  
The search for MB structures proceeds in two sequential phases: phase 1 uses greedy hill-
climbing search and phase 2 uses best-first search with a priority queue of capacity w. In phase 1 
the candidate MB structures are scored with the phase 1 score which is the Bayesian score shown 
in Equation 4.11. This phase of the search begins with the empty graph and terminates in a local 
Figure 4-6: Constraints on the Markov blanket global operators. The nodes are categorized into 
five groups: T = target, P = parent, C = child, S = spouse, and O = other (not in the Markov 
blanket of T). The cells with check marks indicate valid operations and are the only ones that 
need to be considered in generating candidate structures. The cells with an asterisk indicate that 
the operation is valid only if the resulting graph is acyclic.  
T P C S O 
T    ? ? 
P   ?   
C   ?*   
S ?  ?   
O ?  ?   
(a) Add arc X → Y 
   Y  
X T P C S O 
 
T   ?   
P ?  ?   
C   ?   
S   ?   
O      
 
(b) Delete arc X → Y 
   Y  
X T P C S O 
T   ?   
P ?     
C   ?*   
S      
O      
 
(c) Reverse arc X → Y 
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X4 
X1 X2 
X5 
Z 
X3 X4 
X1 X2 
X5 
Z 
X3 
(a) (b) 
Figure 4-7: An example where the application of an operator leads to additional removal of arcs 
to produce a valid Markov blanket structure. Deletion of arc Z → X5 leads to removal of the arc 
X4 → X5 since X5 is no longer a part of the Markov blanket. Reversal of the same arc also leads to 
removal of the arc X4 → X5 since X5 is now a parent and is precluded from having incoming arcs. 
Also, unless X4 → X5 is removed there will be a cycle. 
maximum when none of the successor MB structures generated from the current best MB 
structure has a score higher than that of the current best MB structure. The highest scoring MB 
structure from each iteration of the search is accumulated in a set R. The purpose of this phase is 
to identify a set of MB structures that are highly probable, given data D.  
Phase 2 searches for MB structures that change the current model-averaged estimate of 
P(Zt | xt, D) the most. The intuition here is to find viable competing MB structures for making 
this posterior probability prediction. When no competitive MB structures can be found, the 
prediction is assumed to be stable. Phase 2 differs from phase 1 in two aspects:  it uses best-first 
search 
ing to 
legal MB structures are applied to it; the successor structures are scored with the phase 2 score; 
and it employs a different scoring function for evaluating candidate MB structures.  
At the beginning of phase 2, R contains MB structures that were generated in phase 1. 
Successors to the MB structures in R are generated, scored with the phase 2 score (described in 
detail below) and added to the priority queue Q. At each iteration of the search, the highest 
scoring MB structure in Q is removed from Q and added to R; all global operations lead
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and the scored structures are added to Q. Phase 2 search terminates when no MB structure in Q 
has a score higher than some small value ε or when a period of time t has elapsed, where ε and t 
are user specified. 
The model score for phase 2 is computed as follows. Each successor MB structure G* to 
be added to Q is scored based on how much it changes the current estimate of P(Zt | xt, D); this is 
obtained by model averaging over the MB structures in R. More change is better. The phase 2 
score of a candidate MB structure G* is computed as the distance between two distributions for 
Zt as follows: 
∑
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Specifically, the Kullback-Leibler divergence (KL divergence) is used as the distance metric for 
the experiments described in Chapter 5. The KL divergence, or relative entropy, is a quantity 
which measures the difference between two probability distributions [79]. That is, the phase 2 
score for G* is the KL divergence between the two estimates of P(Zt | xt, D stimate 
computed without and another computed with G* in the set of models over which the model 
), one e
averaging is carried out. Thus, the phase 2 score for a candidate MB structure G* is: 
∑≡=
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The pseudocode for the two-phase search procedure used by the PSMBg algorithm is given in 
Figure 4-8. 
4.4.2 PSMBl search and operators 
 algorithm searches in the space of local MB structures in which the CPDs are 
represented as decision graphs, and uses the two-tier search procedure described in Section 3.5.2. 
e global operators for the outer search procedure as those 
used in the PSMBg algorithm and a set of local operators for the inner search procedure. The 
 for the split, (2) the binary split 
operato
The PSMBl
The PSMBl algorithm employs the sam
PSMBl algorithm may be considered an extension of the PSMBg algorithm, in that, it 
supplements the search procedure used in the PSMBg algorithm with an inner search procedure 
that is invoked at every iteration of the outer search procedure.  
The local operators used by the PSMBl algorithm are those described in Section 3.5.2 
that are used for traversing the space of local decision graph structures. Briefly, they are (1) the 
complete split operator that replaces a leaf node with an internal node and a set of leaf nodes 
corresponding to the states of the parent variable which is used
r that is similar to the complete split operator, except that only two new leaf nodes are 
introduced, and (3) the merge operator that merges two leaf nodes into a single leaf node. An 
example of the application of these operators is illustrated in Figure 3-7. 
The outer search procedure generates global MB structures; a global MB structure is 
specified by a DAG among the domain variables. In essence the DAG specifies the parent set of 
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nodes for each node. The nodes of the DAG are referred to as MB nodes to distinguish them 
from the nodes of the local decision graph structures which are referred to as DG nodes. DG 
nodes a
y the application of the global operator. Given a MB node Xi and its parent MB nodes, 
the sec
This section provides an analysis of the space and time complexity for the PSMBg and the 
PSMBl algorithms.  
re either called internal nodes if the nodes have children or leaf nodes if the nodes are 
terminal. 
The search for MB structures is very similar to that used by the PSMBg algorithm and 
proceeds in two sequential phases. Additionally, for every application of a global operator, a 
secondary search is performed to find an optimal local decision graph structure for the nodes 
affected b
ondary search starts with a decision graph containing a single DG node that represents the 
parameters of the CPD of Xi assuming that Xi has no parents. Application of the local operators 
introduces the parents of Xi as internal DG nodes in the decision graph structure. For reasons of 
efficiency, the secondary search always uses the phase 1 score to score the decision graph 
structure irrespective of which phase in the primary search procedure invokes it. The pseudocode 
for the two-phase and two-tier search procedure used by the PSMBl algorithm is given 
Figure 4 9. 
4.5 SPACE AND TIME COMPLEXITY 
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4.5.1 PSMBg 
he training dataset D, n is the number of domain variables, d is the sum of 
the number of iterations of the search for phase 1 and phase 2, b – the branching factor – is the 
ssors generated from a MB structure, and w is the capacity of the 
priority queue Q. 
meters. For a given MB node, the number of parameters (using a CPT or a 
comple
over the MB nodes, to compute it for a newly generated 
MB structure only those MB nodes whose parent nodes have changed need be evaluated. The 
algorithm 
The PSMBg algorithm runs in O((b + d)Nn) time and uses O((w + d)Nn) space, where N is the 
number of cases in t
maximum number of succe
Space complexity of PSMBg. The PSMBg algorithm searches in the space of MB 
structures using greedy hill-climbing search for phase 1 and best-first search with a priority 
queue of capacity w for phase 2. For d iterations of the search, the maximum number of MB 
structures that is stored is O(w + d). The space required for each MB structure is linear in the 
number of its para
te decision tree) is exponential in the number of its parent nodes. However, the number of 
distinct parameters cannot be greater than the number of cases N in the training data D; the 
remaining parameters have a single default value. Thus, the space required for the parameters of 
a BN node is O(N). In a domain with n variables, a MB structure can have up to n nodes and thus 
requires space of O(Nn). In total, the space required by the PSMBg algorithm that runs for d 
iterations of the search is O((w + d)Nn). 
Time complexity of PSMBg. At each iteration of the search, a maximum of b successor 
MB structures are generated. For d iterations of the search, the number of MB structures 
generated and scored with the phase 1 score is O(bd). Note that both phase 1 and phase 2 require 
successor MB structures to be scored with the phase 1 score. 
Since phase 1 score decomposes 
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number
requires one pass over D and takes 
O(Nn) 
 structure generated in all d iterations of the search will have to be 
evaluat
n
rch 
(namely, phase 1 and phase 2) and each phase uses a two-tier search procedure (namely, outer 
search procedure and inner search procedure). The outer search procedure is the same as the 
search procedure used by the PSMBg algorithm. At each iteration of the outer search procedure, 
 of MB nodes that need to be evaluated is either one (when the add or remove global 
operator is applied) or two (when the reverse global operator is applied). Computing the phase1 
score for a MB node entails estimating the parameters for that node and calculating the marginal 
likelihood from those parameters. Estimating the parameters 
time. Calculating the marginal likelihood requires retrieving every parameter of the CPDs 
associated with the MB node and takes O(N) time. Thus, scoring a MB structure with phase 1 
score takes O((N + 1)n) time.  
Phase 2 score computes the effect of a candidate MB structure on the model averaged 
estimate of the distribution of the target variable. This requires doing inference for the target 
node in a MB structure which takes O(n) since at most n nodes influence the target distribution 
and hence at most n sets of parameters need be retrieved. Computing both phase 1 and phase 2 
scores for a MB structure takes O((N + 1)(n + 1)) time which is approximately O(nN) time. In 
the worst case, every candidate
ed with the phase 2 score. In total, the time required by the PSMBg algorithm that runs 
for d iterations of the search and generates b MB structures at each iteration is O((b + d)Nn). 
4.5.2 PSMBl algorithm 
The PSMBl algorithm runs in O((b + d)Nn2 ) time and uses O((w + d)Nn) space. It has the same 
space complexity as the PSMBg algorithm but has exponential time complexity. 
Space complexity of PSMBl. The PSMBl algorithm employs a two-phase sea
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the inner search procedure is invoked on those MB nodes whose parent nodes have been 
modified. The inner search procedure when invoked on a MB node, locates a local structure 
uired by a CPT 
or a co
f the outer search procedure and 
generat
represented by a decision graph using greedy hill-climbing search in the space of decision 
graphs. The maximum space required by a decision graph is the same as that req
mplete decision tree for that MB node. Hence, the PSMBl algorithm has the same space 
complexity as the PSMBg algorithm, that is, of O((w + d)Nn). 
Time complexity of PSMBl. Estimating the parameters and computing both the phase 1 
and phase 2 scores of a MB node represented by a CPT or a complete decision tree takes O(Nn) 
time for the PSMBg algorithm as described above. The time requirement is the same for a MB 
node represented by a decision graph. For each structure generated by the outer search 
procedure, the inner search procedure can potentially generate all possible decision graphs for 
one or two MB nodes whose parent nodes have changed. The number of possible decision graphs 
for a MB node is given by Equation 4.2 and is exponential in n, that is, of O(2n). In total, the time 
required by the PSMBl algorithm that runs for d iterations o
es b MB structures at each iteration where each MB structure can have O(2n) local 
structures, is of O((b + d)Nn2n). 
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ProcedureGlobalSearchForPSMBg 
// phase 1 greedy hill-climbing search 
1 R ← empty set 
2 BestModel ← empty graph 
3 Score BestModel with phase 1 score 
4 BestScore ← phase 1 score of BestModel 
5 Add BestModel to R 
  
6 Do 
7  For every possible global operator O that can be applied to BestModel 
8   Apply O to BestModel to derive Model 
9   Score Model with phase 1 score 
10   ModelScore ← phase 1 score of Model 
11   If ModelScore > BestScore 
12    BestModel ← Model 
13    BestScore ← ModelScore 
14    FoundBetterModel ← True 
15   End if 
16  End for 
 
17  If FoundBetterModel is True 
18   Add BestModel to R 
19  Else 
20   Terminate do 
21  End if 
22 End do 
 
 // phase 2 best-first search 
23 Q ← empty priority queue with maximum capacity w 
24 Generate all successors for the MB structures in R and add them to Q 
25 Score all MB structures in Q with phase 2 score 
  
26 Do while elapsed time < t 
27  BestModel ← remove MB structure with highest phase 2 score from Q 
28  BestScore ← phase 2 score of BestModel 
29  For every possible global operator O that can be applied to BestModel 
30   Apply O to BestModel to derive Model 
31   Score Model with phase 2 score 
32   Add Model to Q 
33  End for 
 
34  If BestScore > ε 
35   Add BestModel to R 
36  Else 
37   Terminate do 
38  End if 
39 End do 
 
40 Return R 
 
Figure 4-8: Pseudocode for the two-phase (phase 1 and phase 2) search procedure used by the 
PSMBg algorithm. Phase 1 uses greedy hill-climbing search while phase 2 uses best-first search. 
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ProcedureGlobalSearchForPSMBl 
// phase 1 greedy hill-climbing search 
1 R ← empty set 
2 BestMB ← empty graph 
3 Score BestMB with phase 1 score 
4 BestScore ← phase 1 score of BestMB 
5 Add BestMB to R 
  
6 Do 
7  For every possible global operator O that can be applied to BestMB 
8   Apply O to BestMB to derive MB 
9 For every MBNode in MB whose parent nodes have been modified by O do   
 ProcedureLocalSearchForPSMBl(MBNode, MBNodeParents) 
10   Score MB with phase 1 score 
11   MBScore ← phase 1 score of MB 
12   If MBScore > BestScore 
13    BestMB ← MB 
14    BestScore ← MBScore 
15    FoundBetterMB ← True 
16   End if 
17  End for 
 
18  If FoundBetterMB is True 
19   Add BestMB to R 
20  Else 
21   Terminate do 
22  End if 
23 End do 
 
 // phase 2 best-first search 
24 Q ← empty priority queue with maximum capacity w 
25 Generate all successors for the MB structures in R and add them to Q 
26 Score all MB structures in Q with phase 2 score 
  
27 Do while elapsed time < t 
28  BestMB ← remove MB structure with highest phase 2 score from Q 
29  BestScore ← phase 2 score of BestMB 
30  For every possible global operator O that can be applied to BestMB 
31   Apply O to BestMB to derive MB 
32 For every MBNode in MB whose parent nodes have been modified by O do 
 ProcedureLocalSearchForPSMBl(MBNode, MBNodeParents) 
33   Score MB with phase 2 score 
34   Add MB to Q 
35  End for 
 
36  If BestScore > ε 
37   Add BestMB to R 
38  Else 
39   Terminate do 
40  End if 
41 End do 
 
42 Return R                  (continues on next page) 
 
Figure 4-9: Pseudocode for the two-phase (phase 1 and phase 2) and two-tier (outer and inner) 
search procedure used by the PSMBl algorithm. Figure continues on next page. 
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ProcedureLocalSearchForPSMBl(MBNode, MBNodeParents, MB) 
// inner loop greedy hill-climbing search 
Inputs:  MBNode: MB node for which a decision graph (DG) is to be located 
              MBNodeParents: set of parent MB nodes of MBNode 
       MB: current MB structure 
  
43 BestDG ← decision graph for MBNode with a single leaf DGNode  
44 Score BestDG with phase 1 score 
45 BestScore ← phase 1 score of BestDG 
 
46 Do 
47  For every possible local operator O that can be applied to BestDG 
48   Apply O to BestDG to derive DG 
49   Score DG with phase 1 score 
50   DGScore ← phase 1 score of DG 
51   If DGScore > BestScore 
52    BestDG ← DG 
53    BestScore ← DGScore 
54    FoundBetterDG ← True 
55   End if 
56  End for 
 
57  If FoundBetterDG is not True 
58   Terminate do 
59  End if 
60 End do 
 
61 For each MBNodePa in MBNodeParents 
62  If MBNodePa is not represented as a DGNode in BestDG 
63   Remove MBNodePa from MBNodeParents  
64   Remove arc from MBNodePa to MBNode in MB 
65  End if 
66 End for 
  
67 Return MB 
Figure 4-9: Continued from previous page. Pseudocode for the two-phase (phase 1 and phase 2) 
and two-tier (outer and inner) search procedure used by the PSMBl algorithm. The procedure 
ProcedureGlobalSearchForPSMBl is similar to the one used by the PSMBg algorithm shown in 
Figure 4-8. The main difference is in the extra lines 9 and 32 which invoke an additional 
procedure ProcedureLocalSearchPSMBl for the inner search. As in the PSMBg algorithm, the 
PSMBl algorithm uses greedy hill-climbing in phase 1 and best-first search in phase 2. The inner 
search procedure uses greedy hill-climbing. MBNode represents a node in the Markov blanket 
(MB) while DGNode represents a node in a decision graph (DG). 
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5.0  EXPERIMENTAL EVALUATION 
The hypothesis put forth in Section 1.2 is that for at least some performance measures patient-
specific Bayesian network models predict better than population-wide models. This chapter 
evaluates the merits of the patient-specific algorithms on several datasets including a synthetic 
dataset, 21 datasets from the UCI Machine Learning repository (UCI datasets) and three medical 
datasets.  
Section 5.1 describes the UCI datasets and the medical datasets in detail. Section 5.2 
gives details of preprocessing that includes descriptions of the handling of missing values and the 
discretization of continuous variables. The algorithms are evaluated on five performance 
measures that are described in Section 5.3.  Several versions of the patient-specific algorithms 
are used in the experiments and these are described in Section 5.4 along with the algorithms used 
for comparison.  
Sections 5.5 through 5.7 provide the experimental results. Section 5.5 describes the 
experimental evaluation of the patient-specific algorithms on a small synthetic dataset. Section 
5.6 gives results obtained from the PSMBg algorithm which searches in the model space of MB 
structures that capture only global structure, and Section 5.7 gives results obtained from the 
PSMBl algorithm which searches in the model space of MB structures that capture additional 
local structure. The final section provides a summary of the results. 
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5.1 DATASETS 
The publicly available UCI Machine Learning Repository [80] has more than 100 datasets and 
machine learning algorithms are often trained and validated on a subset of these datasets. 
Twenty-one UCI datasets were selected; these datasets have between four and 60 predictor 
variables and a single target variable that has between two and seven classes. The size of the 
Table 5-1: Description of the UCI datasets used in the experiments described in this chapter. In 
the column on predictors, the number of continuous (cnt) and discrete (dsc) predictors as well as 
the total number of predictor variables (excluding the target variable) are given. In the column on 
cases, the numbers of cases used in the experiments are given; this may be less than the total 
number of cases in the original UCI dataset since cases with missing values were removed. In the 
column on test method, “10-fold CV * 2” is short for 10-fold stratified cross-validation done 
twice. 
Dataset # Predictors 
(cnt + dsc = total)
# Classes # Cases Test Method 
australian 6 + 8 = 14 2 690 10-fold CV * 2 
breast-cancer 9 + 0 =   9 2 683 10-fold CV * 2 
cleveland 6 + 9 = 13 2 296 10-fold CV * 2 
corral 0 + 6 =   6 2 128 10-fold CV * 2 
crx 6 + 9 = 15 2 653 10-fold CV * 2 
diabetes 8 + 0 =   8 2 768 10-fold CV * 2 
flare 0 + 10 = 10 2 1066 10-fold CV * 2 
german 7 + 13 = 20 2 1000 10-fold CV * 2 
glass2 9 + 0 =   9 2 163 10-fold CV * 2 
glass 9 + 0 =   9 7 214 10-fold CV * 2 
heart 13 + 0 = 13 2 270 10-fold CV * 2 
hepatitis 6 + 13 = 19 2 80 10-fold CV * 2 
iris 4 + 0 =   4 3 150 10-fold CV * 2 
lymphography 0 + 18 = 18 4 148 10-fold CV * 2 
pima 8 + 0 =   8 2 768 10-fold CV * 2 
postoperative 1 + 7 =   8 3 87 10-fold CV * 2 
sonar 60 + 0 = 60 2 208 10-fold CV * 2 
vehicle 18 + 0 = 18 4 846 10-fold CV * 2 
vote 0 + 16 = 16 2 435 10-fold CV * 2 
wine 13 + 0 = 13 3 178 10-fold CV * 2 
zoo 0 + 16 = 16 7 101 10-fold CV * 2 
 114 
  
datasets, the number and type of predictor variables, and the number of classes (states) taken by 
the target variable are given in Table 5-1. In addition to the UCI datasets, three medical datasets 
with five target variables were used in the experiments (see Table 5-2). Each target variable in a 
medical dataset represents a clinically relevant patient outcome like mortality or the occurrence 
of a clinical condition. In the following sections, the medical datasets are described in detail. 
5.1.1 Pneumonia 
Community acquired pneumonia (CAP) is an important clinical condition, both from a resource-
utilization and a patient-outcome point of view. Pneumonia affects over three million people 
annually in the U.S. [81] and is the sixth leading cause of death [82]. Accurate evaluation of 
CAP patients in the Emergency Department followed by appropriate treatment (including the 
decision whether to admit to the hospital or not) is an important clinical problem. 
Pneumonia Dataset. The pneumonia data comes from the Pneumonia Patient Outcomes 
Research Team (PORT) project and was collected during October 1991 to March 1994 from five 
Table 5-2: Description of the medical datasets used in the experiments described in this chapter. 
In the column on predictors, the number of continuous (cnt) and discrete (dsc) predictors as well 
as the total number of predictor variables (excluding the target variable) are given. All outcome 
variables that were studied are binary. The last column gives the number of cases in the training 
set and the test set respectively. 
Dataset # Predictors 
(cnt + dsc = total) 
Outcome variable # Classes # Cases # Train + # Test 
pneumonia 120 + 36 = 156 dire outcome 2 2287 1601 + 686
sepsis-d 7 + 14 =   21 death 2 1673 1115 + 558
sepsis-s 7 + 14 =   21 severe sepsis 2 1673 1115 + 558
heart failure-d 11 + 10 =   21 death 2 11178 7453 + 3725
heart failure-c 11 + 10 =   21 complication incld. death 2 11178 7453 + 3725
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hospitals in three geographical regions: Pittsburgh, Boston, and Halifax, Nova Scotia. The 
dataset has 2287 CAP hospitalized and ambulatory care patients many of whom where seen in 
the Emergency Department. One purpose of the project was to develop accurate criteria for 
prognosis of patients with CAP that could help physicians assess their risks and provide guidance 
on which patients should be hospitalized. Fine et al. [83] developed a scoring system called the 
Pneumonia Severity Index (PSI) for stratifying patients with CAP with respect to 30-day 
mortality. The PSI was derived from 20 demographic and clinical variables that were selected 
using regression analysis. This dataset has been extensively analyzed with machine learning 
algorithms for predicting various outcomes [84]. 
Pneumonia Predictor Variables. The PORT project collected data on more than 150 
patient variables including demographic data and findings on admission like co-existing diseases, 
symptoms, signs, initial laboratory tests, and initial medications.  
For the experiments, 156 patient variables were selected as predictors; these variables are 
typically available in the Emergency Department at the time the decision whether to admit or not 
is made. The variables include demographic information, history and physical examination 
information, laboratory results, and chest X-ray findings. Of the 156 variables, 120 are discrete 
and the remaining 36 are continuous. A majority of the discrete variables are binary and the rest 
have between three to seven values. The 36 continuous variables are derived mainly from 
laboratory tests and were discretized based on thresholds provided by clinical experts on the 
PORT project.  
Pneumonia Outcome Variables. Several patient outcomes on both inpatients and 
outpatients were measured at 30 days in the PORT project. The binary outcome variable selected 
for prediction is called dire outcome. A patient was considered to have experienced a dire 
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outcome if any of the following occurred: (1) death within 30 days of presentation, (2) an initial 
intensive care unit admission for respiratory failure, respiratory or cardiac arrest, or shock, or (3) 
the presence of one or more specific, severe complications. Based on these criteria, 261 patients 
(11.4%) had a dire outcome.  
5.1.2 Sepsis 
Sepsis is a syndrome of systemic inflammation in response to infection that leads to complex 
physiologic and metabolic changes and can result in multi-system organ dysfunction [85]. Sepsis 
occurs in more than 450,000 individuals annually in the U.S. and is associated with a 30% 
mortality rate [86]. The incidence of sepsis is rising in the U.S. and hospital care of sepsis is a 
significant cost to the healthcare system [87]. Thus, considerable research is underway towards a 
fuller understanding of the complex pathophysiology of human sepsis, including the 
identification of markers predictive of response to specific therapies and subsequent outcomes 
[88]. 
Sepsis Dataset. The sepsis data comes from the GenIMS (Genetic and Inflammatory 
Markers of Sepsis) project that has collected data on 2320 patients with community acquired 
pneumonia who presented to the emergency departments of 30 hospitals in southwestern 
Pennsylvania, Connecticut, Michigan and Tennessee. These patients were followed during their 
hospitalization for the development of sepsis. The aims of the GenIMS project include 
investigating the relationships among genetic polymorphisms, inflammatory mediator response, 
and clinical course and outcome.  
Sepsis Predictor Variables. The GenIMS project collected data on 108 clinical variables 
at the time of patient enrollment in the study and 99 clinical variables on a daily basis during the 
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period of hospitalization. In addition, the project collected data on five inflammatory mediators 
and on 29 genes that are believed to be involved in sepsis. The genetic data include information 
on single nucleotide polymorphisms (SNPs), short tandem repeat (STR) polymorphisms, and 
variable-number-tandem-repeat (VNTR) polymorphisms within the regulatory and coding 
regions of these genes. 
The experimental datasets consist of 21 variables as predictors that include three 
demographic variables, six clinical variables, one inflammatory marker and 10 genetic variables. 
These variables were selected by the GenIMS project investigators for analysis of a subset of the 
dataset to investigate the role of the macrophage migration inhibitory factor (MIF) gene in the 
susceptibility, severity, and outcome of community-acquired pneumonia. 
Sepsis Outcome Variables. Several outcomes including include death, severe sepsis, 
interventions such as mechanical ventilation, and hospital length of stay were measured in the 
project. Two binary outcome variables were selected for prediction: (1) death within 90 days of 
inclusion in the study, and (2) the development of severe sepsis during the study. 
5.1.3 Heart Failure 
Heart failure is an acute and chronic condition that affects 5 million people in the U.S. [89] 
leading to one million hospital admissions each year with a primary discharge diagnosis of heart 
failure and another two million with a secondary discharge diagnosis of this condition [90]. 
Hospital care for heart failure accounts for a significant portion of annual healthcare expenditure 
in the U.S. Accurate evaluation of heart failure patients in the Emergency Department followed 
by appropriate treatment (including the decision whether to admit to the hospital or not) is an 
important clinical problem. However, existing heart failure predictive models and guidelines 
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have limited utility in this setting because they are based on narrowly defined patient subgroups 
rather than the broad spectrum of heart failure patients treated in the Emergency Department, or 
they rely on clinical data unavailable in this setting [91].  
Heart Failure Dataset. The Heart Failure dataset includes 33,533 heart failure patients 
who were hospitalized from the Emergency Departments of 180 general acute care hospitals in 
Pennsylvania for the year 1999. Overall, 1498 (4.5%) patients died during hospitalization. 
Among survivors at hospital discharge, 2269 (6.8%) experienced a serious medical complication. 
This dataset has been analyzed by the original investigators to construct a prediction rule to 
identify patients who are at low risk of death and serious complications [92]. 
Heart Failure Predictor Variables. The Heart Failure dataset contains data on 
numerous variables that were collected the day of admission or the day before admission if the 
patient was already in the Emergency Department at that time. Such information includes 
demographic data, historical and physical examination findings, and electrocardiographic, 
routine laboratory tests and radiographic findings at the time of admission.  
The experimental datasets consist of 21 variables as predictors that include demographic, 
clinical, laboratory, electrocardiographic and radiographic findings. These variables had been 
identified as good predictors during the construction of a prediction rule by the original 
investigators [92].  
Heart Failure Outcome Variables. Outcome variables that were recorded in the study 
included death from any cause and several serious medical complications that occurred during 
the hospitalization. A patient was counted as having a serious medical complication if he or she 
experienced a life-threatening clinical condition or received a life-saving inpatient treatment. 
Life-threatening clinical conditions included were acute myocardial infarction, ventricular 
 119 
  
fibrillation, cardiogenic shock, and cardiac arrest. Life-saving inpatient treatments were: (1) 
resuscitation defined as intubation or mechanical ventilation not initiated during surgery, cardiac 
compression, resuscitation, defibrillation, and (2) reperfusion therapy defined as coronary artery 
bypass graft surgery, percutaneous transluminal coronary angioplasty, or intravenous 
thrombolytics. 
Two binary outcome variables were selected for prediction: (1) the occurrence of death 
from any cause during the hospitalization, and (2) the development of a serious medical 
complication (including death) during the hospitalization. 
5.2 PREPROCESSING 
This section describes the several preprocessing steps that were carried out on the datasets. 
Since, the patient-specific algorithms do not currently handle continuous variables or missing 
values, the continuous variables were discretized and missing values were either imputed or 
eliminated.   
Training and test sets. The UCI datasets were evaluated with two stratified 10-fold 
cross-validation. Hence, each UCI dataset was split twice into 10 stratified training and test folds 
to create a total of 20 training and test folds. All experiments were carried out on the same set of 
20 training and test folds. The medical datasets were each evaluated with a single training and 
test set. For each medical dataset associated with a specific outcome, the training set was created 
by randomly sampling from the entire dataset such that both the training and the test datasets had 
approximately the same proportion of cases with the positive outcome. The training set included 
approximately 70% of the dataset and the test set the remaining 30%. The numbers of cases in 
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Impute(dataset, Dist(i, j)) 
Inputs: dataset with N cases and F features 
             Dist(i, j): distance metric defined on cases i and j that have no missing values 
 
1 Repeat until convergence (i.e., no change in the estimates of the unknown values) 
or until some fixed number of iterations has been reached: 
2 For c∈  },...,1{ N
3  For f ∈  },...,1{ F
4   If value[c, f] = unknown 
5    Re-impute value[c, f] using 1-Nearest Neighbor: 
6 Produce a new estimate of value[c, f] by setting it to 
value[n, f] where n is the nearest neighbor case to c. The 
nearest neighbor case n is the case where value[n, f] ≠ 
missing and Dist(c, n) is the least. 
7   End if 
8  End for 
9 End for 
    
 
Dist(i, j) 
Input: cases i and j that have no missing values and have F features 
 
10 distance ←0 
11 For f ∈  },...,1{ F
12  If f is a continuous variable 
13   distance ←  square(value[i, f] – value[j, f]) + distance 
14  End if 
15  If f is a nominal variable 
16   distance ←  1 + distance if value[i, f] = value[j, f] 
17   distance ←  0 + distance if value[i, f] ≠ value[j, f] 
18  End if 
19 End for 
20 Return distance 
the training and test sets for the medical datasets are given in Table 5-2. The original Heart 
Failure dataset contains 33,533 cases. However, for the experiments described in this chapter 
only one-third of the cases that were randomly selected from the original dataset were used. This 
was done to reduce the running times of the patient-specific algorithms to several days from the 
several weeks that would be needed if the complete dataset was used. 
Figure 5-1: Pseudocode for non-parametric imputation of missing values using 1-Nearest 
Neighbor (modified from [93]). In the pseudocode, values that are missing in the original dataset 
are called “unknown” (as opposed to “known” values that are never missing) and values that have 
not yet been filled-in by the algorithm are called “missing”. 
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Missing values. For the UCI datasets, any case that had one or more missing values was 
removed from the dataset, as is done in [68]. Sixteen of the 21 UCI datasets have no missing 
values and no cases were removed. In the remaining five datasets, removal of missing values 
resulted in a decrease in the size of the dataset of less than 10%.  
The medical datasets have a large proportion of missing values and eliminating cases 
with missing values would have led to substantial reduction in the size of the datasets. Instead, 
the missing values were imputed using an iterative non-parametric imputation algorithm 
described by Caruana [93].  The pseudocode for this algorithm is given in Figure 5-1. This 
method had previously been applied to fill in missing predictor values for the pneumonia dataset 
with good results [93].  
Discretization. All target variables in all the datasets are discrete. However, some of the 
predictor variables are continuous (numerical) as indicated in Tables 5-1 and 5-2. All continuous 
variables were discretized using the method described by Fayyad and Irani [94]. This is an 
entropy based method that analyzes the values of a continuous variable and creates thresholds 
such that the resulting intervals have high information gain. The discretization thresholds were 
determined only from the training sets and then applied to both the training and test sets. 
5.3 PERFORMANCE MEASURES 
Many methods and measures are available to measure the performance of classifiers and 
predictive algorithms [95, 96]. The performance of the algorithms was evaluated on two 
measures of discrimination and three probability measures. The discrimination measures used are 
the misclassification error (ERR) and the area under the ROC curve (AUC). The discrimination 
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Table 5-3: Brief description of the performance measures used in evaluation of the performance 
of the algorithms. For the AUC, scores closer to 1 indicate better performance. For the remaining 
measures, scores closer to 0 indicate better performance. 
 
Performance measure Abbreviation Range Best score
misclassification error ERR [0, 1] 0 
area under the ROC curve AUC [0, 1] 1 
mean squared error / Brier score MSE [0, 2] 0 
mean logarithmic loss / mean cross entropy MXE [0, ∞) 0 
calibration score CAL [0, 1] 0 
measures evaluate how well the algorithm differentiates among the various classes (or values of 
the target variable). The probability measures considered are the logarithmic loss or cross 
entropy (MXE), Brier score or squared error (MSE), and calibration (CAL). The probability 
measures are uniquely minimized (in expectation) when the predicted value for the target of each 
case coincides with the true probability of that case taking that target value. A brief description 
of the measures is given in Table 5-3.  
5.3.1 Misclassification error (ERR) 
Misclassification error (or its complement classification accuracy) is probably the most widely 
used performance measure for evaluating classifiers and prediction algorithms. It is defined as 
the proportion of incorrect class predictions the algorithm makes relative to the size of dataset. If 
an algorithm produces a continuous output, as in the case of a probabilistic classifier, then the 
class with the highest value of the output is declared to be the predicted class. Misclassification 
error is sometimes a poor criterion for assessing performance since it makes the implicit 
assumption that costs of the different kinds of misclassification are equal; an assumption that 
often does not hold in practice. For example, falsely diagnosing a deadly disease in a healthy 
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person is typically considered a less costly error than not diagnosing the disease when it is 
actually present.  
Misclassification error is computed as the number of misclassifications divided by the 
total number of cases in the dataset. It varies from 0 to 1 with 0 representing perfect 
classification. 
5.3.2 Area under the ROC curve (AUC) 
The Receiver Operating Characteristic (ROC) curve is defined only for a binary target and is a 
plot of the sensitivity versus (1 – specificity) for all possible thresholds. Given two classes, 
namely, class 0 and class 1 that the target variable can take, sensitivity is defined as the 
probability of predicting correctly a case that belongs to class 1 and specificity is defined as the 
probability of predicting correctly a case that belongs to class 0. The area under the ROC curve 
(AUC) is typically used as a summary statistic of discrimination. The AUC is equivalent to the 
probability that a randomly chosen case from class 0 will have a smaller predicted probability of 
belonging to class 1 than a randomly chosen case from class 1. Based on this interpretation, the 
binary class AUC can be estimated as follows: 
10
000 2/)1()1|0(ˆ
nn
nnS
AAUCbinary
+−=≡ ,    (5.1) 
where S0 is the sum of the ranks of the cases that belong to class 0, after the cases have been 
ranked in ascending order of the predicted probability of belonging to class 0; n0 is the number of 
cases that belong to class 0 and n1 is the number of cases that belong to class 1 [97, 98]. The 
AUC is generally considered superior to misclassification error since it is independent of costs, 
priors and any classification threshold.  
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Several extensions of the AUC from binary to multiple classes have been described, 
which include the volume under the ROC surface [99] and the mean of the AUCs obtained by 
aggregation over all pairs of classes [98, 100].  For multiple classes, say c classes, the method 
described by Hand and Till [98] is used for computing the AUC, as follows: 
∑
<−= jimulticlass jiAccAUC ),(
ˆ
)1(
2 ,     (5.2) 
where 
2
)|(ˆ)|(ˆ),(ˆ ijAjiAjiA += ,      (5.3) 
such that  represents the binary class AUC when only classes i and j are considered and is 
computed using Equation 5.1. 
)|(ˆ jiA
The AUC varies from 0 to 1 with 1 representing perfect discrimination. 
5.3.3 Brier score or mean squared error (MSE) 
Let a binary target variable Yi take on values in {0, 1}, and let yi denote an indicator variable 
such that yi = 1 if Yi = 1 and yi = 0 if Yi = 0.  Let pi denote the predicted probability that Yi for 
case i takes the value 1. The mean squared error or the Brier score for a dataset of n cases is 
defined as [101]: 
∑
=
−=
n
i
ii
binary pyn
MSE
1
2)(1 .      (5.4) 
If the predicted probabilities pi are constrained to be equal to 0 or 1, the Brier score is equal to 
the misclassification error. The Brier score is a probability measure and depends on the predicted 
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values and not merely on the ranking of the cases based on the values (as in the AUC) or how the 
values fall relative to a threshold (as in the misclassification error). 
The MSE or the generalized Brier score for the multiclass case is a natural extension of 
the binary case [102]. Let a target variable Yi take on values in {0, 1, …, K-1}, and let yik denote 
an indicator variable such that yik = 1 if Yi = k and Yi = 0 otherwise, where k = {0, 1, …, K-1}. 
Let pik denote the predicted probability of class k for case i. The generalized Brier score is 
defined as: 
 ∑∑
=
−
=
−=
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multiclass pyn
MSE
1
1
0
2)(1 .     (5.5) 
The Brier score ranges from 0 to 2 with a score of 0 indicating perfect predictive 
performance. 
5.3.4 Mean logarithmic loss or mean cross-entropy (MXE) 
Mean logarithmic loss or mean cross entropy is another probability measure. Let a binary target 
variable Yi take on values in {0, 1}, and let yi denote an indicator variable such that yi = 1 if Yi = 
1 and yi = 0 if Yi = 0. Let pi denote the predicted probability that Yi for case i takes the value 1. 
The mean logarithmic loss for a dataset of n cases is defined as [103]: 
)1log()1()log(1
1
i
n
i
iii
binary pypyn
MXE −−−−= ∑
=
.   (5.6) 
For the multiclass case, the mean logarithmic loss is defined in a similar fashion to the 
generalized Brier score [104]: 
∑∑
=
−
=
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k
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multiclass pyn
MXE
1
1
0
)log(1 ,     (5.7) 
where yik and pik are defined as in the preceding section.  
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The logarithmic loss ranges from 0 to ∞ with a score of 0 indicating perfect predictive 
performance, meaning that a probability of 1 was assigned to the correct state of Yi in very case. 
5.3.5 Calibration score (CAL) 
The calibration score, CAL, was developed by Caraua [96] and is based on reliability diagrams 
[105]. Let a binary target variable Yi take on values in {0, 1}, and let yi denote an indicator 
variable such that yi = 1 if Yi = 1 and yi = 0 if Yi = 0. Let pi denote the predicted probability that Yi 
for case i takes the value 1. The calibration score is calculated as follows. Order all cases by pi, 
and put cases 1 to c in the same bin, where c is a suitable number that is smaller than the total 
number of test cases. Calculate the proportion of these cases where Yi = 1; this proportion 
approximates the true probability that in these cases Yi takes the value 1. Then calculate the mean 
prediction for these cases. The absolute value of the difference between the observed proportion 
and the mean prediction is the calibration error for this bin. Similarly, compute the calibration 
errors for the bins containing cases 2 to (c + 1), 3 to (c + 1), and so on. Then, CAL is the grand 
mean of the calibration errors of all the bins. For the experiments reported in this chapter, c was 
set to 50. This value of c provided an adequate number of bins since the number of test cases was 
not less than 50 for any dataset. 
For the multiclass case, as before, let pik denote the predicted probability of class k for 
case i. The CAL score is computed separately for each class k over all the cases. The final CAL 
score is the mean of the k CAL scores. 
The CAL score ranges from 0 to 1 with a score of 0 indicating perfect calibration.  
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5.4 MACHINE LEARNING ALGORITHMS 
Several versions of the patient-specific algorithm were evaluated on the UCI and the medical 
datasets and their performance compared with six machine leaning methods that are commonly 
used for developing clinical prediction models. 
5.4.1 Patient-specific algorithms 
Six versions of the patient-specific algorithms are used in the experiments described later in this 
chapter. They are listed in Table 5-4. The PSMBg, PSMBg-MS and the NPSMBg algorithms all 
use MB structures with the complete decision tree representation for CPDs that captures only the 
global MB structure (hence the suffix “g” in the acronym). The PSMBg algorithm is described in 
detail Section 4.4.1 and it performs selective model averaging to estimate the distribution of the 
target variable of the case at hand (i.e., the test case). The MB structures used for the model 
averaging are selected through a two-phase search, where phase 1 of the search is non patient-
specific while phase 2 of the search is patient-specific. Phase 1 uses greedy hill-climbing search 
that terminates at a local maximum and phase 2 uses best-first search and terminates when no 
candidate MB structure has a score higher than a small value ε or when a period of time t has 
elapsed, where ε and t are user specified. The PSMBg-MS algorithm is a model selection version 
of the PSMBg algorithm. It chooses the MB structure that has the highest posterior probability 
from those selected by the PSMBg algorithm in the two-phase search, and uses that single model 
to estimate the distribution of the target variable of the case at hand. Comparing the PSMBg 
algorithm to the PSMBg-MS algorithm measures the effect of approximating the selective model 
averaging by model selection. When the training dataset is large the performance of the PSMBg 
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algorithm and the PSMBg-MS algorithm may be similar if a single model with a relatively large 
posterior probability overwhelms the contributions of the remaining models during model 
averaging. 
The NPSMBg algorithm is the non-patient-specific (i.e., population-wide) version of the 
PSMBg algorithm. Phase 1 of the NPSMBg algorithm is identical to that of the PSMBg 
algorithm. In phase 2, the NPSMBg algorithm accumulates the same number of models as the 
PSMBg algorithm except that the MB structures are identified on the basis of the non-patient-
specific phase 1 score. Thus, the NPSMBg algorithm averages over the same number of models 
as the PSMBg algorithm. Comparing the PSMBg algorithm to the NPSMBg algorithm measures 
the additional effect of the patient-specific heuristic on the performance of model averaging 
Table 5-4: Six versions of the patient-specific algorithm with a brief description of each one. 
 
Acronym Algorithm Phase1 Phase 2 Prediction 
PSMBg 
Patient-specific 
Markov blanket 
(global) 
Is non-patient-specific 
Uses greedy hill-climbing
Uses phase 1 score 
Is patient-specific 
Uses best-first  
Uses phase 2 score 
By model averaging 
over models selected 
in phase 1 and phase 2 
PSMBg-MS 
Patient-specific 
Markov blanket 
(global) – 
Model Selection 
Same as PSMBg Same as PSMBg Based on the highest 
scoring model from 
models selected by 
PSMBg 
NPSMBg 
Non-patient-
specific Markov 
blanket (global) 
Is non-patient-specific 
Uses greedy hill-climbing
Uses phase 1 score 
Is non-patient-specific 
Uses best-first  
Uses phase 1 score 
By model averaging; 
number of selected 
models is the same as 
in PSMBg 
PSMBl 
Patient-specific 
Markov blanket 
(local) 
Is non-patient-specific 
Uses greedy hill-climbing
Uses phase 1 score 
Is patient-specific 
Uses best-first  
Uses phase 2 score 
By model averaging 
over models selected 
in phase 1 and phase 2 
PSMBl-MS 
Patient-specific 
Markov blanket 
(local) – Model 
Selection 
Same as PSMBl Same as PSMBl Based on the highest 
scoring model from 
models selected by 
PSMBl 
Non-patient-
specific Markov 
blanket (local) 
Is non-patient-specific 
Uses greedy hill-climbing
Uses phase 1 score 
Is non-patient-specific 
Uses best-first  NPSMBl Uses phase 1 score 
By model averaging; 
number of selected 
models is the same as 
in PSMBl 
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realized by a non-patient-specific (i.e., population-wide) method. 
The PSMBl, PSMBl-MS and the NPSMBl algorithms are very similar to the PSMBg, 
PSMBg-MS and the NPSMBg algorithms respectively, and differ from them in two respects. 
First, they use MB structures with the decision graph representation for CPDs that captures both 
global and local MB structure (hence the suffix “l” in the acronym). Second, the two-phase 
search procedure of the global algorithms is supplemented with an inner search procedure. 
Specifically, for each phase of the search, the local algorithms use a nested search procedure: an 
outer search procedure (which is the same as in the PSMBg algorithm) that applies the global 
operators to generate global MB structures and in inner search procedure (which is new to the 
PSMBl algorithm) that applies local operators to generate local structures. Note that the inner 
and outer search procedures are distinct from the two phases of the search. In summary, the 
PSMBl algorithm employs a two-phase two-tier search as follows. The outer search procedure of 
phase 1 uses greedy hill-climbing and the outer search procedure for phase 2 uses best-first 
search just as in the PSMBg algorithm. The inner search procedures for both phase 1 and phase 2 
use greedy hill-climbing. The PSMBl algorithm is described in detail Section 4.4.2. 
5.4.2 Comparison algorithms 
The performance of the patient-specific algorithms is compared to the following methods: (1) 
naïve Bayes (NB), (2) C4.5 decision tree (DT), (3) logistic regression (LR), (4) neural networks 
(NN), (5) k-Nearest Neighbor (kNN), and (6) Lazy Bayesian Rules (LBR). The first five methods 
are among the commonest multivariate techniques currently applied in developing clinical 
prediction models [17]. The first four are representative population-wide methods, and the next 
two are examples of patient-specific methods. kNN is a similarity-based patient-specific method. 
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The LBR algorithm induces a rule tailored to the features of the test case that is then used to 
classify it and is described in detail in Section 2.8. It is an example of a model-based patient-
specific method that performs model selection. For all the six methods listed above, the 
implementations in the Weka software package (version 3.4.3) were used. The Weka software 
package is available freely from the Weka machine learning project at the University of Waikato, 
New Zealand [103]. 
5.5 EVALUATION ON SYNTHETIC DATA 
This section describes the evaluation of the PSMBg and PSMBl algorithms on a small synthetic 
dataset. The synthetic domain consists of five binary variables A, B, C, D, Z where Z is a 
deterministic function of the other variables: 
)( DCBAZ ∧∧∨= . 
This function implies the value-specific independence relation )|,,( TADCBZ =⊥  that can be 
represented explicitly by a MB with local structure (i.e., with a decision graph) but not by a MB 
with global structure (i.e., with a CPT or a complete decision tree). The training and the test sets 
used in the experiments are shown in Figure 5-2. The training set simulates a low occurrence of 
A = T (only five out of 69 cases have A = T), and the test set consists of three cases of A = T 
which are not present in the training set. 
The following algorithms were used in the experiments: (1) a complete model averaged 
version of the PSMBg algorithm where model averaging is carried over all 3567 possible MB 
structures, (2) the PSMBg algorithm, (3) the NPSMBg algorithm, (4) the PSMBl algorithm, and 
(5) the NPSMBl algorithm.  
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The settings used for the PSMBg and PSMBl algorithms are as follows: 
• Phase 1: The model score for phase 1 is the Bayesian score computed using 
Equation 4.11 for the PSMBg algorithm and Equation 4.15 for the PSMBl 
algorithm, with a Dirichlet parameter prior with hyperparameters 1=ijkα  for all i, 
j, k. Phase 1 uses greedy hill-climbing search that terminates at a local maximum. 
• Phase 2: The model score for phase 2 is computed using Equation 4.18 that is 
based on KL-divergence. Phase 2 uses best-first search with a priority queue Q 
whose maximum capacity w is set to 1000. Phase 2 search terminates when no 
MB structure in Q has a phase 2 score higher than ε = 0.001 for 10 consecutive 
iterations of the search. The maximum period of running time t for phase 2 was 
not specified since the algorithm terminated in a reasonable period of time with 
the specified value for ε. 
Training set 
 
A,B,C,D,Z 
T,F,F,F,T 
T,F,T,F,T 
T,T,F,T,T 
T,T,T,F,T 
T,T,T,T,T 
F,F,F,F,F 
F,F,F,T,F 
F,F,T,F,F 
F,F,T,T,F 
F,T,F,F,F 
F,T,F,T,F 
F,T,T,F,F 
F,T,T,T,T 
Test set 
 
A,B,C,D,Z 
T,F,F,T,T 
T,T,F,F,T 
T,F,T,T,T 
Repeated 8 times
Figure 5-2: Training and test datasets derived from the deterministic 
function )( DCBAZ ∧∧∨= . The training set contains a total of 69 cases and the test set a 
total of three cases as shown; the test cases are not present in the training set. The training set 
simulates low prevalence of A = T since only five of the 69 cases have this variable value 
combination. 
 132 
  
• The predicted distribution for the target variable of the test case is computed using 
Equation 4.16; for each MB structure the parameters are estimated using 
Equation 4.6. 
5.5.1 Results 
The results are given in Table 5-5. All performance measures except the AUC were computed 
for the test set of three cases. The AUC could not be computed since all the cases in the test set 
are from the same class, Z = T. The results from complete model averaging represent the best 
achievable performance given the training set and the class of MB models with global structure. 
The PSMBg and the NPSMBg algorithms that average over a subset of all models had poorer 
performance than complete model averaging. However, the PSMBg algorithm improved over the 
performance of the NPSMBg algorithm. Though both methods average over the same number of 
models, the PSMBg algorithm uses the patient-specific phase 2 score to choose phase 2 models 
Table 5-5: Results obtained from the training and test sets that are shown in Figure 5-2. The 
AUC could not be computed since the test set has cases from a single class. Results in the first 
column are obtained by model averaging over all 3567 MBs with global structure. Similar 
complete model averaging over all MBs with local structure is not given since it was not 
tractable. 
Performance measure 
PSMBg 
complete 
model 
averaged
PSMBg NPSMBg PSMBl NPSMBl 
Misclassification error 0.0000 0.0000 0.3333 0.0000 0.0000 
- - - - AUC - 
Logarithmic loss 0.0684 0.0783 0.0862 0.0184 0.0183 
Squared error 0.0406 0.0505 0.0585 0.0042 0.0042 
CAL score 0.3720 0.4092 0.4284 0.1106 0.1103 
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while the NPSMBg algorithm uses the non-patient-specific phase 1 score to choose both phase1 
and phase 2 models. The phase 2 models chosen by the PSMBg algorithm are potentially 
different for each test case in contrast to the NPSMBg algorithm which selects the same models 
irrespective of the test case. This result provides support that the patient-specific search for 
models is able to choose models that better approximate the distribution of the target variable of 
the case at hand.   
Figure 5-4 plots the estimate of P(Z = T) for each test case as it varies with each addition 
of a model to the set of models being averaged over. A second curve plots the model score as the 
logarithmic posterior probability of the model given the data; this score measures the relative 
contribution of the model to the final estimate of P(Z = T). Each row in the figure contains a pair 
of plots for a single test case, the plot on the left is obtained from the PSMBg algorithm and the 
corresponding plot on the right is obtained from the NPSMBg algorithm. The plot for the 
estimate of P(Z = T) is shown in black while the plot for the model score is shown in gray.  In 
(a) 
A B C D
Z 
D 
C 
T
Z Z 
A 
F
B 
F
F
F
T 
T
T
(b) 
Figure 5-3: Markov blanket model with the best score discovered by the PSMBl algorithm for the dataset 
given in Table 5-2. The global structure is given in (a) and the corresponding local structure for Z is given by 
the decision graph in (b). All other nodes from A through D have local structures consisting of a single DG 
node. 
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each plot, on going from left to right, the estimate of P(Z = T) initially fluctuates widely and then 
settles to a stable estimate as the number of models providing the estimate increases. In the first 
two test cases the final estimates of P(Z = T) obtained from the patient-specific and non-patient-
specific model averaging respectively are very close; both the PSMBg and the NPSMBg 
algorithms predicted the value of Z correctly as T. In the third test case, the final estimates of 
P(Z = T) are quite different; the PSMBg algorithm predicted the value of Z correctly as T while 
the NPSMBg algorithm predicted the value of Z incorrectly as F.  
Table 5-5 also gives the results obtained from the PSMBl and NPSMBl algorithms. 
Complete model averaging over the space of MB with local structures could not be carried out 
since the number of models in this space is too large to be tractable. Both the PSMBl and 
NPSMBl algorithms have similar performance on the three test cases and show considerable 
improvement in logarithmic loss, squared error and the CAL score over the PSMBg algorithms. 
Their performance is also better than that of complete model averaging over MBs with global 
structure. This is due the fact that the generating model can be represented exactly by a MB with 
local structure. One such structure is shown in Figure 5-3; this structure was discovered by both 
the PSMBl and the NPSMBl algorithms as the best scoring structure. For the three test cases the 
PSMBl algorithm produced estimates of P(Z = T) that are only marginally different from those 
produced by the NPSMBl algorithm, and the two algorithms are nearly indistinguishable on all 
the performance measures. 
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Figure 5-4: Plots of model averaged estimate of P(Z = T) and the model score obtained by the 
PSMBg and the NPSMBg algorithms on the three test cases given in Figure 5-2. Each row 
represents a single test case with the plot on the left obtained from the PSMBg algorithm and the 
plot on the right obtained from the NPSMBg algorithm. The value of the final averaged estimate 
of P(Z = T) is the point where the black curve meets the Y-axis on the right. 
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The best scoring structure shown in Figure 5-3 was the last structure discovered in phase 
1 by both the PSMBl and the NPSMBl algorithms. This structure has a posterior probability 
about 200 times larger than the next best structure, and thus its estimate of Z contributes to a 
great extent to the final model averaged estimate of Z. This explains the lack of improvement in 
performance of the PSMBl algorithm over the NPSMBl algorithm. In contrast, several structures 
with similar posterior probabilities were found by the PSMBg and the NPSMBg algorithms and 
the final model averaged estimate of Z was not dominated by the estimate obtained from a single 
structure. 
5.6 EVALUATION OF THE PSMBG ALGORITHM 
This section describes the evaluation of the PSMBg algorithm on 21 UCI datasets and three 
medical datasets. The performance of the PSMBg algorithm is compared to that of the PSMBg-
MS and the NPSMBg algorithms which are described in Section 5.4.1, and also to that of the six 
comparison machine learning methods which are described in Section 5.4.2. To recall, the 
PSMBg algorithm selects MB structures for model averaging using a two-phase search where 
phase 2 is patient-specific, the PSMBg-MS algorithm is a model selection version of the PSMBg 
algorithm that measures the effect of approximating the model averaging by model selection, and 
the NPSMBg algorithm is a non-patient-specific (i.e., population-wide) version of the PSMBg 
algorithm that measures the additional effect of the patient-specific heuristic on the performance 
of model averaging that can be achieved by a non-patient-specific method. 
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5.6.1 Experimental design 
The experimental design is as follows: 
• For each dataset, a total of 10 machine learning algorithms were run: PSMBg, 
PSMBg-MS, NPSMBg, NB, DT, LR, NN, kNN, LBR and ZR. 
• The datasets used in the experiments are the 21 UCI datasets (listed in Table 5-1) 
and the three medical datasets with five target variables (listed in Table 5-2). 
• Summary statistics were measured using 10-fold stratified cross-validation done 
twice (for a total of 20 training-test pairs) for the UCI datasets and a single 
training-test pair for the medical datasets. The summary statistics were computed 
for misclassification error, the AUC, logarithmic loss, squared error and the CAL 
score. 
• The statistical tests performed were (1) significance testing with the Wilcoxon 
paired-samples signed ranks test, and (2) effect size testing with paired-samples t 
test. 
The settings for the PSMBg algorithm are as follows: 
• Phase 1: The model score for phase 1 is the Bayesian score computed using 
Equation 4.11, with a Dirichlet parameter prior with hyperparameters 1=ijkα  for 
all i, j, k. Phase 1 uses greedy hill-climbing search that terminates at a local 
maximum. 
• Phase 2: The model score for phase 2 is computed using Equation 4.18 that is 
based on KL-divergence. Phase 2 uses best-first search with a priority queue Q 
whose maximum capacity is set to 1000. Phase 2 search terminates when no MB 
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structure in Q has a phase 2 score higher than ε = 0.001 for 10 consecutive 
iterations of the search. The maximum period of running time t for phase 2 was 
not specified since the algorithm terminated in a reasonable period of time on all 
the datasets with the specified value for ε. 
• The predicted distribution for the target variable of the test case is computed using 
Equation 4.16; for each MB structure the parameters are estimated using 
Equation 4.6. 
5.6.2 Results  
Tables 5.6 to 5.10 report the means of the misclassification error, the AUC, logarithmic loss, 
squared error and the CAL score respectively for the PSMBg algorithm, its variants and the 
comparison algorithms. In each table, a row represents a dataset and a column represents an 
algorithm. The last three rows in each table give for each algorithm the overall mean of the 
specified performance measure across the UCI datasets, the medical datasets and the combined 
UCI and medical datasets respectively. The results are also plotted in Figures 5-5 to 5-9 along 
with the standard errors of the means. From the tables, it is seen that on all five performance 
measures, the PSMBg algorithm achieved a better overall average score than all other 
algorithms.  
Tables 5.11 and 5.12 report results from pair-wise comparisons of the performance of the 
algorithms on the combined UCI and medical datasets that is aimed at assessing the statistical 
significance and the magnitude of the observed differences in the measures. Table 5-11 reports 
results from the Wilcoxon paired-samples signed ranks test. This test is a non-parametric 
procedure used to test whether there is sufficient evidence that the median of two probability 
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distributions differ in location. In evaluating algorithms, it can be used to test whether two 
algorithms differ significantly in performance on a specified measure. As it takes into account 
the magnitude and the direction of the difference between paired samples, this test is more 
powerful than the sign test [106]. Being a non-parametric test, it does not make any assumptions 
about the form of the underlying probability distribution of the sampled population. The test is 
carried out by sorting the absolute values of the paired differences from smallest to largest, 
assigning ranks to the absolute values (rank 1 to the smallest, rank 2 to the next smallest, and so 
on) and then finding the sum of the ranks of the positive differences. If the null hypothesis is 
true, the sum of the ranks of the positive differences should be about the same as the sum of the 
ranks of the negative differences.  
Table 5-12 reports results from the paired-samples t test. This test is a parametric 
procedure used to determine whether there is a significant difference between the average values 
of the same performance measure for two different algorithms. The test assumes that the paired 
differences are independent and identically normally distributed. Though the measurements 
themselves may not be normally distributed, the pair-wise differences are often normally 
distributed.  
The results are encouraging in that they show that the PSMBg algorithm never 
underperformed on any performance measure when compared to the other learning methods 
including the variants of the PSMBg algorithm that do model selection and non-patient-specific 
model averaging. This can be seen in the mean differences shown in Table 5-12. For 
misclassification error, logarithmic loss, squared error and the CAL score, the mean difference is 
always negative which denotes that the PSMBg algorithm always has a lower score on these 
measures. For the AUC, the difference is always positive which means that the PSMBg 
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algorithm always has a higher AUC. However, all mean differences are not statistically 
significant at the 0.05 level as can be seen by the p-values in Table 5-12. The best performance is 
seen in logarithmic loss where the PSMBg algorithm significantly outperforms all other 
methods, followed by squared error and CAL score where the PSMBg algorithm significantly 
outperforms many of the methods. On misclassification error and the AUC, the PSMBg 
algorithm has smaller performance gains. Similar results are seen in Table 5.11 that gives the Z 
statistics from the Wilcoxon paired-samples signed ranks test.. 
Table 5-13 gives the average number of models selected by the PSMBg and the NPSMBg 
algorithms in each of the phases for each dataset. The average number of models varies from 
17.99 for the iris dataset (with four predictor variables) to 589.52 for the pneumonia dataset 
(with 152 predictor variables). The average number of phase 1 models in the pneumonia dataset 
was unusually high. This was due to the fact that this dataset has the largest number of variables 
and the phase 1 hill-climbing search terminates at a local maximum after a large number of 
iterations. 
The average running time of the PSMBg algorithm for a single test case was 
approximately 1 hour and 30 minutes (see Table 5-21). This includes time spent in both phase 1 
and 2 of the search. Typically, 70% - 90% of the running time was spent in phase 2. 
5.6.3 Discussion 
Overall, the PSMBg algorithm significantly improved on the probabilities of the predictions 
while maintaining or slightly improving on discrimination over all other algorithms used in the 
experiments. The non-patient-specific NPSMBg algorithm had inferior performance on 
logarithmic loss and squared error but similar performance on the other measures when 
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compared to the PSMBg algorithm. Both the PSMBg and the NPSMBg algorithms average over 
the same number of models and both select the same models in phase 1 of the search. In phase 2 
of the search, while the number of selected models is the same, the two methods identify 
potentially different models. This provides evidence that the models selected in phase 2 by the 
PSMBg algorithm, using patient-specific search, are able to improve the performance of the 
PSMBg algorithm over the already good performance obtained by the NPSMBg algorithm.  
Comparison of the PSMBg algorithm with the PSMBg-MS algorithm shows that model 
averaging outperformed the single best model on all the performance measures (Tables 5.11 and 
5.12).  
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Table 5-6: Mean misclassification errors of different algorithms based on 10-fold cross-
validation done twice on the UCI datasets and a single train-test validation on the medical 
datasets. To avoid cluttering only the mean for each dataset is shown. The bottom three rows give 
the average misclassification errors for the UCI datasets, the medical datasets and all the datasets 
respectively. Best results are in underlined. 
 
Dataset PSMBg PSMBg-MS NPSMBg NB DT LR NN kNN LBR 
australian 0.1457 0.1457 0.1435 0.1449 0.1333 0.1486 0.1848 0.1457  0.1471 
breast-cancer 0.0256 0.0271 0.0256 0.0256 0.0403 0.0337 0.0373 0.0286 0.0256    
cleveland 0.1740 0.1791 0.1740 0.1655 0.2095 0.1655 0.1993 0.1791 0.1655   
corral 0.0000 0.0156 0.0000 0.1328 0.0508 0.1289 0.0000   0.0977 0.1250 
crx 0.1547 0.1577 0.1485 0.1348 0.1317 0.1424 0.1692 0.1485  0.1340 
diabetes 0.2116 0.2129 0.2142 0.2201 0.2194 0.2135  0.2272 0.2201 0.2207 
flare 0.1806 0.1834 0.1825 0.2012 0.1735 0.1721 0.2054 0.1806 0.1750 
german 0.2580 0.2585 0.2580 0.2445 0.2845 0.2425 0.2980 0.2695 0.2475  
glass2 0.1503 0.1564 0.1472 0.1595 0.1933 0.1442 0.1442 0.1411 0.1503 
glass 0.2150 0.2220 0.2196 0.2687 0.2500 0.2547 0.2220 0.2173 0.2500 
heart 0.1778 0.1778 0.1778 0.1630 0.1870 0.1630 0.1963 0.1741 0.1630   
hepatitis 0.0938 0.1000 0.1000 0.1375 0.1250 0.1375 0.1688 0.0688 0.1375 
iris 0.0567 0.0600 0.0633 0.0533 0.0600 0.0567 0.0633 0.0633 0.0533  
lymphography 0.1622 0.1486 0.1622 0.1486 0.2365 0.2365 0.1622 0.1622 0.1520   
pima 0.2155 0.2135 0.2142 0.2214 0.2259 0.2148 0.2389 0.2246  0.2227 
postoperative 0.3391 0.3851 0.3391 0.3103 0.2989 0.3736 0.4138  0.3333 0.3103 
sonar 0.1635 0.1659 0.1731 0.1490 0.1659 0.1442 0.1611 0.1707 0.1490  
vehicle 0.2600 0.2577 0.2612 0.3712 0.2843  0.2914 0.2825 0.2766 0.2784 
vote 0.0453 0.0582 0.0453 0.0927 0.0388 0.0733 0.0711 0.0819 0.0927  
wine 0.0084 0.0084 0.0056 0.0112 0.0702 0.0253 0.0169 0.0281  0.0112 
zoo 0.0347 0.0396 0.0347 0.0644 0.0792 0.0594 0.0495 0.0347   0.0644 
pneumonia 0.1531 0.1516 0.1531 0.2274 0.1443 0.1472 0.1356 0.1137 0.1210 
sepsis-d 0.0986 0.0968 0.0968 0.1649 0.0896 0.0914 0.1272 0.0896 0.1057  
sepsis-s 0.2294 0.2276 0.2276 0.2563 0.2240 0.2312 0.2491 0.2348 0.2204 
heart failure-d 0.0462 0.0464 0.0475 0.0561 0.0448 0.0448 0.0623  0.0464 0.0472 
heart failure-c 0.1246 0.1246 0.1272 0.1426 0.1106 0.1111 0.1420 0.1128 0.1272  
UCI average 0.1463 0.1511 0.1471 0.1629 0.1647 0.1629 0.1672 0.1546 0.1463  
medical average 0.1304 0.1294 0.1304 0.1695 0.1227 0.1251 0.1432 0.1195 0.1304  
overall average 0.1432 0.1469 0.1439 0.1641 0.1566 0.1557 0.1626 0.1478  0.1499 
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Table 5-7: Mean AUCs of different algorithms based on 10-fold cross-validation done twice on 
the UCI datasets and a single train-test validation on the medical datasets. To avoid cluttering 
only the mean for each dataset is shown. The bottom three rows give the average AUCs for the 
UCI datasets, the medical datasets and all the datasets respectively. Best results are in underlined.
 
      
Dataset PSMBg PSMBg-MS NPSMBg NB DT LR NN kNN LBR 
australian 0.9315 0.9303 0.9313 0.9200 0.9032 0.9187 0.8937 0.9092 0.9186  
breast-cancer 0.9926 0.9922 0.9925 0.9933 0.9613 0.9879 0.9818 0.9930 0.9933 
cleveland 0.9098 0.9079 0.9084 0.9141 0.7952 0.9089 0.8781 0.8995 0.9141 
corral 1.0000 0.9997 1.0000 0.9252 0.9916 0.9459 1.0000 0.9827    0.9373 
crx 0.9303 0.9280 0.9302 0.9301 0.9087 0.9138 0.9002 0.9057 0.9302  
diabetes 0.8468 0.8468 0.8466 0.8438 0.7991 0.8439 0.8311 0.8148 0.8423  
flare 0.7289 0.7288 0.7261 0.7557 0.4916  0.7451 0.6445 0.6797 0.7520 
german 0.7662 0.7633 0.7641 0.7903 0.6736 0.7839 0.7340 0.7442  0.7891 
glass2 0.8703 0.8653 0.8700 0.8769 0.7982 0.8845 0.8483 0.8384 0.8826  
glass 0.9364 0.9361 0.9361 0.9408 0.8834 0.9101 0.9241 0.9112 0.9434 
heart 0.9055 0.9049 0.9073 0.9106 0.8239 0.9032 0.8649 0.8791 0.9106 
hepatitis 0.9225 0.9262 0.9237 0.9013 0.8203 0.7784 0.8436 0.8792  0.8970 
iris 0.9890 0.9900 0.9905 0.9938 0.9629 0.9846 0.9785 0.9886 0.9938 
lymphography 0.9139 0.9156 0.9173 0.9193 0.7741 0.8571 0.9192 0.9087 0.9175 
pima 0.8431 0.8424 0.8424 0.8450 0.7977 0.8456 0.8237  0.8134 0.8449 
postoperative 0.5026 0.4943 0.4538 0.5035 0.4228  0.4515 0.4113 0.3665 0.5035 
sonar 0.9203 0.9204 0.9217 0.9343 0.8521 0.9275 0.9331 0.9132 0.9345 
vehicle 0.9234 0.9228 0.9235 0.8655 0.8761 0.9016 0.8931 0.9032 0.9109 
vote 0.9875 0.9850 0.9854 0.9684 0.9578 0.9582 0.9871 0.9735 0.9660 
wine 0.9994 0.9994 0.9994 1.0000 0.9660 0.9967 0.9994 0.9981 1.0000  
zoo 0.9994 0.9992 0.9992 0.9989 0.9565 0.9967 0.9916 0.9995 0.9989 
pneumonia 0.8236 0.8262 0.8261 0.8585 0.5591 0.7414 0.7740 0.7874 0.8306  
sepsis-d 0.8619 0.8618 0.8575 0.8698 0.7894 0.8482 0.8093 0.8517 0.8522  
sepsis-s 0.7689 0.7697 0.7677 0.7748 0.6870 0.7558 0.7401 0.7702 0.7814 
heart failure-d 0.7457 0.7424 0.7393 0.7725 0.1769 0.7607 0.7073  0.7455 0.7576 
heart failure-c 0.7709 0.7698 0.7712 0.7879 0.4573 0.7898 0.6419 0.7465 0.7805  
UCI average 0.8962 0.8952 0.8938 0.8919 0.8293  0.8783 0.8705 0.8715 0.8943 
medical average 0.7942 0.7940 0.7924 0.8127 0.7059 0.7792 0.7345 0.7803 0.8005  
overall average 0.8786 0.8757 0.8743  0.8767 0.8056 0.8592 0.8444 0.8539 0.8763 
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Table 5-8: Mean logarithmic losses of different algorithms based on 10-fold cross-validation 
done twice on the UCI datasets and a single train-test validation on the medical datasets. To avoid 
cluttering only the mean for each dataset is shown. The bottom three rows give the average 
logarithmic losses for the UCI datasets, the medical datasets and all the datasets respectively. Best 
results are in underlined. 
 
Dataset PSMBg PSMBg-MS NPSMBg NB DT LR NN kNN LBR 
australian 0.3390 0.3456 0.3417 0.4476 0.4091 0.7136 0.4263 0.8627 0.4482  
breast-cancer 0.1068 0.1138 0.1083 0.2497 0.2955  0.1485 0.1205 0.2138 0.2497 
cleveland 0.3925 0.4067 0.4021 0.4491 1.3001 0.6500 0.4584 0.8625 0.4491  
corral 0.1018 0.1101 0.0989 0.3326 0.1475 0.2753 0.1542 0.0175 0.3130 
crx 0.3451 0.3564 0.3525 0.4113 0.3783 0.9377 0.4678 0.8747 0.4018  
diabetes 0.4601 0.4606 0.4604 0.4809 0.5497 0.4588 0.6039 0.5028 0.4826  
flare 0.4282 0.4294 0.4314 0.5904 0.4879 0.4042 0.5333 0.5858 0.5182  
german 0.5331 0.5413 0.5377 0.5213 1.4604 0.5229 0.5801 1.5415 0.5221 
glass2 0.4238 0.4302 0.4246 0.4532 0.8498 0.4154 0.8853 0.4562 0.4447  
glass 0.7112 0.7239 0.7113 0.7697 2.3005 4.0749 1.3612 0.8685 0.7264  
heart 0.3996 0.4069 0.3973 0.4560 0.6920 0.3907 0.6109 0.8483 0.4560  
hepatitis 0.2396 0.2517 0.2583 0.4247 0.6122 17.7871 0.3562 0.6253 0.4272  
iris 0.1560 0.1909 0.1620 0.1621 0.5287 0.7579 0.5770 0.2240 0.1621  
lymphography 0.4100 0.4289 0.4430 0.4282 2.9112  21.6371 0.5765 0.7272 0.4409 
pima 0.4647 0.4657 0.4657 0.4793 0.5268 0.4572 0.5873 0.5114  0.4774 
postoperative 0.7381 0.7776 0.7287 0.7953 1.1395 2.8236 1.3339 1.9418 0.7953  
sonar 0.3573 0.3726 0.3743 0.4573 1.2814 0.5762 0.4170 0.5728 0.4554  
vehicle 0.5863 0.5900 0.5866 1.8645 2.3842  3.9997 1.0134 1.2590 0.7815 
vote 0.1393 0.1635 0.1588 0.6804 0.3028 5.5427 0.3171 0.2782  0.5629 
wine 0.0418 0.0402 0.0367 0.0303 0.8270 0.9593 0.1032 0.0409 0.0303 
zoo 0.1297 0.1202 0.1268 0.1474 1.1102 0.5325 0.0596 0.1595 0.1474  
pneumonia 0.5728 0.5713 0.5733 1.8092 1.6659  0.7102 0.5795 0.8787 0.6483 
sepsis-d 0.2525 0.2520 0.2528 0.5183 0.3700 0.3492 0.2569 0.6711  0.3299 
sepsis-s 0.4726 0.4751 0.4748 0.7639 0.5990 0.6016 0.8871 1.5491 0.6199  
heart failure-d 0.3174 0.3179 0.3182 0.3491 0.5374 0.2962 0.3269 1.2575 0.3212 
heart failure-c 0.1690 0.1700 0.1707 0.1797 0.1825 0.1626 0.1740  0.7067 0.1686 
UCI average 0.3573 0.3679 0.3622 0.5063 0.9759  3.0507 0.5497 0.6654 0.4425 
medical average 0.3569 0.3573 0.3580 0.7240 0.6710 0.4240 0.4449 1.0126 0.4176 
overall average 0.3572 0.3659 0.3614 0.5481 0.9173 2.5456 0.5295 0.7322 0.4377 
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Table 5-9: Mean squared errors of different algorithms based on 10-fold cross-validation done 
twice on the UCI datasets and a single train-test validation on the medical datasets. To avoid 
cluttering only the mean for each dataset is shown. The bottom three rows give the average 
squared errors for the UCI datasets, the medical datasets and all the datasets respectively. Best 
results are in underlined. 
    
Dataset PSMBg PSMBg-MS NPSMBg NB DT LR NN kNN LBR 
australian 0.2054 0.2082 0.2060 0.2234 0.2066 0.2116  0.3062 0.2287 0.2287 
breast-cancer 0.0440 0.0449 0.0441 0.0474 0.0731 0.0542 0.0689  0.0484 0.0474 
cleveland 0.2433 0.2499 0.2462 0.2553 0.3516 0.2339 0.3364 0.2526 0.2553  
corral 0.0352 0.0463 0.0354 0.2056 0.0887 0.1836 0.0038 0.1051 0.1951  
crx 0.2081 0.2146 0.2087 0.2092 0.1965 0.2121 0.2948 0.2363 0.2078  
diabetes 0.2978 0.2981 0.2979 0.3073 0.3219 0.2978 0.3156 0.3315 0.3086  
flare 0.2619 0.2626 0.2652 0.3145 0.2846 0.2513 0.3203 0.2843 0.2700 
german 0.3526 0.3570 0.3555 0.3419 0.4196 0.3368 0.5104 0.3591  0.3433 
glass2 0.2469 0.2513 0.2468 0.2450 0.3116 0.2409 0.2572 0.2603 0.2393 
glass 0.3609 0.3635 0.3605 0.3823 0.4186 0.4363 0.4075  0.3880 0.3673 
heart 0.2444 0.2486 0.2420 0.2570 0.3113 0.2394 0.3273 0.2611 0.2570 
hepatitis 0.1410 0.1495 0.1534 0.2079 0.2170 0.2750 0.2579 0.1481  0.2090 
iris 0.0727 0.0828 0.0753 0.0751 0.1122 0.0942 0.1032 0.1086 0.0751  
lymphography 0.2391 0.2353 0.2433 0.2344 0.4162 0.4545 0.2687  0.2650 0.2406 
pima 0.3009 0.3011 0.3011 0.3065 0.3264 0.2968 0.3248 0.3332 0.3060 
postoperative 0.4772 0.5044 0.4748 0.4894 0.4525 0.6011 0.7221 0.6168  0.4894 
sonar 0.2349 0.2391 0.2369 0.2411 0.2887 0.2228 0.2764 0.2402 0.2405  
vehicle 0.3471 0.3481 0.3470 0.5805 0.4171 0.4109 0.4672  0.3934 0.4059 
vote 0.0788 0.0903 0.0810 0.1681 0.0703 0.1461 0.1172 0.1293 0.1529 
wine 0.0183 0.0158 0.0142 0.0191 0.1268 0.0503 0.0213 0.0407 0.0191  
zoo 0.0612 0.0652 0.0630 0.0860 0.1415 0.0991 0.0568 0.0406 0.0860 
pneumonia 0.2442 0.2435 0.2433 0.4149 0.2647 0.2546 0.2453 0.1952 0.2051 
sepsis-d 0.1501 0.1500 0.1516 0.2473 0.1505 0.1513 0.2226 0.1458 0.1754 
sepsis-s 0.3120 0.3123 0.3139 0.4156 0.3428 0.3155 0.4431 0.3499 0.3348 
heart failure-d 0.0839 0.0842 0.0844 0.0951 0.0853 0.0810 0.1161 0.0852 0.0838 
heart failure-c 0.1883 0.1886 0.1892 0.2137 0.1925 0.1726 0.2677 0.1910 0.1913 
UCI average 0.2129 0.2179 0.2142 0.2475 0.2644 0.2547 0.2745 0.2415 0.2354  
medical average 0.1957 0.1957 0.1965 0.2773 0.2072 0.1950 0.2590 0.1934 0.1981 
overall average 0.2096 0.2137 0.2108 0.2532 0.2534 0.2432 0.2715 0.2323 0.2283  
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Table 5-10: Mean CAL scores of different algorithms based on 10-fold cross-validation done 
twice on the UCI datasets and a single train-test validation on the medical datasets. To avoid 
cluttering only the mean for each dataset is shown. The bottom three rows give the average CAL 
scores for the UCI datasets, the medical datasets and all the datasets respectively. Best results are 
in underlined. 
 
Dataset PSMBg PSMBg-MS NPSMBg NB DT LR NN kNN LBR 
australian 0.0470 0.0459 0.0454 0.0775 0.0463 0.0440 0.0526 0.1423 0.0817 
breast-cancer 0.0146 0.0146 0.0144 0.0200 0.0261 0.0155 0.0114 0.0299 0.0200 
cleveland 0.0497 0.0630 0.0569 0.0930 0.0690 0.0295 0.0432 0.1543 0.0930  
corral 0.0583 0.0656 0.0561 0.0470 0.0505 0.0473 0.0162 0.0115 0.0368 
crx 0.0452 0.0518 0.0503 0.0711 0.0440 0.0394 0.0722  0.1354 0.0689 
diabetes 0.0403 0.0401 0.0411 0.0618 0.0633 0.0433 0.0813 0.0662 0.0590  
flare 0.0551 0.0546 0.0562 0.1260 0.0467 0.0414 0.0762 0.1000 0.0707 
german 0.0684 0.0696 0.0699 0.0625 0.1038 0.0504 0.0547 0.2363 0.0645  
glass2 0.0359 0.0395 0.0373 0.0644 0.0386 0.0322 0.0482 0.0561  0.0569 
glass 0.0188 0.0189 0.0186 0.0282 0.0223 0.0262 0.0258 0.0246 0.0241  
heart 0.0498 0.0585 0.0513 0.0913 0.0641 0.0321 0.0624 0.1385 0.0913 
hepatitis 0.0422 0.0294 0.0381 0.0488 0.0306 0.0462 0.0197 0.0492 0.0466  
iris 0.0110 0.0115 0.0114 0.0132 0.0188 0.0142 0.0219 0.0205  0.0132 
lymphography 0.0226 0.0259 0.0256 0.0326 0.0279 0.0863 0.0272  0.0512 0.0359 
pima 0.0532 0.0539 0.0539 0.0596 0.0660 0.0444 0.0960 0.0805 0.0586  
postoperative 0.0404 0.0358 0.0438 0.0436 0.0450  0.0707 0.0844 0.1175 0.0436 
sonar 0.0437 0.0656 0.0643 0.1042 0.0591 0.0814 0.0503 0.1336 0.1045  
vehicle 0.0479 0.0481 0.0480 0.1272 0.0654 0.0632 0.0567 0.0984  0.0690 
vote 0.0247 0.0285 0.0306 0.0722 0.0227 0.0520 0.0603  0.0346 0.0658 
wine 0.0062 0.0043 0.0054 0.0083 0.0247 0.0154 0.0256 0.0133 0.0083  
zoo 0.0065 0.0067 0.0069 0.0078 0.0094 0.0055 0.0029 0.0075 0.0078  
pneumonia 0.0998 0.0991 0.0985 0.2078 0.0696 0.1001 0.0730  0.1051 0.0905 
sepsis-d 0.0353 0.0466 0.0310 0.1255 0.0373 0.0314 0.0161 0.0921  0.0585 
sepsis-s 0.0627 0.0710 0.0690 0.1923 0.0857 0.0578 0.1077 0.2066 0.1329  
heart failure-d 0.0263 0.0288 0.0255 0.0448 0.0667 0.0280 0.0266 0.0490 0.0269  
heart failure-c 0.0533 0.0523 0.0584 0.0854 0.1505 0.0372 0.0586 0.1271 0.0577  
UCI average 0.0372 0.0396 0.0393 0.0600 0.0450 0.0419 0.0471 0.0810 0.0533  
medical average 0.0555 0.0596 0.0565 0.1312 0.0820 0.0509 0.0564 0.1160 0.0733 
overall average 0.0407 0.0434 0.0426 0.0737 0.0521 0.0437 0.0489 0.0877 0.0572  
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Table 5-11: Wilcoxon paired-samples signed ranks test comparing the performance of PSMBg with other 
algorithms. For each performance measure the number on top is the Z statistic and the number at the 
bottom is the corresponding p-value. The Z statistic is negative when PSMBg has a lower score on a 
performance measure than the competing algorithm. On all measures except the AUC, a negative Z 
statistic indicates better performance by PSMBg; on the AUC a positive Z statistic indicates better 
performance by PSMBg. Underlined results indicate p-values of 0.05 or smaller. 
Performance 
measure 
PSMBg-
MS NPSMBg NB DT LR NN kNN LBR 
-2.338 
  
-0.776 -2.121 -2.070 -1.181 -3.861 -0.825 -0.368 Misclassification 
error 0.019 0.438 0.034 0.038 0.238 0.000    0.409 0.713 
2.085 1.257 1.511 4.457 2.197 4.029 4.203 0.927 
AUC 
0.037 0.209 0.131 0.000 0.028 0.000 0.000     0.354 
-3.595 -2.426 -4.280 -4.457 -3.340 -4.254 -4.026 -4.051 
Logarithmic loss 
0.000 0.015 0.000 0.000 0.001 0.000 0.000 0.000        
-3.608 -2.313 -3.975 -3.24 -2.121 -4.127 -3.518 -3.213 
Squared error 
0.000 0.021 0.000 0.000 0.034 0.000 0.000 0.001        
-2.032 -1.867 -4.026 -2.806 -0.063 -4.076 -1.892 -3.543 
CAL score 
0.042 0.062 0.000 0.005 0.949 0.000 0.058 0.000     
 
Table 5-12: Paired-samples t test comparing the performance of PSMBg with other algorithms. For each 
performance measure the number on top is the mean difference between PSMBg and the indicated 
algorithm and the number at the bottom is the corresponding p-value. The mean difference is negative 
when PSMBg has a lower score on a performance measure than the competing algorithm. On all 
measures except the AUC, a negative mean difference indicates better performance by PSMBg; on the 
AUC a positive mean difference indicates better performance by PSMBg. Underlined results indicate p-
values of 0.05 or smaller. 
Performance 
measure 
PSMBg-
MS NPSMBg NB DT LR NN kNN LBR 
-0.004 -0.001 -0.021 -0.013 -0.012 -0.019 -0.005 -0.007 Misclassification 
error 0.077 0.312 0.014 0.021 0.065 0.000   0.334 0.289 
0.001 0.002 0.000 0.104 0.017 0.032 0.023 0.000 
AUC 
0.077 0.242 0.975 0.000 0.022 0.000 0.000    0.932 
-0.009 -0.004 -0.163 -0.211 -0.215 -0.306 -0.140 -0.071 
Logarithmic loss 
0.001 0.026 0.005 0.000 0.006 0.000 0.000 0.000        
-0.004 -0.001 -0.044 -0.044 -0.034 -0.062 -0.023 -0.019 
Squared error 
0.003 0.054 0.002 0.000 0.009 0.002 0.000 0.017       
-0.003 -0.002 -0.033 -0.011 -0.003 -0.047 -0.008 -0.016 
CAL score 
0.044 0.058 0.000 0.018 0.441 0.000 0.079 0.001     
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Figure 5-5: Pairwise plots of the mean misclassification errors of PSMBg vs. competing algorithms. Each 
point represents the mean misclassification errors of PSMBG and a competing algorithm on a single dataset, 
and the crosshairs represent one standard deviation on either side of the mean misclassification errors. Points 
above the diagonal line represent better performance by PSMBg than the competing algorithm. 
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Figure 5-6: Pairwise plots of the mean AUCs of PSMBg vs. competing algorithms. Each point represents the 
mean AUCs of PSMBG and a competing algorithm on a single dataset, and the crosshairs represent one 
standard deviation on either side of the mean AUCs. Points above the diagonal line represent better 
performance by PSMBg than the competing algorithm. 
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Figure 5-7: Pairwise plots of the mean logarithmic losses of PSMBg vs. competing algorithms. Each point 
represents the mean logarithmic losses of PSMBG and a competing algorithm on a single dataset, and the 
crosshairs represent one standard deviation on either side of the mean logarithmic losses. Points above the 
diagonal line represent better performance by PSMBg than the competing algorithm. 
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Figure 5-8: Pairwise plots of the mean squared errors of PSMBg vs. competing algorithms. Each point 
represents the mean squared errors of PSMBG and a competing algorithm on a single dataset, and the 
crosshairs represent one standard deviation on either side of the mean squared errors. Points above the diagonal 
line represent better performance by PSMBg than the competing algorithm. 
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Figure 5-9: Pairwise plots of the mean CAL scores of PSMBg vs. competing algorithms. Each point
represents the mean CAL scores of PSMBG and a competing algorithm on a single dataset, and the crosshairs
represent one standard deviation on either side of the mean CAL scores. Points above the diagonal line 
represent better performance by PSMBg than the competing algorithm. 
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Table 5-13: Average number of models in phases 1 and 2 over which averaging is carried out by the 
PSMBg and NPSMBg algorithms. Both algorithms average over the same number of models in each 
phase. Both algorithms select the same models in phase 1 but potentially different models in phase 2. The 
number of models in phases 1 and 2 is the sum of the models selected in the two phases.  
 
Dataset # models 
phase 1 
# models 
phase 2 
# models 
phases 1 
and 2 
australian 28.55 11.00 39.55 
breast-cancer 18.85 
  
10.15 29.00 
cleveland 20.45 11.99 32.44 
corral 10.65 15.03 25.68 
crx 32.10 13.42 45.52 
diabetes 11.65 10.03 21.68 
flare 20.75 11.44 32.19 
german 22.45 19.23 41.68 
glass2 12.05 13.26 25.31 
glass 15.80 10.73 26.53 
heart 18.50 11.32 29.82 
hepatitis 27.45 26.63 54.08 
iris 7.25 10.74 17.99 
lymphography 51.55 37.83 89.38 
pima 40.40 16.97 57.37 
postoperative 12.00 10.02 22.02 
sonar 11.65 10.09 21.74 
vehicle 1.15 21.09 22.24 
vote 59.80 18.44 78.24 
wine 39.30 10.73 50.03 
zoo 45.55 13.53 59.08 
pneumonia 577.00 12.52 589.52 
sepsis-d 23.80 11.45 35.25 
sepsis-s 27.00 13.63 40.63 
heart failure-d 47.00 19.07 66.07 
heart failure-c 22.00 20.92 42.92 
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5.7 EVALUATION OF THE PSMBL ALGORITHM 
This section describes the evaluation of the performance of the PSMBl algorithm and compares 
its performance to that of the PSMBg algorithm. Analogous to the PSMBg algorithm, the PSMBl 
algorithm selects MB structures for model averaging using a two-phase search where phase 2 is 
patient-specific. The difference between the two is in the model space: the PSMBl algorithm 
searches in the richer space of MB structures that explicitly represent local structure by using 
decision graphs for CPDs. The performance of the PSMBl algorithm is compared to: (1) the 
PSMBl-MS algorithm which is a model selection version of the PSMBl algorithm, (2) the 
NPSMBl algorithm which is a non-patient-specific (i.e., population-wide) version of the PSMBl 
algorithm, and (3) the PSMBg algorithm. The first two algorithms are analogous to the PSMBg-
MS and the NPSMBg algorithms. The PSMBl-MS algorithm chooses the model with the highest 
posterior probability from the set of models identified by the PSMBl algorithm, and uses that 
single model for predicting the target variable of the case at hand. The NPSMBl algorithm 
averages over the same number of models as the PSMBl algorithm except that the patient-
specific model score of phase 2 is not used to score models; instead all models are scored with 
the non-patient-specific model score of phase 1.  
5.7.1 Experimental design 
The experimental design for the evaluation the PSMBl algorithm is the same as that for the 
PSMBg algorithm and is described in section 5.6.1. 
 155 
  
5.7.2 Results 
Tables 5-15 to 5-19 report the means of the misclassification error, the AUC, logarithmic loss, 
squared error and the CAL score respectively. The last three rows in each table give for each 
algorithm the overall mean of the specified performance measure across the UCI datasets, the 
medical datasets and combined UCI and medical datasets respectively. The results are also 
plotted in Figures 5-8 and 5-9 along with the standard errors of means. Table 5-18 reports results 
from the paired-samples t test and Table 5-19 reports results from the Wilcoxon paired-samples 
signed ranks test for the combined UCI and medical datasets. The PSMBl algorithm performed 
significantly better than the PSMBl-MS algorithm on all measures except the CAL score, which 
is similar to the results obtained from the PSMBg algorithm. However, the PSMBl algorithm 
showed no improvement in performance over the NPSMBl algorithm. When compared to the 
PSMBg algorithm, the PSMBl algorithm performed at a similar level on all the measures except 
the AUC on which it performed slightly worse. 
The average running time of the PSMBl algorithm for a single test case was 
approximately 5 hours and 30 minutes (see Table 5-21). This includes time spent in both phase 1 
and 2 of the search. Typically, 80% - 90% of the running time was spent in phase 2. 
5.7.3 Discussion 
While on the synthetic dataset the PSMBl algorithm performed considerably better than the 
PSMBg algorithm, on most of the UCI datasets and on all the medical datasets it showed no 
improvement over the PSMBg algorithm. One exception is the corral dataset which is a synthetic 
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dataset with seven variables of which four deterministically determine the target variable Z as 
follows: 
)()( DCBAZ ∧∨∧= . 
Of the remaining two variables, one is correlated with Z and the other is irrelevant for predicting 
Z. On this dataset, the PSMBl algorithm significantly improved on logarithmic loss, squared 
error and the CAL score over the PSMBg algorithm while both algorithms had perfect 
performance on misclassification error and the AUC. The superior performance of the PSMBl 
algorithm stems from the fact that the deterministic function can be represented exactly by a MB 
with local structure. In fact, the PSMBl-MS algorithm which chooses the best scoring model 
performed even better since the chosen model is the generating model. 
Two possible reasons may explain the inability of the PSMBl algorithm to improve 
significantly over the performance of the PSMBg algorithm in the UCI and medical datasets. 
First, there may not be many value-specific independencies present in the datasets and the 
PSMBl algorithm may be capturing spurious value-specific independencies. Second, the patient-
specific phase 2 search as implemented in the PSMBl algorithm is not optimal. Ideally, in phase 
2 every candidate MB structure should be evaluated with the patient-specific phase 2 score. 
However, for reasons of computational efficiency, phase 2 search in the PSMBl algorithm is 
implemented as follows. At each iteration of the outer search procedure, all possible global 
operators are applied to the current best MB structure to generate successor MB structures. Then, 
for each successor MB structure, the inner search procedure is invoked on those MB nodes 
whose parent sets have been modified by the application of the global operator. For each MB 
node on which it is invoked, the inner search procedure performs greedy hill-climbing search to 
identify a decision graph with phase 1 score, rather than a decision graph with high phase 2 score 
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(see the pseudocode for ProcedureLocalSearchForPSMBl in Figure 4-9). This is because the 
phase 1 score is computed efficiently for the MB node in question, while computation of the 
phase 2 score requires doing inference in the MB and is less efficient in the current 
implementation of the PSMBl algorithm. After the inner search procedure returns decision 
graphs with high phase 1 scores, the phase 2 score is computed for the MB. A more efficient 
implementation of the PSMBl algorithm can allow the inner search procedure to evaluate 
candidate local structures with the phase 2 score, which can potentially improve its performance.  
5.8 SUMMARY 
The two patient-specific algorithms, namely, the PSMBg and the PSMBl algorithms, were 
evaluated on one synthetic, 21 UCI and three medical datasets. Their performances on five 
measures were compared to that of non-patient-specific and model selection versions as well six 
commonly used predictive algorithms.  
The PSMBg algorithm improved the prediction of the target variable on average over all 
the comparison algorithms. The greatest improvements occurred in logarithmic loss and squared 
error, followed by good improvement in calibration and smaller improvements in 
misclassification error and the AUC. In addition, the PSMBg algorithm that performs Bayesian 
model averaging in conjunction with the patient-specific heuristic had better performance than 
either model selection with the patient-specific heuristic or non-patient-specific Bayesian model 
averaging. 
The PSMBl algorithm did not improve significantly over the PSMBg algorithm on any 
measure. In addition, the PSMBl algorithm that performs Bayesian model averaging in 
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conjunction with the patient-specific heuristic had better performance than model selection with 
the patient-specific heuristic but performed on par with non-patient-specific Bayesian model 
averaging. The use of local structure did not lead to significant improvements over the use of 
global structure alone. Possible reasons for this lack of improvement were given in the previous 
section. 
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Table 5-14: Mean misclassification errors of 
different algorithms based on 10-fold cross-
validation done twice on the UCI datasets and a 
single train-test validation on the medical 
datasets. To avoid cluttering only the mean for 
each dataset is shown. The bottom three rows 
give the average misclassification errors for the 
UCI datasets, for the medical datasets and for all 
the datasets respectively. Best results are 
underlined. 
Table 5-15: Mean AUCs of different algorithms 
based on 10-fold cross-validation done twice on 
the UCI datasets and a single train-test 
validation on the medical datasets. To avoid 
cluttering only the mean for each dataset is 
shown. The bottom three rows give the average 
AUCs for the UCI datasets, for the medical 
datasets and for all the datasets respectively. 
Best results are underlined. 
 
Dataset PSMBl PSMBl-MS 
NPSMBl PSMBg
australian 0.1428 0.1457 0.1428 0.1457
breast-cancer 0.0264 0.0271 0.0271 0.0256 
cleveland 0.1723 0.1774 0.1807 0.1740
corral 0.0000 0.0000 0.0000 0.0000 
crx 0.1455 0.1462 0.1386 0.1547
diabetes 0.2188 0.2194 0.2168 0.2116 
flare 0.1820 0.1815 0.1801 0.1806
german 0.2480 0.2460 0.2475 0.2580
glass2 0.1718 0.1718 0.1840 0.1503 
glass 0.2734 0.2850 0.2734 0.2150 
heart 0.1704 0.1741 0.1759 0.1778
hepatitis 0.1438 0.1375 0.1500 0.0938 
iris 0.0533 0.0533 0.0533 0.0567
lymphography 0.1486 0.1588 0.1520 0.1622
pima 0.2155 0.2148 0.2129 0.2155
postoperative 0.2989 0.2989 0.2989 0.3391
sonar 0.1731 0.1755 0.1731 0.1635 
vehicle 0.2902 0.2908 0.2931 0.2600 
vote 0.0603 0.0625 0.0647 0.0453 
wine 0.0140 0.0140 0.0140 0.0084 
zoo 0.0396 0.0396 0.0396 0.0347 
pneumonia 0.1530 0.1545 0.1532 0.1531
sepsis-d 0.1022 0.1022 0.1022 0.0986 
sepsis-s 0.2079 0.2133 0.2061 0.2294
heart failure-d 0.0467 0.0479 0.0466 0.0462 
heart failure-c 0.1241 0.1255 0.1244 0.1246
UCI average 0.1518 0.1533 0.1533 0.1463 
medical average 0.1268 0.1287 0.1265 0.1304
overall average 0.1521 0.1537 0.1533 0.1478 
Dataset PSMBl PSMBl-MS 
NPSMBl PSMBg
australian 0.9209 0.9189 0.9208 0.9315 
breast-cancer 0.9910 0.9907 0.9910 0.9926 
cleveland 0.9049 0.9035 0.9036 0.9098 
corral 1.0000 1.0000 1.0000 1.0000 
crx 0.9242 0.9231 0.9262 0.9303 
diabetes 0.8436 0.8425 0.8451 0.8468 
flare 0.7140 0.7138 0.7185 0.7289 
german 0.7662 0.7659 0.7667 0.7662
glass2 0.8763 0.8752 0.8757 0.8703
glass 0.9242 0.9214 0.9244 0.9364 
heart 0.9076 0.9076 0.9081 0.9055
hepatitis 0.8312 0.8243 0.8203 0.9225 
iris 0.9930 0.9938 0.9930 0.9890
lymphography 0.9124 0.9195 0.9195 0.9139
pima 0.8444 0.8444 0.8449 0.8431
postoperative 0.4363 0.4346 0.4324 0.5026 
sonar 0.9292 0.9253 0.9332 0.9203
vehicle 0.9135 0.9134 0.9131 0.9234 
vote 0.9822 0.9813 0.9808 0.9875 
wine 1.0000 1.0000 1.0000 0.9994
zoo 0.9879 0.9871 0.9865 0.9994 
pneumonia 0.8232 0.8241 0.8238 0.8236
sepsis-d 0.8597 0.8583 0.8549 0.8619 
sepsis-s 0.7594 0.7617 0.7609 0.7689 
heart failure-d 0.7465 0.7472 0.7464 0.7457
heart failure-c 0.7702 0.7717 0.7711 0.7709
UCI average 0.8859 0.8851 0.8859 0.8962 
medical average 0.7918 0.7926 0.7914 0.7942 
overall average 0.8792 0.8785 0.8791 0.8786 
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Table 5-16: Mean squared errors of different 
algorithms based on 10-fold cross-validation 
done twice on the UCI datasets and a single 
train-test validation on the medical datasets. To 
avoid cluttering only the mean for each dataset 
is shown. The bottom three rows give the 
average squared errors for the UCI datasets, for 
the medical datasets and for all the datasets 
respectively. Best results are in underlined. 
 
Table 5-17: Mean logarithmic losses of 
different algorithms based on 10-fold cross-
validation done twice on the UCI datasets and a 
single train-test validation on the medical 
datasets. To avoid cluttering only the mean for 
each dataset is shown. The bottom three rows 
give the average logarithmic losses for the UCI 
datasets, for the medical datasets and for all the 
datasets respectively. Best results are underlined. 
Dataset PSMBl PSMBl-MS 
NPSMBl PSMBg
australian 0.3589 0.3651 0.3607 0.3390 
breast-cancer 0.1206 0.1248 0.1239 0.1068 
cleveland 0.4205 0.4337 0.4276 0.3925 
corral 0.0457 0.0290 0.0425 0.1018
crx 0.3683 0.3753 0.3673 0.3451 
diabetes 0.4655 0.4671 0.4644 0.4601 
flare 0.4365 0.4385 0.4346 0.4282 
german 0.5221 0.5240 0.5221 0.5331
glass2 0.4571 0.4574 0.4611 0.4238 
glass 0.7598 0.7650 0.7598 0.7112 
heart 0.3998 0.4026 0.3999 0.3996 
hepatitis 0.4200 0.4949 0.4960 0.2396 
iris 0.1618 0.1614 0.1619 0.1560 
lymphography 0.4164 0.4445 0.4328 0.4100 
pima 0.4632 0.4641 0.4627 0.4647
postoperative 0.6882 0.6948 0.6881 0.7381
sonar 0.3334 0.3541 0.3310 0.3573
vehicle 0.5986 0.5994 0.5975 0.5863 
vote 0.1848 0.2024 0.2040 0.1393 
wine 0.0227 0.0286 0.0226 0.0418
zoo 0.1256 0.1256 0.1255 0.1297
pneumonia 0.5748 0.5751 0.5746 0.5728 
sepsis-d 0.2586 0.2597 0.2610 0.2525 
sepsis-s 0.4704 0.4717 0.4642 0.4726
heart failure-d 0.3170 0.3181 0.3170 0.3174
heart failure-c 0.1692 0.1697 0.1691 0.1690 
UCI average 0.3700 0.3787 0.3755 0.3573 
medical average 0.3580 0.3589 0.3572 0.3569 
overall average 0.3695 0.3776 0.3744 0.3572 
Dataset PSMBl PSMBl-MS 
NPSMBl PSMBg
australian 0.2137 0.2166 0.2140 0.2054 
breast-cancer 0.0445 0.0444 0.0458 0.0440 
cleveland 0.2535 0.2596 0.2574 0.2433 
corral 0.0086 0.0051 0.0074 0.0352
crx 0.2132 0.2164 0.2098 0.2081 
diabetes 0.3012 0.3028 0.3007 0.2978 
flare 0.2679 0.2691 0.2671 0.2619 
german 0.3444 0.3450 0.3439 0.3526
glass2 0.2577 0.2574 0.2619 0.2469 
glass 0.3745 0.3769 0.3745 0.3609 
heart 0.2429 0.2449 0.2438 0.2444
hepatitis 0.2084 0.2315 0.2295 0.1410 
iris 0.0758 0.0757 0.0759 0.0727 
lymphography 0.2350 0.2441 0.2391 0.2391
pima 0.3009 0.3013 0.3001 0.3009
postoperative 0.4386 0.4429 0.4385 0.4772
sonar 0.2201 0.2301 0.2179 0.2349
vehicle 0.3580 0.3585 0.3577 0.3471 
vote 0.0958 0.1024 0.1056 0.0788 
wine 0.0160 0.0184 0.0156 0.0183
zoo 0.0632 0.0656 0.0632 0.0612 
pneumonia 0.2452 0.2463 0.2451 0.2442 
sepsis-d 0.1579 0.1581 0.1590 0.1501 
sepsis-s 0.3077 0.3083 0.3030 0.3120
heart failure-d 0.0842 0.0849 0.0842 0.0839 
heart failure-c 0.1882 0.1893 0.1884 0.1883
UCI average 0.2159 0.2159 0.2176 0.2129 
medical average 0.1966 0.1974 0.1959 0.1957 
overall average 0.2174 0.2207 0.2188 0.2145 
  
Table 5-18: Mean CAL scores of different 
algorithms based on 10-fold cross-validation done 
twice on the UCI datasets and a single train-test 
validation on the medical datasets. To avoid 
cluttering only the mean for each dataset is shown. 
The bottom three rows give the average CAL scores 
for the UCI datasets, for the medical datasets and for 
all the datasets respectively. Best results are 
underlined. 
 
 
 
 
PSMBl NPSMBl PSMBgPSMBl-
MS  Dataset 
0.0380 0.0436 0.0409 0.0470australian  
0.0139 0.0141 0.0147 0.0146breast-cancer  
0.0672 0.0775 0.0716 0.0497cleveland   
0.0255 0.0190 0.0240 0.0583corral  
0.0438 0.0473 0.0451 0.0452crx  
0.0451 0.0447 0.0391 0.0403diabetes 
 
 
0.0581 0.0600 0.0558 0.0551flare  
0.0533 0.0576 0.0515 0.0684german  
0.0580 0.0466 0.0547 0.0359glass2  
 0.0274 0.0282 0.0274 0.0188glass  
0.0574 0.0625 0.0586 0.0498heart  
0.0401 0.0445 0.0366 0.0422hepatitis  
0.0139 0.0135 0.0140 0.0110iris   
0.0212 0.0264 0.0247 0.0226lymphography  
0.0458 0.0542 0.05320.0496pima  
0.0547 0.0482 0.0552 0.0404postoperative  
 0.0561 0.0650 0.0609 0.0437sonar  
0.0300 0.0303 0.0306 0.0479vehicle  
0.0289 0.0322 0.0337 0.0247vote  
0.0085 0.0079 0.0078 0.0062  wine  
0.0058 0.0057 0.0058 0.0065zoo  
0.0994 0.0999 0.0995 0.0998pneumonia  
0.0323 0.0314 0.0314 0.0353sepsis-d   
 
0.0608 0.0676 0.0519 0.0627sepsis-s  
0.0255 0.0264 0.0258 0.0263heart failure-d  
0.0530 0.0538 0.0531 0.0533heart failure-c  
   UCI average 0.0379 0.0391 0.0384 0.0372 
medical average 0.0542 0.0558 0.0523 0.0555 
  
overall average 0.0387 0.0400 0.0387 0.0382 
 162 
  
Table 5-19: Wilcoxon paired-samples signed ranks test comparing the performance of PSMBl with other 
algorithms. For each performance measure the number on top is the Z statistic and the number at the 
bottom is the corresponding p-value. The Z statistic is negative when PSMBl has a lower score on a 
performance measure than the competing algorithm. On all measures except the AUC, a negative Z 
statistic indicates better performance by PSMBl; on the AUC a positive Z statistic indicates better 
performance by PSMBl. Underlined results indicate p-values of 0.05 or smaller. 
  Performance 
measure 
PSMBl-
MS NPSMBl PSMBg
-2.122 -1.350 -0.695 Misclassification 
error 0.034 0.177 0.487    
2.235 0.282 -2.581 
AUC 
0.025 0.778 0.010  
-3.458 -0.766 -1.430 
Logarithmic loss
0.001 0.444 0.153  
-3.469 -0.539 -1.120 
Squared error 
0.001 0.539 0.263    
-1.278 -0.243 -0.532 
CAL score 
0.201 0.808 0.594 
 
Table 5-20: Paired-samples t test comparing the performance of PSMBl with other algorithms. For each 
performance measure the number on top is the mean difference between PSMBl and the indicated 
algorithm and the number at the bottom is the corresponding p-value. The mean difference is negative 
when PSMBl has a lower score on a performance measure than the competing algorithm. On all measures
except the AUC, a negative mean difference indicates better performance by PSMBl; on the AUC a 
positive mean difference indicates better performance by PSMBl. Underlined results indicate p-values of 
0.05 or smaller. 
Performance 
measure 
PSMBl-
MS NPSMBl PSMBg
  -0.002 -0.001 0.004 Misclassification 
error 0.056 0.163 0.343 
0.001 0.000 -0.010 
AUC 
0.0490.193 0.881  
-0.008 -0.005 0.012   Logarithmic loss
0.033 0.169 0.222  
  -0.003 -0.001 0.002 
Squared error 
0.007 0.213 0.478  
-0.001 0.000 0.000 
CAL score   0.233 0.971 0.860 
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Table 5-21: Approximate running times of the various algorithms. For each algorithm, the time shown is 
the average running time for a single test case over all the UCI and medical datasets. For both population-
wide and the patient-specific algorithms the running time includes the time for learning the model and for 
doing inference for the target variable of the test case. 
Average running time for a 
test case Algorithm  
Naïve Bayes < 1 minute 
Decision Tree (Classification Tree) < 1 minute 
Logistic Regression < 1 minute 
Neural Networks < 1 minute 
  k-Nearest Neighbor < 1 minute 
Lazy Bayesian Rule ~ 1 minute 
  PSMBg ~ 1 hour 30 minutes 
PSMBl ~ 5 hours 30 minutes 
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Figure 5-10: Pairwise plots of the mean misclassification errors (top row), mean AUCs (middle row) and 
mean logarithmic losses (bottom row) of PSMBl vs. competing algorithms. Each point represents the mean 
score of PSMBl and a competing algorithm on a single dataset, and the crosshairs represent one standard 
deviation on either side of the mean score. Points above the diagonal line represent better performance by 
PSMBl than the competing algorithm. 
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Figure 5-11: Pairwise plots of the mean squared errors (top row) and the mean CAL scores (bottom row) of 
PSMBl vs. competing algorithms. Each point represents the mean score of PSMBl and a competing algorithm 
on a single dataset, and the crosshairs represent one standard deviation on either side of the mean score. Points 
above the diagonal line represent better performance by PSMBl than the competing algorithm. 
  
 166 
  
6.0  CONCLUSIONS 
In this dissertation, I presented a new framework for learning predictive models that is 
characterized by the use of a patient-specific heuristic in selecting models for Bayesian model 
averaging (BMA). I implemented two basic algorithms using Bayesian network Markov blanket 
(MB) models and evaluated them extensively on several datasets. The patient-specific algorithms 
were able to better predict the target by improving on probabilistic, discriminative and 
calibration measures when compared to several commonly used machine learning methods. A 
summary of the findings is presented in the next section followed by some directions for future 
work in the last section. 
6.1 CONTRIBUTIONS AND FINDINGS 
This section summarizes the main contributions and the experimental results of the research 
presented in this dissertation. 
This dissertation described the development and evaluation of a new approach for 
learning predictive models that are relevant to a single patient case. The new patient-specific 
methods that were developed use Bayesian network models, carry out selective Bayesian model 
averaging to predict the outcome of interest for the patient case at hand, and employ a patient-
specific heuristic to locate a set of suitable models to average over. The main contribution is the 
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development of a new search heuristic for identifying models over which to perform Bayesian 
model averaging that is guided by the features of the patient case at hand. This heuristic was 
implemented in two algorithms, namely, the patient-specific Markov blanket (global) (PSMBg) 
and the patient-specific Markov blanket (local) (PSMBl) algorithms. Both algorithms employ the 
patient-specific heuristic to select models in the space of MB structures but differ in the model 
space. The difference between the model spaces of the two algorithms lies in the representation 
used for the CPDs: the PSMBg algorithm uses conditional probability tables (CPTs) that capture 
explicitly only the global structure while the PSMBl algorithm uses decision graphs that capture 
explicitly global and local structure. Given a set of parents, a node in a MB structure has only 
one global structure represented by a CPT but has several distinct local structures represented by 
decision graphs. Since the global structure is equivalent to one of the possible local structures, 
the model space of the PSMBg algorithm is a subset of that of the PSMBl algorithm.  
A second contribution is the development of new operators to traverse the space of MB 
structures; these operators are modifications of operators used in existing techniques for learning 
general Bayesian network structures.  
A third contribution is the development of a new hierarchical structure prior for BNs and 
MBs with local decision graph structures that penalizes complex decision graph structures over 
simpler ones. This structure prior is used in computing the Bayesian score that is used by the 
PSMBl algorithm.  
The experimental results demonstrate that the PSMBg algorithm improves prediction of 
the target variable on a variety of performance measures when compared to several population-
wide predictive algorithms. The greatest improvements occur in logarithmic loss and squared 
error, followed by good improvement in calibration and smaller improvements in 
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misclassification error and the AUC. Bayesian model averaging has better performance than 
Bayesian model selection, and within model averaging, patient-specific Bayesian model 
averaging has better performance than non-patient-specific Bayesian model averaging though the 
improvement is not as large as that of model averaging over model selection. 
The PSMBl algorithm also improves prediction of the target variable when compared to 
several population-wide predictive algorithms. However, it did not significantly improve on the 
performance of the PSMBg algorithm on any measure.  
Overall, Bayesian model averaging in conjunction with patient-specific search led to 
better performance than either non-patient-specific Bayesian model averaging or patient-specific 
search for a single good model. However, the use of local structure did not lead to significant 
improvements over the use of global structure alone. The implementation of patient-specific 
phase 2 in the PSMBl algorithm may have limited the performance of local structures. 
6.2 DISCUSSION 
This section summarizes some of the key aspects of the patient-specific method. The essence of 
the patient-specific method lies in the model score used in phase 2 of the search. This score is 
sensitive to both the posterior probability of the model and the predicted distribution for the 
outcome variable of the patient case at hand (see Equations 4.17 and 4.16). Typically, methods 
that evaluate models with a score employ a score that is sensitive only to the fit of the model to 
the training data and not to the prediction of the outcome variable.  
Several situations are possible where the patient-specific method has no advantage over a 
population-wide method. As one example, in a domain where complete BMA is tractable and 
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model averaging is carried out over all models in the model space, a search heuristic that selects 
a subset of models such as the one used by the patient-specific method is superfluous. Typically, 
in real life domains complete BMA over all models is not tractable due to the enormous number 
of models in the model space. Thus, the patient-specific method is useful for selective model 
averaging where it identifies a potentially relevant set of models that is predictive of the patient 
case at hand. As another example, in a domain where features that are relevant are commonly 
present, selection of relevant variables may not be a problem. In such a situation, the variables 
selected by a population-wide method are likely to be relevant for predicting any future case and 
the patient-specific method that performs model selection will likely select the same set of 
variables for each new case. 
There are several open questions regarding the behavior of the patient-specific method. 
Characterizing the bias of the selective model averaged prediction of the patient-specific method 
is an open problem. In contrast, the bias of selective BMA over models that are chosen randomly 
is low. However, the variance of selective BMA over models that are chosen randomly is likely 
to be much larger than the variance of selective BMA over models chosen by the patient-specific 
method which is constrained to prefer models that are good fit to the training data. 
Another open issue is the comparison of the performance of patient-specific selective 
BMA to that of other ensemble methods. Ensemble methods construct a set of predictive models 
that predict the target variable for a new case by taking a weighted average of their predictions. 
In addition to BMA, examples of other ensemble methods include bagging, boosting and 
stacking [107, 108]. Boosting, in particular, has been shown to improve on the performance of a 
single model for classification and for predictive tasks. Boosting selects a new model by 
weighting more those training cases that have been misclassified by the models selected 
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previously. The patient-specific method described in this dissertation selects a new model that 
disagrees considerably with the predictions of models selected previously. Thus, both methods 
select a set of models that are diverse with respect to different heuristics. 
6.3 FUTURE WORK 
The experimental work presented in this research is intended as a first step in exploring the 
utility of the patient-specific framework. Several extensions and directions for future work are 
feasible. 
Efficient computation of phase 2 score. In the current implementation of the PSMBl 
algorithm, the inner search procedure in phase 2 search evaluates candidate local structures with 
the non-patient-specific phase 1 score rather than the patient-specific phase 2 score. Only the 
local decision graph structure that has the highest phase 1 score is evaluated with the phase 2 
score.  Ideally, the patient-specific phase 2 score should be computed for every candidate local 
structure that is encountered by the inner search procedure. In the current implementation, 
computation of the phase 2 score is less efficient than the computation of the phase 1 score. More 
efficient implementations of the phase 2 score with caching of intermediate computational results 
will enable the scoring of all local structures.  
Unified search. The encapsulated search strategy employed by the PSMBl algorithm 
decouples the problem of network structure learning (global structure) from that of learning the 
CPD structures (local structure). However, this strategy typically leads to considerable 
duplication of effort. This arises due to the repetitive characteristic of the inner search procedure: 
the search for local structure of the CPD is restarted with every addition of a new parent. Often, 
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the new parent is irrelevant and will be discarded when the local structure is learned. Unified 
search employs a single search procedure with operators that modify explicitly only the local 
structure, since a set of local structures is sufficient to determine the global structure. Unified 
search will typically learn the local structure of a MB node only once and is potentially more 
efficient. However, the downside of unified search is that operations like reversing an arc in the 
global structure are not well defined. 
Alternative dissimilarity metric for phase 2 scores. The computation of the phase 2 
score (See Equation 4.17) requires a dissimilarity metric to compare the predictive distributions 
of the target variable in candidate MB structures. The current implementation of the PSMB 
algorithms use KL divergence as the dissimilarity metric. The experimental results indicate that 
KL divergence optimizes most logarithmic loss since the largest improvement in performance is 
observed on this measure. Alternative dissimilarity metrics may optimize other performance 
measures. The following dissimilarity metric, for example, has the potential for optimizing 
misclassification error: 
)',|(max),|(max)',( MZPMZPMMf tt XX −= , 
where the phase 2 score, , for the candidate model M’ is the absolute value of the 
difference in the maximum probabilities achieved in the distributions for the target Zt estimated 
by the current model M and the candidate model M’. 
)',( MMf
Alternative models. The patient-specific framework is a general formulation and any 
statistical model can be substituted for MB structures. Alternative models that would be 
interesting to explore include logistic regression models and decision trees. 
Comparison with other ensemble techniques. Several non-Bayesian ensemble 
techniques such as bagging, boosting and stacking have been shown to improve on the 
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performance of a single model for classification and for predictive tasks. Further comparisons 
between patient-specific selective Bayesian model averaging and these non-Bayesian ensemble 
techniques would be worthwhile. 
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APPENDIX 
COUNTING MARKOV BLANKET STRUCTURES 
This section gives the derivation of a formula for counting the number of possible Markov 
blanket (MB) structures with respect to a specified domain variable. 
The MB of a node in a Bayesian network (BN) consists of its parents, its children, and 
the parents of its children (spouses). With respect to a MB, the nodes can be categorized into five 
groups: (1) the target node, (2) parent nodes of the target, (3) child nodes of the target, (4) 
spousal nodes, which are parent nodes of the children, and (5) other nodes, which are not part of 
the MB. The node under consideration is called the target node. A parent node is one that has an 
outgoing arc to the target node and may have additional outgoing arcs to one or more child 
nodes. A child node is one that has an incoming arc from the target node, may have additional 
incoming arcs from parent nodes, spousal nodes and other child nodes, and may have outgoing 
arcs to other child nodes. A spousal node is one that has outgoing arcs to one or more child 
nodes and has neither an incoming arc from the target node nor an outgoing arc to the target 
node. An other node is one that is not in the MB and is considered to be a potential spousal node. 
An example demonstrating the various types of nodes in a MB is given in Figure A-1.  
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The number of possible Markov blanket structures for a domain with m variables (where 
m excludes the target variable) is given by the following equation: 
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where, mp is number of parent nodes, mc is the number of child nodes, mso is the number of 
spousal and other nodes, and m = mp + mc + mso. BN(mc) is the number of DAGs that can be 
constructed from mc nodes. The number of DAGs that can be constructed from n variables is 
given by the following recurrence formula [73, 74]: 
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,  (A.2) 
where C(n, k) is the count of the number ways to choose k objects from n distinct objects. 
Equation A.1 is derived as follows. The terms inside the double summation count the 
number of MB structures for a specified number of mp, mc and mso nodes. The first term gives the 
number of ways m can be partitioned into mp parent nodes, mc child nodes and mso spousal and 
other nodes. The second term gives the number of distinct MB structures that differ only in the 
P 
Figure A-1: An example of a Markov blanket demonstrating various node types. T is the target 
node, P is a parent node, C is a child node, S is a spousal node, and O is an other node. 
P S O T 
C C 
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presence or absence of arcs from parent nodes to child nodes. Each parent node can have an arc 
to none, one or more child nodes for a total of  distinct MB structures. For mp parent nodes, 
the number of distinct MB structures that differ only in the presence or absence of arcs from 
parent nodes to child nodes is . The third term gives the number of distinct MB structures 
that differ only in the presence or absence of arcs from spousal and other nodes to child nodes. 
This derivation is similar to the derivation of the previous term. Each spousal or other node can 
have an arc to none, one or more child nodes for a total of  distinct MB structures. For mso 
spousal or other nodes, the number of distinct MB structures that differ only in the presence or 
absence of arcs from spousal or other nodes to child nodes is . The fourth and last term 
gives the number of DAGs that can be formed with mc child nodes. The summation is carried 
over all possible values of mp and mc; selection of particular values for mp and mc determines the 
value of mso and hence no explicit summation is required over the values of mso.  
cm2
pcmm2
som2
2 soc mm
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